{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "d8fb5b29-8444-4372-af75-4c5d45f92c04",
   "metadata": {},
   "outputs": [],
   "source": [
    "from Bio import Entrez\n",
    "import pandas as pd\n",
    "from time import sleep\n",
    "from datetime import datetime"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "82159ddc-dc97-48e4-92ef-ab40b2eec5b8",
   "metadata": {},
   "outputs": [],
   "source": [
    "def fetch_papers(query: str, max_results: int = 10) -> list:\n",
    "    # Fetch papers from PubMed with query\n",
    "    Entrez.email = \"zanwarpratham@gmail.com\"\n",
    "    try:\n",
    "        # Search PubMed\n",
    "        handle = Entrez.esearch(db=\"pubmed\", term=query, retmax=max_results)\n",
    "        search_results = Entrez.read(handle)\n",
    "        handle.close()\n",
    "\n",
    "        # Fetch details for each paper\n",
    "        id_list = search_results[\"IdList\"]\n",
    "        handle = Entrez.efetch(db=\"pubmed\", id=\",\".join(id_list), retmode=\"xml\")\n",
    "        sleep(1)\n",
    "        papers = Entrez.read(handle)\n",
    "        handle.close()\n",
    "\n",
    "        return papers[\"PubmedArticle\"]\n",
    "    except Exception as e:\n",
    "        print(f\"Error fetching papers: {e}\")\n",
    "        return []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "b57af404-97ea-48a1-927c-ba0163eed02b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('CpG oligodeoxynucleotide', attributes={'MajorTopicYN': 'N'}), StringElement('E6', attributes={'MajorTopicYN': 'N'}), StringElement('E7', attributes={'MajorTopicYN': 'N'}), StringElement('HPV DNA vaccine', attributes={'MajorTopicYN': 'N'}), StringElement('HSP70', attributes={'MajorTopicYN': 'N'}), StringElement('IL-28B gene adjuvant', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780219', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '09'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s12985-024-02604-7', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1743-422X', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '22', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Virology journal', 'ISOAbbreviation': 'Virol J'}, 'ArticleTitle': 'Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant.', 'Pagination': {'StartPage': '3', 'MedlinePgn': '3'}, 'Abstract': {'AbstractText': ['Therapeutic human papillomavirus (HPV) DNA vaccine is an attractive option to control existed HPV infection and related lesions. The two early viral oncoproteins, E6 and E7, are continuously expressed in most HPV-related pre- and cancerous cells, and are ideal targets for therapeutic vaccines. We have previously developed an HPV 16 DNA vaccine encoding a modified E7/HSP70 (mE7/HSP70) fusion protein, which demonstrated significant antitumor effects in murine models. In this study, we employed multifaceted approach to enhance the potency of the HPV16 DNA vaccine. Strategies including inserting CpG oligodeoxynucleotide (CpG ODNs) into the vaccine vector backbone, selecting cytokine gene adjuvants, combining plasmids encoding mE6/HSP70 and mE7/HSP70, and utilizing electroporation for vaccination. Our findings revealed that mice immunized with CpG-modified vaccines, coupled with an IL-28B gene adjuvant exhibited heightened antigen-specific CD8<sup>+</sup> T cell responses. Additionally, the combination of mE6/HSP70 and mE7/HSP70 plasmids synergistically enhanced the specific CD8<sup>+</sup> T cell response. Furthermore, vaccination with CpG-modified mE7/HSP70 and mE6/HSP70 plasmids, alongside the Interleukin-28B (IL-28B) gene adjuvant, generated substantial preventive and therapeutic antitumor effects against HPV E6- and E7-expressing tumors in C57BL/6 mice. These results suggested that integrating these multiple strategies into an HPV DNA vaccine holds promise for effectively controlling HPV infection and related diseases.'], 'CopyrightInformation': '© 2024. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.'}, {'Identifier': [], 'Affiliation': 'Department of Immunology, Hebei North University, Zhangjiakou, China.'}], 'Identifier': [], 'LastName': 'Zhou', 'ForeName': 'Yan', 'Initials': 'Y'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.'}], 'Identifier': [], 'LastName': 'Zhang', 'ForeName': 'Ting', 'Initials': 'T'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.'}], 'Identifier': [], 'LastName': 'Wang', 'ForeName': 'Zhirong', 'Initials': 'Z'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China. xuemeixu@vip.sina.com.'}], 'Identifier': [], 'LastName': 'Xu', 'ForeName': 'Xuemei', 'Initials': 'X'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': 'JYT2022005', 'Agency': 'the basic scientific research business of Hebei North University', 'Country': ''}, {'GrantID': 'No. 2021-I2M-1-043', 'Agency': 'CAMS Innovation Fund for Medical Sciences', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'Virol J', 'NlmUniqueID': '101231645', 'ISSNLinking': '1743-422X'}, 'CoiStatement': 'Declarations. Ethical approval: This study was approved by the Ethical Committee of Hebei North University (Approval No. HBNU20231222116). Consent for publication: All authors approved the publication of this manuscript. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'de Sanjosé S, Brotons M, Pavón MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13. PMID:28964706.', 'ArticleIdList': [StringElement('28964706', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.bpobgyn.2017.08.015', attributes={'IdType': 'doi'})]}, {'Citation': 'Cheng MA, Farmer E, Huang C, Lin J, Hung CF, Wu TC. Therapeutic DNA vaccines for human Papillomavirus and associated diseases. Hum Gene Ther. 2018;29(9):971–96. PMID: 29316817. PMCID: PMC6152857.', 'ArticleIdList': [StringElement('29316817', attributes={'IdType': 'pubmed'}), StringElement('6152857', attributes={'IdType': 'pmc'}), StringElement('10.1089/hum.2017.197', attributes={'IdType': 'doi'})]}, {'Citation': 'Orbegoso C, Murali K, Banerjee S. The current status of immunotherapy for cervical cancer. Rep Pract Oncol Radiother. 2018;23(6):580–588. PMID: 30534022. PMCID: PMC6277269.'}, {'Citation': 'Lee SJ, Yang A, Wu TC. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. J Gynecol Oncol. 2016;27(5):e51. PMID: 27329199. PMCID: PMC4944018.', 'ArticleIdList': [StringElement('27329199', attributes={'IdType': 'pubmed'}), StringElement('4944018', attributes={'IdType': 'pmc'}), StringElement('10.3802/jgo.2016.27.e51', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim TJ, Jin HT, Hur SY, Yang HG. Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients. Nat Commun. 2014;5:5317. PMID: 25354725. PMCID: PMC4220493.', 'ArticleIdList': [StringElement('25354725', attributes={'IdType': 'pubmed'}), StringElement('10.1038/ncomms6317', attributes={'IdType': 'doi'})]}, {'Citation': 'Choi YJ, Hur SY, Kim TJ, A Phase II, Prospective. Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3. Clin Cancer Res. 2020;26(7):1616–23. PMID:31727676.', 'ArticleIdList': [StringElement('31727676', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-19-1513', attributes={'IdType': 'doi'})]}, {'Citation': 'Trimble CL, Morrow MP, Kraynyak KA. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasis 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet. 2015;386(10008):2078–2088. PMID: 26386540. PMCID: PMC4888059.'}, {'Citation': 'Aggarwal C, Cohen RB, Morrow MP, Kraynyak KA, Sylvester AJ, Knoblock DM, et al. Immunotherapy targeting HPV16/18 generates potent immune responses in HPV-associated head and neck cancer. Clin Cancer Res. 2019;25(1):110–24. PMID: 30242022. PMCID: PMC6320307.', 'ArticleIdList': [StringElement('30242022', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-18-1763', attributes={'IdType': 'doi'})]}, {'Citation': 'Youn JW, Hur SY, Woo JW, Kim YM, Lim MC, Park SY, et al. Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial. Lancet Oncol. 2020;21(12):1653–60. PMID: 33271094.'}, {'Citation': 'Zong JB, PENG QL, WANG QY, et al. Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8<sup>+</sup> T cell responses and anti-tumor effects. Oncol Rep. 2009;22(4):953–61. PMID:19724878.', 'ArticleIdList': [StringElement('19724878', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang QY, Xu YF, Fan DS et al. Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8<sup>+</sup> T-lymphocyte induction and anti-tumor activity of DNA vaccine. Zhong guo Yi Xue Ke Xue Yuan Xue Bao. 2007;29(5):584\\u2009–\\u200991. (Article in Chinese). PMID: 18051710.'}, {'Citation': 'de Oliveira LM, Morale MG, Chaves AA, et al. Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine. PLoS ONE. 2015;10(9):e0138686. 2015.PMID: 26390407.', 'ArticleIdList': [StringElement('26390407', attributes={'IdType': 'pubmed'}), StringElement('4577214', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0138686', attributes={'IdType': 'doi'})]}, {'Citation': 'Thomas KJ, Smith KL, Youde SJ, et al. HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function. Int J Cancer. 2008;122(12):2791–9. PMID: 18366058.', 'ArticleIdList': [StringElement('18366058', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ijc.23475', attributes={'IdType': 'doi'})]}, {'Citation': 'Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jongh BM, Drijfhout JW, ter Schegget J, Melief CM, Kast MW. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol. 1993;23(9):2242–9. PMID: 7690326.', 'ArticleIdList': [StringElement('7690326', attributes={'IdType': 'pubmed'}), StringElement('10.1002/eji.1830230929', attributes={'IdType': 'doi'})]}, {'Citation': 'Lipford GB, Bauer S, Wagner H, Heeg K. Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumor antigen, E6. Immunology. 1995;84(2):298–303. PMID: 7751006.', 'ArticleIdList': [StringElement('7751006', attributes={'IdType': 'pubmed'}), StringElement('1415088', attributes={'IdType': 'pmc'})]}, {'Citation': 'Gao F, Zheng M, Fan J. A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants. Hum Vaccin Immunother. 2023;19(1):2186110. PMID: 36882925.', 'ArticleIdList': [StringElement('36882925', attributes={'IdType': 'pubmed'}), StringElement('10026892', attributes={'IdType': 'pmc'}), StringElement('10.1080/21645515.2023.2186110', attributes={'IdType': 'doi'})]}, {'Citation': 'Kayraklioglu N, Horuluoglu B, Klinman DM. CpG Oligonucleotides as Vaccine Adjuvants. Methods Mol Biol. 2021;2197:51–85. PMID: 32827132.', 'ArticleIdList': [StringElement('32827132', attributes={'IdType': 'pubmed'}), StringElement('10.1007/978-1-0716-0872-2_4', attributes={'IdType': 'doi'})]}, {'Citation': 'Yu YZ, Ma Y, Xu WH, et al. Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines. Med Microbiol Immunol. 2015;204:481–91. PMID:25265876.', 'ArticleIdList': [StringElement('25265876', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00430-014-0359-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines. 2012;11(2):189–209. PMID: 22309668. PMCID: PMC3293989.', 'ArticleIdList': [StringElement('22309668', attributes={'IdType': 'pubmed'}), StringElement('3293989', attributes={'IdType': 'pmc'}), StringElement('10.1586/erv.11.188', attributes={'IdType': 'doi'})]}, {'Citation': 'Grasse M, Meryk A, Miggitsch C, Grubeck-Loebenstein B. GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine. Vaccine. 2018;36:4672–80. PMID: 29961602. PMCID: PMC7116485.', 'ArticleIdList': [StringElement('29961602', attributes={'IdType': 'pubmed'}), StringElement('7116485', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.vaccine.2018.06.033', attributes={'IdType': 'doi'})]}, {'Citation': 'Suschak JJ, Shoemaker KBCJ, et al. The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice. J Infect Dis. 2018;218(suppl5):S519–S. 527.PMID:30053157.', 'ArticleIdList': [StringElement('30053157', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Klinman DM, Klaschik S, Sato T, Tross D. CpG oligonucleotides as adjuvants for vaccines targeting infectious disease. Adv Drug Deliv Rev. 2009;61(3):248–55. PMID:19272313.', 'ArticleIdList': [StringElement('19272313', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.addr.2008.12.012', attributes={'IdType': 'doi'})]}, {'Citation': 'Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines. 2011;10(4):499–511. PMID: 21506647. PMCID: PMC3108434.'}, {'Citation': 'Yu ZY, Li N, Ma Y, et al. Three types of human CpG motifs differentially modulate and augment immunogenicity of nonviral and viral replicon DNA vaccines as built-in adjuvants. Eur J Immunol. 2013;43(1):228–39. PMID: 23037552.', 'ArticleIdList': [StringElement('23037552', attributes={'IdType': 'pubmed'}), StringElement('10.1002/eji.201242690', attributes={'IdType': 'doi'})]}, {'Citation': 'Shirota H, Klinman DM. Recent progress concerning CpG DNA and its use as a vaccine adjuvant. Expert Rev Vaccines. 2014;13(2):299–312. PMID: 24308579. PMCID: PMC6335645.'}, {'Citation': 'Didierlaurent AM, Laupèze B, Pasquale AD, et al. Adjuvant system AS01:helping to overcome the challenges of modern vaccines. Expert Rev Vaccines. 2017;16(1):55–63. PMID:27448771.', 'ArticleIdList': [StringElement('27448771', attributes={'IdType': 'pubmed'}), StringElement('10.1080/14760584.2016.1213632', attributes={'IdType': 'doi'})]}, {'Citation': 'Christensen D, et al. Cationic liposomes as vaccine adjuvants. Expert Rev Vaccines. 2011;10(4):513–21. PMID:21506648.', 'ArticleIdList': [StringElement('21506648', attributes={'IdType': 'pubmed'}), StringElement('10.1586/erv.11.17', attributes={'IdType': 'doi'})]}, {'Citation': 'Hawkins WG, Trcka J, Segal N, et al. The role of lipopolysaccharide in T-cell responses following DNA vaccination. Vaccine. 2003;21(13–14):1548–53. PMID:12615452.', 'ArticleIdList': [StringElement('12615452', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S0264-410X(02)00676-X', attributes={'IdType': 'doi'})]}, {'Citation': 'Kianmehr Z, Soleimanjahi H, Ardestani SK, Fotouhi F, Abdoli A. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice. Med Microbiol Immunol. 2015;204(2):205–13. PMID: 25187406.', 'ArticleIdList': [StringElement('25187406', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00430-014-0356-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Li K, Gao L, Gao H, et al. Codon optimization and woodchuck hepatitis virus posttranscriptional regulatory element enhance the immune responses of DNA vaccines against infectious bursal disease virus in chickens. Virus Res. 2013;175(2):120–7. PMID:23631937.', 'ArticleIdList': [StringElement('23631937', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.virusres.2013.04.010', attributes={'IdType': 'doi'})]}, {'Citation': 'Duan F, Chen J, Yao H, et al. Enhanced therapeutic efficacy of Listeria-based cancer vaccine with codon-optimized HPV16 E7. Hum Vaccin Immunother. 2021;17(6):1568–77. PMID:33449866. PMCID: PMC8115762.', 'ArticleIdList': [StringElement('33449866', attributes={'IdType': 'pubmed'}), StringElement('8115762', attributes={'IdType': 'pmc'}), StringElement('10.1080/21645515.2020.1839291', attributes={'IdType': 'doi'})]}, {'Citation': 'Li L, Petrovsky N. Molecular mechanisms for enhanced DNA vaccine immunogenicity. Expert Rev Vaccine. 2016;15(3):313–29. PMID:26707950. PMCID: PMC4955855.', 'ArticleIdList': [StringElement('10.1586/14760584.2016.1124762', attributes={'IdType': 'doi'})]}, {'Citation': 'Lambricht L, Vanvarenberg K, Beuckelaer AD, et al. Coadministration of a plasmid encoding HIV-1 Gag Enhances the efficacy of cancer DNA vaccines. Mol Ther. 2016;24(9):1686–96. PMID:27434590. PMCID: PMC5223100.', 'ArticleIdList': [StringElement('27434590', attributes={'IdType': 'pubmed'}), StringElement('5113100', attributes={'IdType': 'pmc'}), StringElement('10.1038/mt.2016.122', attributes={'IdType': 'doi'})]}, {'Citation': 'Chen H, Zheng XY, Wang R, et al. Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prME antigen dengue virus serotype 2 infection. Clin Immunol. 2016;171:41–9. PMID:27578400.', 'ArticleIdList': [StringElement('27578400', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.clim.2016.08.021', attributes={'IdType': 'doi'})]}, {'Citation': 'Li LL, Wang HR, Zhou ZY, et al. One-prime multi-boost strategy immunization with recombinant DNA, adenovirus, and MVA vector. Antiviral Res. 2016;128:20–7. PMID:26821205.', 'ArticleIdList': [StringElement('26821205', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.antiviral.2016.01.014', attributes={'IdType': 'doi'})]}, {'Citation': 'Peng SW, Qiu J, Yang A, et al. Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease. Cell Biosci. 2016;6:16. PMID:26918115. PMCID: PMC4766698.', 'ArticleIdList': [StringElement('26918115', attributes={'IdType': 'pubmed'}), StringElement('4766698', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13578-016-0080-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Li Y, Subjeck J, Yang G, et al. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy. Vaccine. 2006;24(25):5360–70. PMID:16714072.', 'ArticleIdList': [StringElement('16714072', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.vaccine.2006.04.028', attributes={'IdType': 'doi'})]}, {'Citation': 'Zong JB, Wang CH, Wang QY, et al. HSP70 and modified HPV16 E7 fusion gene without the addition of a signal peptide gene sequence as a candidate therapeutic tumor vaccine. Oncol Rep. 2013;30(6):3020–6. PMID:24065282.', 'ArticleIdList': [StringElement('24065282', attributes={'IdType': 'pubmed'}), StringElement('10.3892/or.2013.2742', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang X, Yu C, Zhao J, et al. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8<sup>+</sup> T cell response and inhibits the PSCA<sup>+</sup> tumors growth in mice. J Gene Med. 2007;9(8):715–26. PMID:17595048.', 'ArticleIdList': [StringElement('17595048', attributes={'IdType': 'pubmed'}), StringElement('10.1002/jgm.1067', attributes={'IdType': 'doi'})]}, {'Citation': 'Murshid A, Gong J, Calderwood SK. The role of heat shock protein in antigen cross presentation. Front Immunol. 2012;3:63. PMID:22566944. PMCID: PMC3342350.', 'ArticleIdList': [StringElement('22566944', attributes={'IdType': 'pubmed'}), StringElement('3342350', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2012.00063', attributes={'IdType': 'doi'})]}, {'Citation': 'Guzhova IV, Margulis BA. HSP70-based anti-cancer immunotherapy. Hum Vaccin Immunother. 2016;12(10):2529–35. PMID:27294301. PMCID: PMC5084976.', 'ArticleIdList': [StringElement('27294301', attributes={'IdType': 'pubmed'}), StringElement('5084976', attributes={'IdType': 'pmc'}), StringElement('10.1080/21645515.2016.1190057', attributes={'IdType': 'doi'})]}, {'Citation': 'Ragonnaud E, Andersson AC, Mariya S, Pedersen AG, Burk RD, Folgori A, et al. Therapeutic vaccine against primate papillomavirus infections of the cervix. J Immunother. 2017;40(2):51–61. PMID: 28166180.'}, {'Citation': 'Stanley MA, Sterling JC, et al. Host responses to infection with human papillomavirus. Curr Probl Dermatol. 2014;45:58–74. PMID:24643178.', 'ArticleIdList': [StringElement('24643178', attributes={'IdType': 'pubmed'}), StringElement('10.1159/000355964', attributes={'IdType': 'doi'})]}, {'Citation': 'de Sanjose S, Brotons M, Pavon MA. The natural history of human papillomavirus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2–13. PMID:28964706.', 'ArticleIdList': [StringElement('28964706', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.bpobgyn.2017.08.015', attributes={'IdType': 'doi'})]}, {'Citation': 'Klingelhutz AJ, Roman A. Cellular transformation by human papillomaviruses: Lessons learned by comparing high- and low-risk viruses. Virology. 2012;424(2):77–98. PMID:22284986.', 'ArticleIdList': [StringElement('22284986', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.virol.2011.12.018', attributes={'IdType': 'doi'})]}, {'Citation': 'Shi W, Bu P, Liu J, et al. Human Papillomavirus Type 16 E7 DNA Vaccine: Mutation in the Open Reading Frame of E7 Enhances Specific Cytotoxic T-Lymphocyte Induction and Antitumor Activity. J Virol. 1999;73(9):7877–81. PMID: 10438884.', 'ArticleIdList': [StringElement('10438884', attributes={'IdType': 'pubmed'}), StringElement('104321', attributes={'IdType': 'pmc'}), StringElement('10.1128/JVI.73.9.7877-7881.1999', attributes={'IdType': 'doi'})]}, {'Citation': 'Osen W, Peiler T, Öhlschläger P, et al. A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity. Vaccine. 2001;19(30):4276–86. PMID:11457555.', 'ArticleIdList': [StringElement('11457555', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S0264-410X(01)00154-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Ohlschläger P, Pes M, Osen W, Dürst M, Schneider A, Gissmann L, et al. An improved rearranged human Papillomavirus type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response. Vaccine. 2006;24(15):2880–93. PMID: 16472545.'}, {'Citation': 'Almajhdi FN, Senger T, Amer HM, et al. Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: Optimization by different ways of sequence rearrangements (shuffling). PLoS ONE. 2014;9(11):e113461. PMID:25422946.', 'ArticleIdList': [StringElement('25422946', attributes={'IdType': 'pubmed'}), StringElement('4244082', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0113461', attributes={'IdType': 'doi'})]}, {'Citation': 'Brinkman JA, Xu X, Kast WM. The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors. Vaccine. 2007;25(17):3437–44. PMID: 17241713. PMCID: PMC1885421.', 'ArticleIdList': [StringElement('17241713', attributes={'IdType': 'pubmed'}), StringElement('1885421', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.vaccine.2006.12.045', attributes={'IdType': 'doi'})]}, {'Citation': 'Kutzler MA, Robinson TM, Chattergoon MA, et al. Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8<sup>+</sup>T cells that function and longevity of CD8<sup>+</sup> T cells that are partially independent of CD4<sup>+</sup> T cell help. J Immunol. 2005;175(1):112–23. PMID:15972637.', 'ArticleIdList': [StringElement('15972637', attributes={'IdType': 'pubmed'}), StringElement('10.4049/jimmunol.175.1.112', attributes={'IdType': 'doi'})]}, {'Citation': 'Li W, Li S, Hu Y, Tang B, et al. Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting. Vaccine. 2008;26(26):3282–90. PMID:18472194.', 'ArticleIdList': [StringElement('18472194', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.vaccine.2008.03.081', attributes={'IdType': 'doi'})]}, {'Citation': 'Eickhoff CS, Vasconcelos JR, Sullivan NL, et al. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. PLoS Negl Trop Dis. 2011;5(3):e983. PMID:21408124. PMCID: PMC3050911.', 'ArticleIdList': [StringElement('21408124', attributes={'IdType': 'pubmed'}), StringElement('3050911', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pntd.0000983', attributes={'IdType': 'doi'})]}, {'Citation': 'Morrow MP, Pankhong P, Laddy DJ, et al. Cooparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood. 2009;113(23):5868–77. PMID:19304955.', 'ArticleIdList': [StringElement('19304955', attributes={'IdType': 'pubmed'}), StringElement('2700323', attributes={'IdType': 'pmc'}), StringElement('10.1182/blood-2008-11-190520', attributes={'IdType': 'doi'})]}, {'Citation': 'Morrow MP, Yan J, Pankhong P, et al. Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukine-12(IL-12) or IL-28B vaccine adjuvants in rhesus macaques. Clin Vaccine Immunol. 2010;17(10):1493–9. PMID:20685940.', 'ArticleIdList': [StringElement('20685940', attributes={'IdType': 'pubmed'}), StringElement('2952990', attributes={'IdType': 'pmc'}), StringElement('10.1128/CVI.00181-10', attributes={'IdType': 'doi'})]}, {'Citation': 'Morrow MP, Yan J, Pankhong P, et al. IL-28B/IFN-λ3 drives granzyme B loading and significantly increases CTL killing activity in Macaques. Mol Ther. 2010;18(9):1714–23. PMID:20571540.', 'ArticleIdList': [StringElement('20571540', attributes={'IdType': 'pubmed'}), StringElement('2956930', attributes={'IdType': 'pmc'}), StringElement('10.1038/mt.2010.118', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhou Y, Wang ZY, Xu YQ, et al. Optimized DNA vaccine enhanced by adjuvant IL-28B induces protective immune responses against herpes simplex virus type 2 in mice. Viral Immunol. 2017;30(8):601–14. PMID:28650722.', 'ArticleIdList': [StringElement('28650722', attributes={'IdType': 'pubmed'}), StringElement('10.1089/vim.2017.0033', attributes={'IdType': 'doi'})]}, {'Citation': 'Sabbaghi A, Zargar M, Zolfaghari MR, et al. Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model. Arch Virol. 2021;166(2):545–57. PMID: 33409549.', 'ArticleIdList': [StringElement('33409549', attributes={'IdType': 'pubmed'}), StringElement('7787640', attributes={'IdType': 'pmc'}), StringElement('10.1007/s00705-020-04900-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Luo Y, Ma X, Liu X, et al. IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization. Int Immunol. 2016;28(2):77–85. PMID:26521300.', 'ArticleIdList': [StringElement('26521300', attributes={'IdType': 'pubmed'}), StringElement('10.1093/intimm/dxv061', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu C, Xue RY, Li GC et al. pGM-CSF as an adjuvant in DNA vaccination against SARS-CoV-2. Int J Biol Macromol. 2024;264(Pt 2):130660. PMID: 38460634.'}, {'Citation': 'Ruan JZ, Duan Y, Li FG, et al. Enhanced synergistic anti-Lewis lung carcinoma effect of a DNA vaccine harboring a MUC1-VEGFR2 fusion gene used with GM-CSF as an adjuvant. Clin Exp Pharmacol Physiol. 2017;44(1):71–8. PMID:27562635.', 'ArticleIdList': [StringElement('27562635', attributes={'IdType': 'pubmed'}), StringElement('10.1111/1440-1681.12654', attributes={'IdType': 'doi'})]}, {'Citation': 'Ding Z, Zhu H, Mo L, et al. FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine. Aging. 2019;11(24):11893–904. PMID: 31881013.', 'ArticleIdList': [StringElement('31881013', attributes={'IdType': 'pubmed'}), StringElement('6949056', attributes={'IdType': 'pmc'}), StringElement('10.18632/aging.102494', attributes={'IdType': 'doi'})]}, {'Citation': 'Chen H, Gao N, Fan DY, et al. Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice. PLoS ONE. 2012;7(4):e34602. PMID:22493704. PMCID: PMC3321030.', 'ArticleIdList': [StringElement('22493704', attributes={'IdType': 'pubmed'}), StringElement('3321030', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0034602', attributes={'IdType': 'doi'})]}, {'Citation': 'Shirota H, Tross D, Klinman DM, et al. CpG oligonucleotides as cancer vaccine adjuvants. Vaccine. 2015;3:390–407. PMID:26343193.', 'ArticleIdList': [StringElement('10.3390/vaccines3020390', attributes={'IdType': 'doi'})]}, {'Citation': 'Ma Y, Jiao YY, Yu YZ et al. A Built-In CpG Adjuvant in RSV F Protein DNA Vaccine Drives a Th1 Polarized and Enhanced Protective Immune Response. Viruses.2018;10(1):38–50. PMID:29342954. PMCID: PMC5795451.'}, {'Citation': 'Pant S, Wainberg ZA, Weekes CD, et al. Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial. Nat Med. 2024;30(2):531–42. PMID: 38195752.', 'ArticleIdList': [StringElement('38195752', attributes={'IdType': 'pubmed'}), StringElement('10878978', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41591-023-02760-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Hsieh SM, Liu WD, Huang YS, Lin YJ, Hsieh EF, Lian WC, et al. Safety and immunogenicity of a recombinant stabilized prefusion SARS-CoV-2 spike protein vaccine (MVC-COV1901) adjuvanted with CpG 1018 and aluminum hydroxide in healthy adults: a phase 1, dose-escalation study. EClinicalMedicine. 2021;38:100989. PMID: 34222848. PMCID: PMC8233066.'}, {'Citation': 'Peng S, Tomson TT, Trimble C, et al. A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects. Gene Ther. 2006;13(3):257–65. PMID: 16177818.', 'ArticleIdList': [StringElement('16177818', attributes={'IdType': 'pubmed'}), StringElement('2174916', attributes={'IdType': 'pmc'}), StringElement('10.1038/sj.gt.3302646', attributes={'IdType': 'doi'})]}, {'Citation': 'Liang Y, Cui L, Xiao L et al. Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation. Front Immunol. 2022;13:876579. PMID: 35603155.'}, {'Citation': 'Lin KY, Guarnier FG, Staveley-O’Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 1996;56(1):21–6. PMID: 8548765.', 'ArticleIdList': [StringElement('8548765', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Qian X, Lu Y, Liu Q, Chen K, Zhao Q, Song J. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16 mE6∆/mE7/TBhsp70∆ fusion protein vaccine in an animal model. Immunol Lett. 2006;102(2):191–201. PMID:16242781.', 'ArticleIdList': [StringElement('16242781', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.imlet.2005.09.004', attributes={'IdType': 'doi'})]}, {'Citation': 'Yan J, Reichenbach DK, Corbitt N, Hokey DA, Ramanathan MP, McKinney KA, Weiner DB, Sewell D. Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen. Vaccine [Internet]. 2009;27(3):431–40. PMID: 19022315. PMCID: PMC4477831.', 'ArticleIdList': [StringElement('19022315', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.vaccine.2008.10.078', attributes={'IdType': 'doi'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '21'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '21'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '4', 'Day': '28'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '12', 'Day': '9'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780219', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s12985-024-02604-7', attributes={'IdType': 'doi'}), StringElement('10.1186/s12985-024-02604-7', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('Artificial sweetener', attributes={'MajorTopicYN': 'N'}), StringElement('Cancer', attributes={'MajorTopicYN': 'N'}), StringElement('Core targets', attributes={'MajorTopicYN': 'N'}), StringElement('Machine learning', attributes={'MajorTopicYN': 'N'}), StringElement('Molecular dynamics simulation', attributes={'MajorTopicYN': 'N'}), StringElement('Network toxicology', attributes={'MajorTopicYN': 'N'}), StringElement('Pathways in cancer', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780215', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '09'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s12967-024-06047-0', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1479-5876', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '23', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Journal of translational medicine', 'ISOAbbreviation': 'J Transl Med'}, 'ArticleTitle': 'An integrative analysis reveals cancer risk associated with artificial sweeteners.', 'Pagination': {'StartPage': '32', 'MedlinePgn': '32'}, 'Abstract': {'AbstractText': [StringElement('Artificial sweeteners (AS) have been widely utilized in the food, beverage, and pharmaceutical industries for decades. While numerous publications have suggested a potential link between AS and diseases, particularly cancer, controversy still surrounds this issue. This study aims to investigate the association between AS consumption and cancer risk.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'BACKGROUND'}), StringElement(\"Targets associated with commonly used AS were screened and validated using databases such as CTD, STITCH, Super-PRED, Swiss Target Prediction, SEA, PharmMapper, and GalaxySagittarius. Cancer-related targets were sourced from GeneCards, OMIM, and TTD databases. AS-cancer targets were identified through the intersection of these datasets. A network visualization ('AS-targets-cancer') was constructed using Cytoscape 3.9.0. Protein-protein interaction analysis was conducted using the STRING database to identify significant AS-cancer targets. GO and KEGG enrichment analyses were performed using the DAVID database. Core targets were identified from significant targets and genes involved in the 'Pathways in cancer' (map05200). Molecular docking and dynamics simulations were employed to verify interactions between AS and target proteins. Pan-cancer and univariate Cox regression analyses of core targets across 33 cancer types were conducted using GEPIA 2 and SangerBox, respectively. Gene chip datasets (GSE53757 for KIRC, GSE21354 for LGG, GSE42568 for BRCA, and GSE46602 for PRAD) were retrieved from the GEO database, while transcriptome and overall survival data were obtained from TCGA. Data normalization and identification of differentially expressed genes (DEGs) were performed on these datasets using R (version 4.3.2). Gene Set Enrichment Analysis (GSEA) was employed to identify critical pathways in the gene expression profiles between normal and cancer groups. A cancer risk prognostic model was constructed for key targets to further elucidate their significance in cancer initiation and progression. Finally, the HPA database was utilized to investigate variations in the expression of key AS-cancer target proteins across KIRC, LGG, BRCA, PRAD, and normal tissues.\", attributes={'Label': 'METHODS', 'NlmCategory': 'METHODS'}), StringElement(\"Seven commonly used AS (Aspartame, Acesulfame, Sucralose, NHDC, Cyclamate, Neotame, and Saccharin) were selected for study. A total of 368 AS-cancer intersection targets were identified, with 48 notable AS-cancer targets, including TP53, EGFR, SRC, PIK3R1, and EP300, retrieved. GO biological process analysis indicated that these targets are involved in the regulation of apoptosis, gene expression, and cell proliferation. Thirty-five core targets were identified from the intersection of the 48 significant AS-cancer targets and genes in the 'Pathways in cancer' (map05200). KEGG enrichment analysis of these core targets revealed associations with several cancer types and the PI3K-Akt signaling pathway. Molecular docking and dynamics simulations confirmed interactions between AS and these core targets. HSP90AA1 was found to be highly expressed across the 33 cancer types, while EGF showed the opposite trend. Univariate Cox regression analysis demonstrated strong associations of core targets with KIRC, LGG, BRCA, and PRAD. DEGs of AS-cancer core targets across these four cancers were analyzed. GSEA revealed upregulated and downregulated pathways enriched in KIRC, LGG, BRCA, and PRAD. Cancer risk prognostic models were constructed to elucidate the significant roles of key targets in cancer initiation and progression. Finally, the HPA database confirmed the crucial function of these targets in KIRC, LGG, BRCA, and PRAD.\", attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('This study integrated data mining, machine learning, network toxicology, molecular docking, molecular dynamics simulations, and clinical sample analysis to demonstrate that AS increases the risk of kidney cancer, low-grade glioma, breast cancer, and prostate cancer through multiple targets and signaling pathways. This paper provides a valuable reference for the safety assessment and cancer risk evaluation of food additives. It urges food safety regulatory agencies to strengthen oversight and encourages the public to reduce consumption of foods and beverages containing artificial sweeteners and other additives.', attributes={'Label': 'CONCLUSION', 'NlmCategory': 'CONCLUSIONS'})], 'CopyrightInformation': '© 2025. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Hubei Key Laboratory of Renal Disease Occurrence and Intervention, Medical School, Hubei Polytechnic University, Guilin North Road No 16, Huangshi, 435003, Hubei, People's Republic of China. xiejumin@hbpu.edu.cn.\"}], 'Identifier': [StringElement('0000-0002-4493-4548', attributes={'Source': 'ORCID'})], 'LastName': 'Xie', 'ForeName': 'Jumin', 'Initials': 'J'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Hubei Key Laboratory of Renal Disease Occurrence and Intervention, Medical School, Hubei Polytechnic University, Guilin North Road No 16, Huangshi, 435003, Hubei, People's Republic of China.\"}], 'Identifier': [], 'LastName': 'Zhu', 'ForeName': 'Ying', 'Initials': 'Y'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Hubei Key Laboratory of Renal Disease Occurrence and Intervention, Medical School, Hubei Polytechnic University, Guilin North Road No 16, Huangshi, 435003, Hubei, People's Republic of China.\"}], 'Identifier': [], 'LastName': 'Yang', 'ForeName': 'Zixuan', 'Initials': 'Z'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Hubei Key Laboratory of Renal Disease Occurrence and Intervention, Medical School, Hubei Polytechnic University, Guilin North Road No 16, Huangshi, 435003, Hubei, People's Republic of China.\"}], 'Identifier': [], 'LastName': 'Yu', 'ForeName': 'Zhang', 'Initials': 'Z'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Hubei Key Laboratory of Renal Disease Occurrence and Intervention, Medical School, Hubei Polytechnic University, Guilin North Road No 16, Huangshi, 435003, Hubei, People's Republic of China.\"}], 'Identifier': [], 'LastName': 'Yang', 'ForeName': 'Mingzhi', 'Initials': 'M'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Medical College of YiChun University, Xuefu Road No 576, Yichun, 336000, Jiangxi, People's Republic of China. wangqz1001@163.com.\"}], 'Identifier': [], 'LastName': 'Wang', 'ForeName': 'Qingzhi', 'Initials': 'Q'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': '2022BCE054', 'Agency': 'Local special projects in major health of Hubei Provincial Science and Technology Department', 'Country': ''}, {'GrantID': '23xjz08A', 'Agency': 'Key scientific research projects of Hubei polytechnic University', 'Country': ''}, {'GrantID': '23xjz04AK', 'Agency': 'Hubei polytechnic University · Huangshi Daye Lake high-tech Zone University Science Park joint open fund project', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'J Transl Med', 'NlmUniqueID': '101190741', 'ISSNLinking': '1479-5876'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: The public data we used to validate our key genes were sourced from the TCGA, GEO, and HPA databases, as cited in our paper. This data was utilized solely for research purposes. Consent for publication: The authors have all agreed to publication. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'What Are Artificial Sweeteners? [ https://health.usnews.com/wellness/food/articles/a-guide-to-artificial-sweeteners-the-next-generation ].'}, {'Citation': 'Kmietowicz Z. Artificial sweeteners do not aid weight loss or improve health, says WHO. BMJ. 2023;381:1112.', 'ArticleIdList': [StringElement('37188367', attributes={'IdType': 'pubmed'}), StringElement('10.1136/bmj.p1112', attributes={'IdType': 'doi'})]}, {'Citation': 'Guidelines Review Committee NaFSN. Use of non-sugar sweeteners: WHO guideline. Geneva: World Health Organization; 2023.'}, {'Citation': 'Wilk K, Korytek W, Pelczyńska M, Moszak M, Bogdański P. the effect of artificial sweeteners use on sweet taste perception and weight loss efficacy: a review. Nutrients. 2022;14:1261.', 'ArticleIdList': [StringElement('35334918', attributes={'IdType': 'pubmed'}), StringElement('8954878', attributes={'IdType': 'pmc'}), StringElement('10.3390/nu14061261', attributes={'IdType': 'doi'})]}, {'Citation': 'Debras C, Deschasaux-Tanguy M, Chazelas E, Sellem L, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaësse C, De Sa A, Lutchia R, et al. Artificial sweeteners and risk of type 2 diabetes in the prospective nutrinet-santé cohort. Diabetes Care. 2023;46:1681–90.', 'ArticleIdList': [StringElement('37490630', attributes={'IdType': 'pubmed'}), StringElement('10465821', attributes={'IdType': 'pmc'}), StringElement('10.2337/dc23-0206', attributes={'IdType': 'doi'})]}, {'Citation': 'Daoust L. Artificial sweeteners and type 2 diabetes. Nat Food. 2023;4:739.', 'ArticleIdList': [StringElement('37735508', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s43016-023-00846-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Basson AR, Rodriguez-Palacios A, Cominelli F. Artificial sweeteners: history and new concepts on inflammation. Front Nutr. 2021;8: 746247.', 'ArticleIdList': [StringElement('34631773', attributes={'IdType': 'pubmed'}), StringElement('8497813', attributes={'IdType': 'pmc'}), StringElement('10.3389/fnut.2021.746247', attributes={'IdType': 'doi'})]}, {'Citation': 'Martkets RA. Artificial and natural sweetener market forecasts from 2023 to 2028. Res Martkets. 2023;2023:207.'}, {'Citation': 'Samaniego-Vaesken ML, Ruiz E, Partearroyo T, Aranceta-Bartrina J, Gil Á, González-Gross M, Ortega RM, Serra-Majem L, Varela-Moreiras G. Added sugars and low- and no-calorie sweeteners in a representative sample of food products consumed by the Spanish ANIBES study population. Nutrients. 2018;10:4.', 'ArticleIdList': [StringElement('10.3390/nu10091265', attributes={'IdType': 'doi'})]}, {'Citation': 'Redruello-Requejo M, González-Rodríguez M, Samaniego-Vaesken Mª DL, Montero-Bravo A, Partearroyo T, Varela-Moreiras G. Low- and no-calorie sweetener (LNCS) consumption patterns amongst the Spanish adult population. Nutrients. 1845;2021:13.'}, {'Citation': 'High-Intensity Sweeteners [ https://www.fda.gov/food/food-additives-petitions/high-intensity-sweeteners ]'}, {'Citation': 'Rios-Leyvraz MMJ. Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. Geneva: World Health Organization; 2022.'}, {'Citation': 'Zhang Y, Tang Z, Shi Y, Li L. Associations between artificial sweetener intake from cereals, coffee, and tea and the risk of type 2 diabetes mellitus: a genetic correlation, mediation, and mendelian randomization analysis. PLoS ONE. 2024;19: e0287496.', 'ArticleIdList': [StringElement('38324548', attributes={'IdType': 'pubmed'}), StringElement('10849235', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0287496', attributes={'IdType': 'doi'})]}, {'Citation': 'Pan H, Feng C, Zhou Z, Huang J, Deng J, Zhou Y, Wang Y, Mu X, Wang Q, Wang K, Lu Z. The causal association between artificial sweeteners and the risk of cancer: a Mendelian randomization study. Food Funct. 2024;15:4527–37.', 'ArticleIdList': [StringElement('38576413', attributes={'IdType': 'pubmed'}), StringElement('10.1039/D3FO05756A', attributes={'IdType': 'doi'})]}, {'Citation': 'Palomar-Cros A, Straif K, Romaguera D, Aragonés N, Castaño-Vinyals G, Martin V, Moreno V, Gómez-Acebo I, Guevara M, Aizpurua A, et al. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain). Int J Cancer. 2023;153:979–93.', 'ArticleIdList': [StringElement('37323037', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ijc.34577', attributes={'IdType': 'doi'})]}, {'Citation': 'Alharthi SAS, Alaisayi KHA, Alalawi LYS, Alamri ROS, Abu-Elfotuh K, Alenazi TS, Amirthalingam P, Albariqi HAH, Mohammed AA, Alsubayti N, et al. The consumption pattern and perception of using artificial sweeteners among the public in Tabuk region, Saudi Arabia. Front Public Health. 2023;11:1166868.', 'ArticleIdList': [StringElement('37427264', attributes={'IdType': 'pubmed'}), StringElement('10323410', attributes={'IdType': 'pmc'}), StringElement('10.3389/fpubh.2023.1166868', attributes={'IdType': 'doi'})]}, {'Citation': 'WH Organization. Guideline: sugars intake for adults and children. Geneva: World Health Organization; 2015.'}, {'Citation': 'Debras C, Chazelas E, Sellem L, Porcher R, Druesne-Pecollo N, Esseddik Y, de Edelenyi FS, Agaësse C, De Sa A, Lutchia R, et al. Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort. BMJ. 2022;378: e071204.', 'ArticleIdList': [StringElement('36638072', attributes={'IdType': 'pubmed'}), StringElement('9449855', attributes={'IdType': 'pmc'}), StringElement('10.1136/bmj-2022-071204', attributes={'IdType': 'doi'})]}, {'Citation': 'Debras C, Chazelas E, Srour B, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaësse C, De Sa A, Lutchia R, Gigandet S, et al. Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study. PLoS Med. 2022;19:e1003950.', 'ArticleIdList': [StringElement('35324894', attributes={'IdType': 'pubmed'}), StringElement('8946744', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pmed.1003950', attributes={'IdType': 'doi'})]}, {'Citation': 'Iizuka K. Is the use of artificial sweeteners beneficial for patients with diabetes mellitus? The advantages and disadvantages of artificial sweeteners. Nutrients. 2022;14:40.', 'ArticleIdList': [StringElement('10.3390/nu14214446', attributes={'IdType': 'doi'})]}, {'Citation': 'Kränkel N, Rauch-Kroehnert U. Artificial sweetener sucralose: a possible modulator of autoimmune diseases. Signal Transduct Target Ther. 2023;8:377.', 'ArticleIdList': [StringElement('37779177', attributes={'IdType': 'pubmed'}), StringElement('10543406', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41392-023-01607-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Basson AR, Katz J, Singh S, Celio F, Cominelli F, Rodriguez-Palacios A. Sweets and inflammatory bowel disease: patients favor artificial sweeteners and diet foods/drinks over table sugar and consume less fruits/vegetables. Inflamm Bowel Dis. 2023;29:1751–9.', 'ArticleIdList': [StringElement('36680556', attributes={'IdType': 'pubmed'}), StringElement('10628924', attributes={'IdType': 'pmc'}), StringElement('10.1093/ibd/izac272', attributes={'IdType': 'doi'})]}, {'Citation': 'Qin X. The possible link between artificial sweeteners such as saccharin and sucralose and inflammatory bowel disease deserves further study. Inflamm Bowel Dis. 2016;22:E17.', 'ArticleIdList': [StringElement('26978727', attributes={'IdType': 'pubmed'}), StringElement('10.1097/MIB.0000000000000760', attributes={'IdType': 'doi'})]}, {'Citation': 'Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514:181–6.', 'ArticleIdList': [StringElement('25231862', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nature13793', attributes={'IdType': 'doi'})]}, {'Citation': 'Greenhill C. Gut microbiota: not so sweet–artificial sweeteners can cause glucose intolerance by affecting the gut microbiota. Nat Rev Endocrinol. 2014;10:637.', 'ArticleIdList': [StringElement('25246083', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nrendo.2014.167', attributes={'IdType': 'doi'})]}, {'Citation': 'Cai S, Xie N, Zheng L, Li Q, Zhang S, Huang Q, Luo W, Wu M, Wang Y, Du Y, et al. Sweet taste receptors play roles in artificial sweetener-induced enhanced urine output in mice. NPJ Sci Food. 2024;8:2.', 'ArticleIdList': [StringElement('38182603', attributes={'IdType': 'pubmed'}), StringElement('10770165', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41538-023-00236-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Shil A, Zhang J, Chichger H. Investigating the use and awareness of artificial sweeteners among diabetic patients in Bangladesh. PLoS ONE. 2023;18: e0295272.', 'ArticleIdList': [StringElement('38091359', attributes={'IdType': 'pubmed'}), StringElement('10718416', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0295272', attributes={'IdType': 'doi'})]}, {'Citation': 'Girigosavi KB, Etta I, Kambham S, Panjiyar BK. Sweet surprises: an in-depth systematic review of artificial sweeteners and their association with cerebrovascular accidents. Curr Nutr Rep. 2024;10:1.'}, {'Citation': 'Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, Nimer N, Haghikia A, Li XS, Wu Y, Saha PP, et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med. 2023;29:710–8.', 'ArticleIdList': [StringElement('36849732', attributes={'IdType': 'pubmed'}), StringElement('10334259', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41591-023-02223-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Wiklund AE, Guo X, Gorokhova E. Cardiotoxic and neurobehavioral effects of sucralose and acesulfame in Daphnia: toward understanding ecological impacts of artificial sweeteners. Comp Biochem Physiol C Toxicol Pharmacol. 2023;273: 109733.', 'ArticleIdList': [StringElement('37619954', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.cbpc.2023.109733', attributes={'IdType': 'doi'})]}, {'Citation': 'Tagorti G, Yalçın B, Güneş M, Burgazlı AY, Kaya B. Comparative evaluation of natural and artificial sweeteners from DNA damage, oxidative stress, apoptosis, to development using Drosophila melanogaster. Drug Chem Toxicol. 2023;47:1–12.'}, {'Citation': 'Patil S, Jalal RAS, Albar DH, Bansal SJ, Patil S, Nagaral S, Finch J, Bernard CA, Baeshen HA, Awan KH. Intake of artificial sweeteners by children: boon or bane? J Contemp Dent Pract. 2023;24:137–45.', 'ArticleIdList': [StringElement('37272146', attributes={'IdType': 'pubmed'}), StringElement('10.5005/jp-journals-10024-3435', attributes={'IdType': 'doi'})]}, {'Citation': 'Pearlman M, Obert J, Casey L. The association between artificial sweeteners and obesity. Curr Gastroenterol Rep. 2017;19:64.', 'ArticleIdList': [StringElement('29159583', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11894-017-0602-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Han S, Yang J, Park JE, Kim JH. Artificial sweeteners and pancreatic cancer: is aspartame a culprit or a coincidence? Pak J Med Sci. 2024;40:790.', 'ArticleIdList': [StringElement('38545014', attributes={'IdType': 'pubmed'}), StringElement('10963998', attributes={'IdType': 'pmc'}), StringElement('10.12669/pjms.40.4.8490', attributes={'IdType': 'doi'})]}, {'Citation': 'Balint IB, Erdodi BT. Is there a promoting role for artificial sweeteners in the evolution of bladder cancer? A meta-analysis of current literature. Minerva Surg. 2024;79:92–9.', 'ArticleIdList': [StringElement('37987752', attributes={'IdType': 'pubmed'}), StringElement('10.23736/S2724-5691.23.10000-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Hoover RN, Strasser PH. Artificial sweeteners and human bladder cancer. Preliminary results. Lancet. 1980;1:837–40.', 'ArticleIdList': [StringElement('6103207', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S0140-6736(80)91350-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Ozonoff D. Artificial sweeteners and bladder cancer. N Engl J Med. 1980;303:341–2.', 'ArticleIdList': [StringElement('7383136', attributes={'IdType': 'pubmed'}), StringElement('10.1056/NEJM198008073030617', attributes={'IdType': 'doi'})]}, {'Citation': 'Soffritti M, Belpoggi F, Tibaldi E, Esposti DD, Lauriola M. Life-span exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environ Health Perspect. 2007;115:1293–7.', 'ArticleIdList': [StringElement('17805418', attributes={'IdType': 'pubmed'}), StringElement('1964906', attributes={'IdType': 'pmc'}), StringElement('10.1289/ehp.10271', attributes={'IdType': 'doi'})]}, {'Citation': 'Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ Health Perspect. 2006;114:379–85.', 'ArticleIdList': [StringElement('16507461', attributes={'IdType': 'pubmed'}), StringElement('10.1289/ehp.8711', attributes={'IdType': 'doi'})]}, {'Citation': 'Gao Y, Yin L, Zhang Y, Li X, Liu L. Associations of saccharin intake with all-cause, cardiovascular and cancer mortality risk in USA adults. Br J Nutr. 2024;132:1–9.', 'ArticleIdList': [StringElement('38772904', attributes={'IdType': 'pubmed'}), StringElement('10.1017/S0007114524002034', attributes={'IdType': 'doi'})]}, {'Citation': 'Li X, Liu Y, Wang Y, Li X, Liu X, Guo M, Tan Y, Qin X, Wang X, Jiang M. Sucralose promotes colitis-associated colorectal cancer risk in a murine model along with changes in microbiota. Front Oncol. 2020;10:710.', 'ArticleIdList': [StringElement('32582527', attributes={'IdType': 'pubmed'}), StringElement('7286428', attributes={'IdType': 'pmc'}), StringElement('10.3389/fonc.2020.00710', attributes={'IdType': 'doi'})]}, {'Citation': 'Mela DJ, McLaughlin J, Rogers PJ. Perspective: standards for research and reporting on low-energy (“artificial”) sweeteners. Adv Nutr. 2020;11:484–91.', 'ArticleIdList': [StringElement('31925418', attributes={'IdType': 'pubmed'}), StringElement('7231577', attributes={'IdType': 'pmc'}), StringElement('10.1093/advances/nmz137', attributes={'IdType': 'doi'})]}, {'Citation': 'Davis AP, Wiegers TC, Wiegers J, Wyatt B, Johnson RJ, Sciaky D, Barkalow F, Strong M, Planchart A, Mattingly CJ. CTD tetramers: a new online tool that computationally links curated chemicals, genes, phenotypes, and diseases to inform molecular mechanisms for environmental health. Toxicol Sci. 2023;195:155–68.', 'ArticleIdList': [StringElement('37486259', attributes={'IdType': 'pubmed'}), StringElement('10535784', attributes={'IdType': 'pmc'}), StringElement('10.1093/toxsci/kfad069', attributes={'IdType': 'doi'})]}, {'Citation': 'Szklarczyk D, Santos A, von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44:D380-384.', 'ArticleIdList': [StringElement('26590256', attributes={'IdType': 'pubmed'}), StringElement('10.1093/nar/gkv1277', attributes={'IdType': 'doi'})]}, {'Citation': 'Gallo K, Goede A, Preissner R, Gohlke BO. SuperPred 3.0: drug classification and target prediction-a machine learning approach. Nucleic Acids Res. 2022;50:W726-w731.', 'ArticleIdList': [StringElement('35524552', attributes={'IdType': 'pubmed'}), StringElement('9252837', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkac297', attributes={'IdType': 'doi'})]}, {'Citation': 'Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47:W357-w364.', 'ArticleIdList': [StringElement('31106366', attributes={'IdType': 'pubmed'}), StringElement('6602486', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkz382', attributes={'IdType': 'doi'})]}, {'Citation': 'Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. Relating protein pharmacology by ligand chemistry. Nat Biotechnol. 2007;25:197–206.', 'ArticleIdList': [StringElement('17287757', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nbt1284', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, Lai L, Pei J, Li H. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45:W356-w360.', 'ArticleIdList': [StringElement('28472422', attributes={'IdType': 'pubmed'}), StringElement('5793840', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkx374', attributes={'IdType': 'doi'})]}, {'Citation': 'Ko J, Park H, Heo L, Seok C. GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Res. 2012;40:W294-297.', 'ArticleIdList': [StringElement('22649060', attributes={'IdType': 'pubmed'}), StringElement('3394311', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gks493', attributes={'IdType': 'doi'})]}, {'Citation': 'Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinf. 2016;54:1.', 'ArticleIdList': [StringElement('10.1002/cpbi.5', attributes={'IdType': 'doi'})]}, {'Citation': 'Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:D514-517.', 'ArticleIdList': [StringElement('15608251', attributes={'IdType': 'pubmed'}), StringElement('10.1093/nar/gki033', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhou Y, Zhang Y, Lian X, Li F, Wang C, Zhu F, Qiu Y, Chen Y. Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Res. 2021. https://doi.org/10.1093/nar/gkab953 .', 'ArticleIdList': [StringElement('10.1093/nar/gkab953', attributes={'IdType': 'doi'}), StringElement('34865123', attributes={'IdType': 'pubmed'}), StringElement('8789079', attributes={'IdType': 'pmc'})]}, {'Citation': 'Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605-d612.', 'ArticleIdList': [StringElement('33237311', attributes={'IdType': 'pubmed'}), StringElement('10.1093/nar/gkaa1074', attributes={'IdType': 'doi'})]}, {'Citation': 'Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.', 'ArticleIdList': [StringElement('14597658', attributes={'IdType': 'pubmed'}), StringElement('403769', attributes={'IdType': 'pmc'}), StringElement('10.1101/gr.1239303', attributes={'IdType': 'doi'})]}, {'Citation': 'Xie J, Chen R, Wang Q, Mao H. Exploration and validation of Taraxacum mongolicum anti-cancer effect. Comput Biol Med. 2022;148: 105819.', 'ArticleIdList': [StringElement('35810695', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.compbiomed.2022.105819', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35:W169-175.', 'ArticleIdList': [StringElement('17576678', attributes={'IdType': 'pubmed'}), StringElement('1933169', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkm415', attributes={'IdType': 'doi'})]}, {'Citation': 'Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, Feuermann M, Gaudet P, Harris NL, Hill DP, et al. The gene ontology knowledgebase in 2023. Genetics. 2023;224:1.'}, {'Citation': 'Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res. 2000;28:235–42.', 'ArticleIdList': [StringElement('10592235', attributes={'IdType': 'pubmed'}), StringElement('102472', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/28.1.235', attributes={'IdType': 'doi'})]}, {'Citation': 'Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–61.', 'ArticleIdList': [StringElement('19499576', attributes={'IdType': 'pubmed'}), StringElement('3041641', attributes={'IdType': 'pmc'}), StringElement('10.1002/jcc.21334', attributes={'IdType': 'doi'})]}, {'Citation': 'Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785–91.', 'ArticleIdList': [StringElement('19399780', attributes={'IdType': 'pubmed'}), StringElement('2760638', attributes={'IdType': 'pmc'}), StringElement('10.1002/jcc.21256', attributes={'IdType': 'doi'})]}, {'Citation': 'Schöning-Stierand K, Diedrich K, Fährrolfes R, Flachsenberg F, Meyder A, Nittinger E, Steinegger R, Rarey M. ProteinsPlus: interactive analysis of protein-ligand binding interfaces. Nucleic Acids Res. 2020;48:W48-w53.', 'ArticleIdList': [StringElement('32297936', attributes={'IdType': 'pubmed'}), StringElement('7319454', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkaa235', attributes={'IdType': 'doi'})]}, {'Citation': 'Shamsol Azman ANS, Tan JJ, Abdullah MNH, Bahari H, Lim V, Yong YK. Network pharmacology and molecular docking analysis of active compounds in Tualang Honey against atherosclerosis. Foods. 2023;12:35.', 'ArticleIdList': [StringElement('10.3390/foods12091779', attributes={'IdType': 'doi'})]}, {'Citation': 'Arshia AH, Shadravan S, Solhjoo A, Sakhteman A, Sami A. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations. Comput Biol Med. 2021;139: 104967.', 'ArticleIdList': [StringElement('34739968', attributes={'IdType': 'pubmed'}), StringElement('8545757', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.compbiomed.2021.104967', attributes={'IdType': 'doi'})]}, {'Citation': 'He X, Man VH, Yang W, Lee TS, Wang J. A fast and high-quality charge model for the next generation general AMBER force field. J Chem Phys. 2020;153: 114502.', 'ArticleIdList': [StringElement('32962378', attributes={'IdType': 'pubmed'}), StringElement('7728379', attributes={'IdType': 'pmc'}), StringElement('10.1063/5.0019056', attributes={'IdType': 'doi'})]}, {'Citation': 'Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11:3696–713.', 'ArticleIdList': [StringElement('26574453', attributes={'IdType': 'pubmed'}), StringElement('4821407', attributes={'IdType': 'pmc'}), StringElement('10.1021/acs.jctc.5b00255', attributes={'IdType': 'doi'})]}, {'Citation': 'Fu T, Zheng G, Tu G, Yang F, Chen Y, Yao X, Li X, Xue W, Zhu F. Exploring the binding mechanism of metabotropic glutamate receptor 5 negative allosteric modulators in clinical trials by molecular dynamics simulations. ACS Chem Neurosci. 2018;9:1492–502.', 'ArticleIdList': [StringElement('29522307', attributes={'IdType': 'pubmed'}), StringElement('10.1021/acschemneuro.8b00059', attributes={'IdType': 'doi'})]}, {'Citation': 'Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98-w102.', 'ArticleIdList': [StringElement('28407145', attributes={'IdType': 'pubmed'}), StringElement('5570223', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkx247', attributes={'IdType': 'doi'})]}, {'Citation': 'Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41:D991-995.', 'ArticleIdList': [StringElement('23193258', attributes={'IdType': 'pubmed'}), StringElement('10.1093/nar/gks1193', attributes={'IdType': 'doi'})]}, {'Citation': 'Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47.', 'ArticleIdList': [StringElement('25605792', attributes={'IdType': 'pubmed'}), StringElement('4402510', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/gkv007', attributes={'IdType': 'doi'})]}, {'Citation': 'Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.', 'ArticleIdList': [StringElement('16199517', attributes={'IdType': 'pubmed'}), StringElement('1239896', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.0506580102', attributes={'IdType': 'doi'})]}, {'Citation': 'Tay JK, Narasimhan B, Hastie T. Elastic net regularization paths for all generalized linear models. J Stat Softw. 2023;106:36.', 'ArticleIdList': [StringElement('10.18637/jss.v106.i01', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang H, Lengerich BJ, Aragam B, Xing EP. Precision Lasso: accounting for correlations and linear dependencies in high-dimensional genomic data. Bioinformatics. 2019;35:1181–7.', 'ArticleIdList': [StringElement('30184048', attributes={'IdType': 'pubmed'}), StringElement('10.1093/bioinformatics/bty750', attributes={'IdType': 'doi'})]}, {'Citation': 'May WL. Kaplan-Meier survival analysis. In: Schwab M, editor. Encyclopedia of cancer. Berlin: Springer, Berlin Heidelberg; 2009. p. 1590–3.', 'ArticleIdList': [StringElement('10.1007/978-3-540-47648-1_3196', attributes={'IdType': 'doi'})]}, {'Citation': 'Lorent M, Giral M, Foucher Y. Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality. Stat Med. 2014;33:2379–89.', 'ArticleIdList': [StringElement('24399671', attributes={'IdType': 'pubmed'}), StringElement('10.1002/sim.6079', attributes={'IdType': 'doi'})]}, {'Citation': 'Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75:25–36.', 'ArticleIdList': [StringElement('35124947', attributes={'IdType': 'pubmed'}), StringElement('8831439', attributes={'IdType': 'pmc'}), StringElement('10.4097/kja.21209', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, AlNajdawi S, Ikotun MA, Forestiero A, Gul F, Ezugwu AE, Jia H, Zare M, Mahajan S, Alshinwan M. 11—quantum approximate optimization algorithm: a review study and problems. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 147–65.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00007-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Al Turk AA, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Hussien AG, Jia H. 2—social spider optimization algorithm: survey and new applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 15–31.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00011-X', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Alshatti SM, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Ezugwu AE, Hanandeh ES, Jia H, Zare M. 9—spider monkey optimizations: application review and results. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 117–31.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00003-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Odah S, Ikotun MA, Alsoud AR, Forestiero A, Ezugwu AE, Hanandeh ES, Jia H, Zare M. 10—marine predator’s algorithm: a survey of recent applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 133–45.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00010-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Ra A, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Ezugwu AE, Hanandeh ES, Jia H. 8 - Whale optimization algorithm: analysis and full survey. In: Abualigah L, editor. Metaheuristic Optimization Algorithms. Burlington: Morgan Kaufmann; 2024. p. 105–15.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00015-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Abusaleem A, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Ezugwu AE, Hanandeh ES, Jia H. 6—arithmetic optimization algorithm: a review and analysis. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 73–87.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00012-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Al-Abadi L, Ikotun AM, Al-Saqqar F, Izci D, Zhang P, Şahin CB, El-Bashir M, Sumari P. 15—a review of mothflame optimization algorithm: analysis and applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 205–19.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00006-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Al-Hilo G, Raza A, Ezugwu AE, Nasar MRA, Mughaid A, AlZu’bi S, Aldiabat K, Al-diabat M. 13—a review of Henry gas solubility optimization algorithm: a robust optimizer and applications. In: Abualigah L, editor. Metaheuristic Optimization Algorithms. Burlington: Morgan Kaufmann; 2024. p. 177–92.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00013-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Sheikhan A, Ikotun MA, Zitar RA, Alsoud AR, Al-Shourbaji I, Hussien AG, Jia H. 1—particle swarm optimization algorithm: review and applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 1–14.'}, {'Citation': 'Abualigah L, Ababneh A, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Ezugwu AE, Hanandeh ES, Jia H. 4—a survey of cuckoo search algorithm: optimizer and new applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 45–57.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00018-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Sbenaty B, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Ezugwu AE, Hanandeh ES, Jia H. 7—aquila optimizer: review, results and applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 89–103.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00001-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Ahmad EN, Ikotun AM, Zitar RA, Alsoud AR, Khodadadi N, Ezugwu AE, Jia H. 3—animal migration optimization algorithm: novel optimizer, analysis, and applications. In: Abualigah L, editor. Metaheuristic Optimization Algorithms. Burlington: Morgan Kaufmann; 2024. p. 33–43.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00008-X', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Hawamdeh W, Zitar RA, AlZu’bi S, Mughaid A, Hanandeh ES, Alsoud AR, El-kenawy E-SM. 18—Salp swarm algorithm: survey, analysis, and new applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 241–58.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00009-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Abualigah L, Faweer S, Raza A, Gul F, Ezugwu AE, Alshinwan M, Nasar MRA, Mughaid A, AlZu’bi S. 12—crow search algorithm: a survey of novel optimizer and its recent applications. In: Abualigah L, editor. Metaheuristic optimization algorithms. Burlington: Morgan Kaufmann; 2024. p. 167–76.', 'ArticleIdList': [StringElement('10.1016/B978-0-443-13925-3.00004-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, et al. Proteomics tissue-based map of the human proteome. Science. 2015;347:1260419.', 'ArticleIdList': [StringElement('25613900', attributes={'IdType': 'pubmed'}), StringElement('10.1126/science.1260419', attributes={'IdType': 'doi'})]}, {'Citation': 'Yu X, Yu F, Li Z, Shi T, Xia Z, Li G. Occurrence, distribution, and ecological risk assessment of artificial sweeteners in surface and ground waters of the middle and lower reaches of the Yellow River (Henan section, China). Environ Sci Pollut Res Int. 2023;30:52609–23.', 'ArticleIdList': [StringElement('36840868', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11356-023-26073-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Li D, Zheng Q, Thomas KV, Dang AK, Binh VN, Anh NTK, Thai PK. Use of artificial sweeteners and caffeine in a population of Hanoi: an assessment by wastewater-based epidemiology. Sci Total Environ. 2023;868: 161515.', 'ArticleIdList': [StringElement('36634775', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.scitotenv.2023.161515', attributes={'IdType': 'doi'})]}, {'Citation': 'Sultana T, Metcalfe CD. Calibration and field validation of POCIS passive samplers for tracking artificial sweeteners as indicators of municipal wastewater contamination in surface waters. Environ Monit Assess. 2022;194:564.', 'ArticleIdList': [StringElement('35788916', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s10661-022-10150-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Tran NH, Hu J, Li J, Ong SL. Suitability of artificial sweeteners as indicators of raw wastewater contamination in surface water and groundwater. Water Res. 2014;48:443–56.', 'ArticleIdList': [StringElement('24156949', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.watres.2013.09.053', attributes={'IdType': 'doi'})]}, {'Citation': 'Shil A, Chichger H. Artificial sweeteners negatively regulate pathogenic characteristics of two model gut bacteria, E. coli and E. faecalis. Int J Mol Sci. 2021;22:5228.', 'ArticleIdList': [StringElement('34063332', attributes={'IdType': 'pubmed'}), StringElement('8156656', attributes={'IdType': 'pmc'}), StringElement('10.3390/ijms22105228', attributes={'IdType': 'doi'})]}, {'Citation': 'Yu Z, Henderson IR, Guo J. Non-caloric artificial sweeteners modulate conjugative transfer of multi-drug resistance plasmid in the gut microbiota. Gut Microbes. 2023;15:2157698.', 'ArticleIdList': [StringElement('36524841', attributes={'IdType': 'pubmed'}), StringElement('10.1080/19490976.2022.2157698', attributes={'IdType': 'doi'})]}, {'Citation': 'Hosseini A, Barlow GM, Leite G, Rashid M, Parodi G, Wang J, Morales W, Weitsman S, Rezaie A, Pimentel M, Mathur R. Consuming artificial sweeteners may alter the structure and function of duodenal microbial communities. iScience. 2023;26:108530.', 'ArticleIdList': [StringElement('38125028', attributes={'IdType': 'pubmed'}), StringElement('10730370', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.isci.2023.108530', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhu C, Ji D, Ma J, Da M. Association between artificial sweeteners-aspartame consumption and colorectal cancer risk: evidence-based strategies. Oncology. 2023. https://doi.org/10.1159/000534812 .', 'ArticleIdList': [StringElement('10.1159/000534812', attributes={'IdType': 'doi'}), StringElement('38092009', attributes={'IdType': 'pubmed'}), StringElement('10676074', attributes={'IdType': 'pmc'})]}, {'Citation': 'Ye X, Zhang Y, He Y, Sheng M, Huang J, Lou W. Association between consumption of artificial sweeteners and breast cancer risk: a systematic review and meta-analysis of observational studies. Nutr Cancer. 2023;75:795–804.', 'ArticleIdList': [StringElement('36795026', attributes={'IdType': 'pubmed'}), StringElement('10.1080/01635581.2023.2178957', attributes={'IdType': 'doi'})]}, {'Citation': 'van Eyk AD. The effect of five artificial sweeteners on Caco-2, HT-29 and HEK-293 cells. Drug Chem Toxicol. 2015;38:318–27.', 'ArticleIdList': [StringElement('25317478', attributes={'IdType': 'pubmed'}), StringElement('10.3109/01480545.2014.966381', attributes={'IdType': 'doi'})]}, {'Citation': 'Yoon AR, Lee S, Kim JH, Park Y, Koo T, Yun CO. CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer. Mol Ther. 2024;32:3618–28.', 'ArticleIdList': [StringElement('39066480', attributes={'IdType': 'pubmed'}), StringElement('11489544', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ymthe.2024.07.017', attributes={'IdType': 'doi'})]}, {'Citation': 'Yoo YA, Quan S, Yang W, Guo Q, Rodríguez Y, Chalmers ZR, Dufficy MF, Lackie B, Sagar V, Unno K, et al. Asparagine dependency is a targetable metabolic vulnerability in TP53-altered castration-resistant prostate cancer. Cancer Res. 2024;84:3004–22.', 'ArticleIdList': [StringElement('38959335', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-23-2910', attributes={'IdType': 'doi'})]}, {'Citation': 'Cederquist GY, Boe LA, Walsh M, Freedman GM, Maxwell KN, Taunk N, Braunstein LZ. Radiation-associated secondary cancer in patients with breast cancer harboring TP53 germline variants. JAMA Oncol. 2024;10:1588–90.', 'ArticleIdList': [StringElement('39264591', attributes={'IdType': 'pubmed'}), StringElement('10.1001/jamaoncol.2024.3683', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang S, Lai JC, Li Y, Tang C, Lu J, Han M, Ye X, Jia L, Cui W, Yang J, et al. Loss of CDKN2A enhances the efficacy of immunotherapy in EGFR mutant non-small cell lung cancer. Cancer Res. 2024. https://doi.org/10.1158/0008-5472.CAN-24-1817 .', 'ArticleIdList': [StringElement('10.1158/0008-5472.CAN-24-1817', attributes={'IdType': 'doi'}), StringElement('39700396', attributes={'IdType': 'pubmed'}), StringElement('11694061', attributes={'IdType': 'pmc'})]}, {'Citation': 'Voronkova MA, Johnson B, Gandhi N, Koomen JM, Patrick M, Shanthi Bhupathi S, Wu VM, Elliott A, Vanderwalde A, Halmos B, Hazlehurst LA. ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer. NPJ Precis Oncol. 2024;8:250.', 'ArticleIdList': [StringElement('39496753', attributes={'IdType': 'pubmed'}), StringElement('11535241', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41698-024-00736-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Dent RA, Kim SB, Oliveira M, Barrios C, O’Shaughnessy J, Isakoff SJ, Saji S, Freitas-Junior R, Philco M, Bondarenko I, et al. Ipatasertib plus paclitaxel for patients with PIK3CA/AKT1/PTEN-altered locally advanced unresectable or metastatic triple-negative breast cancer in the IPATunity130 phase III trial. Clin Cancer Res. 2024;30:4329–38.', 'ArticleIdList': [StringElement('39058425', attributes={'IdType': 'pubmed'}), StringElement('11443247', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-24-0465', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang TT, Chiang CY, Nair JR, Wilson KM, Cheng K, Lee JM. AKT1 interacts with DHX9 to mitigate R loop-induced replication stress in ovarian cancer. Cancer Res. 2024;84:887–904.', 'ArticleIdList': [StringElement('38241710', attributes={'IdType': 'pubmed'}), StringElement('10947874', attributes={'IdType': 'pmc'}), StringElement('10.1158/0008-5472.CAN-23-1908', attributes={'IdType': 'doi'})]}, {'Citation': 'Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, et al. The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy. Br J Cancer. 2024;131:1656–67.', 'ArticleIdList': [StringElement('39390250', attributes={'IdType': 'pubmed'}), StringElement('11554838', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41416-024-02875-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Gupta I, Gaykalova DA. Unveiling the role of PIK3R1 in cancer: a comprehensive review of regulatory signaling and therapeutic implications. Semin Cancer Biol. 2024;106–107:58–86.', 'ArticleIdList': [StringElement('39197810', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.semcancer.2024.08.004', attributes={'IdType': 'doi'})]}, {'Citation': 'Li H, Lin R, Zhang Y, Zhu Y, Huang S, Lan J, Lu N, Xie C, He S, Zhang W. N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation. Mol Cancer. 2024;23:5.', 'ArticleIdList': [StringElement('38184597', attributes={'IdType': 'pubmed'}), StringElement('10770956', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-023-01917-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang Z, Li Y, Qian Y, Zhai E, Zhao Z, Zhang T, Liu Y, Ye L, Wei R, Zhao R, et al. Tumor-secreted LCN2 impairs gastric cancer progression via autocrine inhibition of the 24p3R/JNK/c-Jun/SPARC axis. Cell Death Dis. 2024;15:756.', 'ArticleIdList': [StringElement('39424639', attributes={'IdType': 'pubmed'}), StringElement('11489581', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-024-07153-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Song Q, Zhou Z, Bai J, Liu N. A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer. Clin Transl Oncol. 2023;25:2587–606.', 'ArticleIdList': [StringElement('37000291', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s12094-023-03143-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Sain A, Khamrai D, Kandasamy T, Naskar D. Apigenin exerts anti-cancer effects in colon cancer by targeting HSP90AA1. J Biomol Struct Dyn. 2023. https://doi.org/10.1080/07391102.2023.2299305 .', 'ArticleIdList': [StringElement('10.1080/07391102.2023.2299305', attributes={'IdType': 'doi'}), StringElement('38157250', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Szczuka I, Wierzbicki J, Serek P, Szczęśniak-Sięga BM, Krzystek-Korpacka M. Heat shock proteins HSPA1 and HSP90AA1 are upregulated in colorectal polyps and can be targeted in cancer cells by anti-inflammatory oxicams with arylpiperazine pharmacophore and benzoyl moiety substitutions at thiazine ring. Biomolecules. 2021;11:1588.', 'ArticleIdList': [StringElement('34827586', attributes={'IdType': 'pubmed'}), StringElement('8615942', attributes={'IdType': 'pmc'}), StringElement('10.3390/biom11111588', attributes={'IdType': 'doi'})]}, {'Citation': 'Phelan JD, Staudt LM. Double-headed molecule activates cell-death pathways in cancer cells. Nature. 2023;620:285–6.', 'ArticleIdList': [StringElement('37495782', attributes={'IdType': 'pubmed'}), StringElement('10.1038/d41586-023-02213-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560–75.', 'ArticleIdList': [StringElement('36864290', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41580-023-00585-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Stanilov N, Velikova T, Stanilova S. Navigating the cytokine seas: targeting cytokine signaling pathways in cancer therapy. Int J Mol Sci. 2024;25:1009.', 'ArticleIdList': [StringElement('38256080', attributes={'IdType': 'pubmed'}), StringElement('10815616', attributes={'IdType': 'pmc'}), StringElement('10.3390/ijms25021009', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang KM, Zhao DC, Li ZY, Wang Y, Liu JN, Du T, Zhou L, Chen YH, Yu QC, Chen QS, et al. Inactivated cGAS-STING signaling facilitates endocrine resistance by forming a positive feedback loop with AKT kinase in ER+HER2- breast cancer. Adv Sci. 2024;11: e2403592.', 'ArticleIdList': [StringElement('10.1002/advs.202403592', attributes={'IdType': 'doi'})]}, {'Citation': 'Khawar MB, Yu S, Afzal A, Sun H. Unraveling the complex landscape of endocrine resistance in breast cancer: emerging role of long noncoding RNA AGPG and beyond. Chin Med J (Engl). 2024;137:1985–7.', 'ArticleIdList': [StringElement('39033392', attributes={'IdType': 'pubmed'}), StringElement('10.1097/CM9.0000000000003228', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu B, Liu Y, Yang S, Ye J, Hu J, Chen S, Wu S, Liu Q, Tang F, Liu Y, et al. Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER(+) breast cancer. Cancer Lett. 2024;600: 217179.', 'ArticleIdList': [StringElement('39154704', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.canlet.2024.217179', attributes={'IdType': 'doi'})]}, {'Citation': 'Khoshdel F, Mottaghi-Dastjerdi N, Yazdani F, Salehi S, Ghorbani A, Montazeri H, Soltany-Rezaee-Rad M, Goodarzy B. CTGF, FN1, IL-6, THBS1, and WISP1 genes and PI3K-Akt signaling pathway as prognostic and therapeutic targets in gastric cancer identified by gene network modeling. Discov Oncol. 2024;15:344.', 'ArticleIdList': [StringElement('39133458', attributes={'IdType': 'pubmed'}), StringElement('11319544', attributes={'IdType': 'pmc'}), StringElement('10.1007/s12672-024-01225-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Benichou E, Seffou B, Topçu S, Renoult O, Lenoir V, Planchais J, Bonner C, Postic C, Prip-Buus C, Pecqueur C, et al. The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism. Nat Commun. 1879;2024:15.'}, {'Citation': 'Tian Y, Zhao L, Gui Z, Liu S, Liu C, Yu T, Zhang L. PI3K/AKT signaling activates HIF1α to modulate the biological effects of invasive breast cancer with microcalcification. NPJ Breast Cancer. 2023;9:93.', 'ArticleIdList': [StringElement('37957150', attributes={'IdType': 'pubmed'}), StringElement('10643473', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41523-023-00598-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang Y, Sun X, Yang Q, Guo C. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway. Phytother Res. 2023;37:3380–93.', 'ArticleIdList': [StringElement('37073890', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ptr.7811', attributes={'IdType': 'doi'})]}, {'Citation': 'Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 2017;13:815–27.', 'ArticleIdList': [StringElement('28808415', attributes={'IdType': 'pubmed'}), StringElement('5555100', attributes={'IdType': 'pmc'}), StringElement('10.7150/ijbs.20052', attributes={'IdType': 'doi'})]}, {'Citation': 'Mei Q, Li X, Zhang K, Wu Z, Li X, Meng Y, Guo M, Luo G, Fu X, Han W. Genetic and methylation-induced loss of miR-181a2/181b2 within chr9q33.3 facilitates tumor growth of cervical cancer through the PIK3R3/Akt/FoxO signaling pathway. Clin Cancer Res. 2017;23:575–86.', 'ArticleIdList': [StringElement('27503199', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-16-0303', attributes={'IdType': 'doi'})]}, {'Citation': 'Motokura T, Bloom T, Kim HG, Jüppner H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350:512–5.', 'ArticleIdList': [StringElement('1826542', attributes={'IdType': 'pubmed'}), StringElement('10.1038/350512a0', attributes={'IdType': 'doi'})]}, {'Citation': 'Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, Rouault JP, Santa Lucia B, Duret L, Vuillaume M, et al. Rearrangement of CCND1 (BCL1/PRAD1) 3’ untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. Blood. 1994;83:3689–96.', 'ArticleIdList': [StringElement('8204893', attributes={'IdType': 'pubmed'}), StringElement('10.1182/blood.V83.12.3689.3689', attributes={'IdType': 'doi'})]}, {'Citation': 'Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood. 1996;88:674–81.', 'ArticleIdList': [StringElement('8695815', attributes={'IdType': 'pubmed'}), StringElement('10.1182/blood.V88.2.674.bloodjournal882674', attributes={'IdType': 'doi'})]}, {'Citation': 'Lew DJ, Dulić V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 1991;66:1197–206.', 'ArticleIdList': [StringElement('1833066', attributes={'IdType': 'pubmed'}), StringElement('10.1016/0092-8674(91)90042-W', attributes={'IdType': 'doi'})]}, {'Citation': 'Santra MK, Wajapeyee N, Green MR. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature. 2009;459:722–5.', 'ArticleIdList': [StringElement('19412162', attributes={'IdType': 'pubmed'}), StringElement('2722223', attributes={'IdType': 'pmc'}), StringElement('10.1038/nature08011', attributes={'IdType': 'doi'})]}, {'Citation': 'Dougherty MK, Müller J, Ritt DA, Zhou M, Zhou XZ, Copeland TD, Conrads TP, Veenstra TD, Lu KP, Morrison DK. Regulation of Raf-1 by direct feedback phosphorylation. Mol Cell. 2005;17:215–24.', 'ArticleIdList': [StringElement('15664191', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.molcel.2004.11.055', attributes={'IdType': 'doi'})]}, {'Citation': 'Brondello JM, Pouysségur J, McKenzie FR. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science. 1999;286:2514–7.', 'ArticleIdList': [StringElement('10617468', attributes={'IdType': 'pubmed'}), StringElement('10.1126/science.286.5449.2514', attributes={'IdType': 'doi'})]}, {'Citation': 'Walsh JG, Cullen SP, Sheridan C, Lüthi AU, Gerner C, Martin SJ. Executioner caspase-3 and caspase-7 are functionally distinct proteases. Proc Natl Acad Sci U S A. 2008;105:12815–9.', 'ArticleIdList': [StringElement('18723680', attributes={'IdType': 'pubmed'}), StringElement('2529079', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.0707715105', attributes={'IdType': 'doi'})]}, {'Citation': 'Peng T, Tao X, Xia Z, Hu S, Xue J, Zhu Q, Pan X, Zhang Q, Li S. Pathogen hijacks programmed cell death signaling by arginine ADPR-deacylization of caspases. Mol Cell. 2022;82:1806-1820.e1808.', 'ArticleIdList': [StringElement('35338844', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.molcel.2022.03.010', attributes={'IdType': 'doi'})]}, {'Citation': 'Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37–43.', 'ArticleIdList': [StringElement('7596430', attributes={'IdType': 'pubmed'}), StringElement('10.1038/376037a0', attributes={'IdType': 'doi'})]}, {'Citation': 'Shi X, Sun Q, Hou Y, Zeng H, Cao Y, Dong M, Ding J, Shao F. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature. 2023;624:442–50.', 'ArticleIdList': [StringElement('37993714', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41586-023-06742-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK, Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet. 1996;13:442–9.', 'ArticleIdList': [StringElement('8696339', attributes={'IdType': 'pubmed'}), StringElement('10.1038/ng0896-442', attributes={'IdType': 'doi'})]}, {'Citation': 'Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature. 2004;430:226–31.', 'ArticleIdList': [StringElement('15241418', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nature02650', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther. 2021;6:386.', 'ArticleIdList': [StringElement('34776511', attributes={'IdType': 'pubmed'}), StringElement('8591115', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41392-021-00780-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Schubbert S, Zenker M, Rowe SL, Böll S, Klein C, Bollag G, van der Burgt I, Musante L, Kalscheuer V, Wehner LE, et al. Germline KRAS mutations cause noonan syndrome. Nat Genet. 2006;38:331–6.', 'ArticleIdList': [StringElement('16474405', attributes={'IdType': 'pubmed'}), StringElement('10.1038/ng1748', attributes={'IdType': 'doi'})]}, {'Citation': 'Niihori T, Aoki Y, Narumi Y, Neri G, Cavé H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, et al. Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nat Genet. 2006;38:294–6.', 'ArticleIdList': [StringElement('16474404', attributes={'IdType': 'pubmed'}), StringElement('10.1038/ng1749', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang J, Beauchemin M, Bertrand R. Bcl-xL phosphorylation at Ser49 by polo kinase 3 during cell cycle progression and checkpoints. Cell Signal. 2011;23:2030–8.', 'ArticleIdList': [StringElement('21840391', attributes={'IdType': 'pubmed'}), StringElement('3708862', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.cellsig.2011.07.017', attributes={'IdType': 'doi'})]}, {'Citation': 'Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, et al. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell. 2007;129:45–56.', 'ArticleIdList': [StringElement('17418785', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.cell.2007.01.045', attributes={'IdType': 'doi'})]}, {'Citation': 'Di Donato M, Di Zazzo E, Salvati A, Sorrentino C, Giurato G, Fiore D, Proto MC, Rienzo M, Casamassimi A, Gazzerro P, et al. RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer. J Transl Med. 2023;21:736.', 'ArticleIdList': [StringElement('37853459', attributes={'IdType': 'pubmed'}), StringElement('10585774', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12967-023-04621-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Ye F, Yuan Z, Tang Y, Li J, Liu X, Sun X, Chen S, Ye X, Zeng Z, Zhang XK, Zhou H. Endocytic activation and exosomal secretion of matriptase stimulate the second wave of EGF signaling to promote skin and breast cancer invasion. Cell Rep. 2024;43: 114002.', 'ArticleIdList': [StringElement('38547126', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.celrep.2024.114002', attributes={'IdType': 'doi'})]}, {'Citation': 'Fernandez MK, Sinha M, Kühnemuth R, Renz M. Repeated FRAP of the actin-binding protein CapG in the cell nucleus-a functional assay for EGF signaling in the single live breast cancer cell. Sci Rep. 2024;14:23159.', 'ArticleIdList': [StringElement('39369027', attributes={'IdType': 'pubmed'}), StringElement('11455965', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41598-024-73887-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Liang XB, Dai ZC, Zou R, Tang JX, Yao CW. The therapeutic potential of CDK4/6 inhibitors, novel cancer drugs, in kidney diseases. Int J Mol Sci. 2023;24:13558.', 'ArticleIdList': [StringElement('37686364', attributes={'IdType': 'pubmed'}), StringElement('10487876', attributes={'IdType': 'pmc'}), StringElement('10.3390/ijms241713558', attributes={'IdType': 'doi'})]}, {'Citation': 'Rocha AS, Paternot S, Coulonval K, Dumont JE, Soares P, Roger PP. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation. Mol Biol Cell. 2008;19:4814–25.', 'ArticleIdList': [StringElement('18799615', attributes={'IdType': 'pubmed'}), StringElement('2575166', attributes={'IdType': 'pmc'}), StringElement('10.1091/mbc.e08-06-0617', attributes={'IdType': 'doi'})]}, {'Citation': 'Li W, Guo F, Zeng R, Liang H, Wang Y, Xiong W, Wu H, Yang C, Jin X. CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer. Cancer Res. 2024. https://doi.org/10.1158/0008-5472.CAN-23-3704 .', 'ArticleIdList': [StringElement('10.1158/0008-5472.CAN-23-3704', attributes={'IdType': 'doi'}), StringElement('39700408', attributes={'IdType': 'pubmed'}), StringElement('11458156', attributes={'IdType': 'pmc'})]}, {'Citation': 'Liang H, Yang C, Zeng R, Song Y, Wang J, Xiong W, Yan B, Jin X. Targeting CBX3 with a Dual BET/PLK1 inhibitor enhances the antitumor efficacy of CDK4/6 inhibitors in prostate cancer. Adv Sci. 2023;10: e2302368.', 'ArticleIdList': [StringElement('10.1002/advs.202302368', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang SP, Bao BY, Hour TC, Huang CY, Yu CC, Liu CC, Lee YC, Huang CN, Pao JB, Huang CH. Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy. PLoS ONE. 2012;7: e41219.', 'ArticleIdList': [StringElement('22844442', attributes={'IdType': 'pubmed'}), StringElement('3402522', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0041219', attributes={'IdType': 'doi'})]}, {'Citation': 'Köksal Karayildirim Ç, Nalbantsoy A, Karabay Yavaşoğlu N. Prunetin inhibits nitric oxide activity and induces apoptosis in urinary bladder cancer cells via CASP3 and TNF-α genes. Mol Biol Rep. 2021;48:7251–9.', 'ArticleIdList': [StringElement('34599704', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11033-021-06719-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Liang R, Chen W, Chen XY, Fan HN, Zhang J, Zhu JS. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways. Pathol Res Pract. 2021;218: 153318.', 'ArticleIdList': [StringElement('33370709', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.prp.2020.153318', attributes={'IdType': 'doi'})]}, {'Citation': 'Guan X, Liu Z, Liu H, Yu H, Wang LE, Sturgis EM, Li G, Wei Q. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. Faseb j. 2013;27:1404–12.', 'ArticleIdList': [StringElement('23271051', attributes={'IdType': 'pubmed'}), StringElement('3606531', attributes={'IdType': 'pmc'}), StringElement('10.1096/fj.12-223420', attributes={'IdType': 'doi'})]}, {'Citation': 'Ohashi R, Angori S, Batavia AA, Rupp NJ, Ajioka Y, Schraml P, Moch H. Loss of CDKN1A mRNA and protein expression are independent predictors of poor outcome in chromophobe renal cell carcinoma patients. Cancers. 2020;12:465.', 'ArticleIdList': [StringElement('32079343', attributes={'IdType': 'pubmed'}), StringElement('7072616', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers12020465', attributes={'IdType': 'doi'})]}, {'Citation': 'Freeman MR, Washecka R, Chung LW. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. Cancer Res. 1989;49:6221–5.', 'ArticleIdList': [StringElement('2572319', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Stumm G, Eberwein S, Rostock-Wolf S, Stein H, Pomer S, Schlegel J, Waldherr R. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int J Cancer. 1996;69:17–22.', 'ArticleIdList': [StringElement('8600053', attributes={'IdType': 'pubmed'}), StringElement('10.1002/(SICI)1097-0215(19960220)69:1<17::AID-IJC4>3.0.CO;2-Z', attributes={'IdType': 'doi'})]}, {'Citation': 'Angori S, Banaei-Esfahani A, Mühlbauer K, Bolck HA, Kahraman A, Karakulak T, Poyet C, Feodoroff M, Potdar S, Kallioniemi O, et al. Ex vivo drug testing in patient-derived papillary renal cancer cells reveals EGFR and the BCL2 family as therapeutic targets. Eur Urol Focus. 2023;9:751–9.', 'ArticleIdList': [StringElement('36933996', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.euf.2023.03.005', attributes={'IdType': 'doi'})]}, {'Citation': 'Tang Y, Song T, Gao L, Mao F. Venetoclax synergizes sunitinib in renal cell carcincoma through inhibition of Bcl-2. Anticancer Agents Med Chem. 2023;23:2027–34.', 'ArticleIdList': [StringElement('37581518', attributes={'IdType': 'pubmed'}), StringElement('10.2174/1871520623666230815143303', attributes={'IdType': 'doi'})]}, {'Citation': 'Fang Z, Zhang N, Yuan X, Xing X, Li X, Qin X, Liu Z, Neo S, Liu C, Kong F, et al. GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma. J Exp Clin Cancer Res. 2022;41:173.', 'ArticleIdList': [StringElement('35549739', attributes={'IdType': 'pubmed'}), StringElement('9097325', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-022-02382-6', attributes={'IdType': 'doi'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '7', 'Day': '21'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '12', 'Day': '25'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780215', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s12967-024-06047-0', attributes={'IdType': 'doi'}), StringElement('10.1186/s12967-024-06047-0', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('APC gene', attributes={'MajorTopicYN': 'N'}), StringElement('Chromosome 5q deletion', attributes={'MajorTopicYN': 'N'}), StringElement('De novo mutation', attributes={'MajorTopicYN': 'N'}), StringElement('Familial adenomatous polyposis', attributes={'MajorTopicYN': 'N'}), StringElement('Intellectual disability', attributes={'MajorTopicYN': 'N'}), StringElement('Whole APC deletion', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': [], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780213', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '09'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s13053-024-00297-1', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1731-2302', attributes={'IssnType': 'Print'}), 'JournalIssue': DictElement({'Volume': '23', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Print'}), 'Title': 'Hereditary cancer in clinical practice', 'ISOAbbreviation': 'Hered Cancer Clin Pract'}, 'ArticleTitle': 'Two independent families with de novo whole APC gene deletion and intellectual disability: a case report.', 'Pagination': {'StartPage': '1', 'MedlinePgn': '1'}, 'Abstract': {'AbstractText': [StringElement('Familial adenomatous polyposis (FAP) is an autosomal dominant colorectal tumour syndrome characterised by the formation of multiple adenomatous polyps throughout the colon. It is important to understand the extracolonic phenotype that characterizes FAP. Most previous case reports of patients with both FAP and intellectual disability (ID) have described deletions in all or part of chromosome 5q, including the APC locus. However, it remains unclear whether the ID phenotype in patients with FAP is due to APC disruption or another genetic defect in the deleted 5q region.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'BACKGROUND'}), StringElement('Patient of family 1 is a 32-year-old woman presented with\\u2009>\\u2009500 colorectal adenomatous polyps, gastric fundic gland polyposis, several duodenal adenomas, and mild intellectual disability (ID). She had no known family history of the FAP phenotype or ID. By copy number trio analysis, a 15.4\\xa0Mb interstitial heterozygous de novo deletion including APC region was observed in 5q21.2. q22.3. The patient in family 2 was a 29-year-old man with approximately 50 colorectal adenomatous polyps, fundic gland polyposis in the stomach, non-ampullary adenomas in the duodenum, and mild ID. He had no family history of the FAP phenotype or ID. Using copy number trio analysis, a de novo 9.8\\xa0Mb heterozygous deletion was identified on 5q22.1. q23.1 which includes the APC region.', attributes={'Label': 'CASE PRESENTATION', 'NlmCategory': 'METHODS'}), StringElement('Based on previous reports and the present study, we narrowed down the 5p deletion region associated with ID in FAP. Further investigation is required to understand ID due to 5q stromal deletion.', attributes={'Label': 'CONCLUSIONS', 'NlmCategory': 'CONCLUSIONS'})], 'CopyrightInformation': '© 2025. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. iwaizumi@hama-med.ac.jp.'}, {'Identifier': [], 'Affiliation': 'Clinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan. iwaizumi@hama-med.ac.jp.'}], 'Identifier': [], 'LastName': 'Iwaizumi', 'ForeName': 'Moriya', 'Initials': 'M'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Taniguchi', 'ForeName': 'Terumi', 'Initials': 'T'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Clinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Kojima', 'ForeName': 'Risa', 'Initials': 'R'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Clinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Osawa', 'ForeName': 'Harumo', 'Initials': 'H'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Tatsuta', 'ForeName': 'Kyota', 'Initials': 'K'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Sakata', 'ForeName': 'Mayu', 'Initials': 'M'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Osawa', 'ForeName': 'Satoshi', 'Initials': 'S'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Clinical and Molecular Genetics Center, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}, {'Identifier': [], 'Affiliation': 'Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Kurachi', 'ForeName': 'Kiyotaka', 'Initials': 'K'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.'}], 'Identifier': [], 'LastName': 'Sugimoto', 'ForeName': 'Ken', 'Initials': 'K'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': '22K08053', 'Agency': 'Japan Society for the Promotion of Science', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'Poland', 'MedlineTA': 'Hered Cancer Clin Pract', 'NlmUniqueID': '101231179', 'ISSNLinking': '1731-2302'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: The present study was approved by the Ethics Committee of Hamamatsu University School of Medicine (approval no. 17–222). Informed consent was obtained from all patients, and the study was performed in accordance with the Declaration of Helsinki. Consent for publication: Verbal and written informed consent was obtained from the patients and their patients for the release of this case report and accompanying images. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Patel R, Hyer W. Practical management of polyposis syndromes. Frontline Gastroenterol. 2019;10:379–87. https://doi.org/10.1136/flgastro-2018-101053.[firstpublishedonline;2019/10/28] .', 'ArticleIdList': [StringElement('10.1136/flgastro-2018-101053.[firstpublishedonline;2019/10/28]', attributes={'IdType': 'doi'}), StringElement('31656563', attributes={'IdType': 'pubmed'}), StringElement('6788137', attributes={'IdType': 'pmc'})]}, {'Citation': 'Shintani T, Takeuchi Y, Fujikawa A, Noda M. Directional neuronal migration is impaired in mice lacking adenomatous polyposis coli 2. J Neurosci. 2012;32:6468–84. https://doi.org/10.1523/JNEUROSCI.0590-12.2012 .', 'ArticleIdList': [StringElement('10.1523/JNEUROSCI.0590-12.2012', attributes={'IdType': 'doi'}), StringElement('22573669', attributes={'IdType': 'pubmed'}), StringElement('6621124', attributes={'IdType': 'pmc'})]}, {'Citation': 'Ivaniutsin U, Chen Y, Mason JO, Price DJ, Pratt T. Adenomatous polyposis coli is required for early events in the normal growth and differentiation of the developing cerebral cortex. Neural Dev. 2009;4:3. https://doi.org/10.1186/1749-8104-4-3 .', 'ArticleIdList': [StringElement('10.1186/1749-8104-4-3', attributes={'IdType': 'doi'}), StringElement('19149881', attributes={'IdType': 'pubmed'}), StringElement('2649069', attributes={'IdType': 'pmc'})]}, {'Citation': 'Imura T, Wang X, Noda T, Sofroniew MV, Fushiki S. Adenomatous polyposis coli is essential for both neuronal differentiation and maintenance of adult neural stem cells in subventricular zone and hippocampus. Stem Cells. 2010;28:2053–64. https://doi.org/10.1002/stem.524 .', 'ArticleIdList': [StringElement('10.1002/stem.524', attributes={'IdType': 'doi'}), StringElement('21089118', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Preitner N, Quan J, Nowakowski DW, Hancock ML, Shi J, Tcherkezian J, et al. APC is an RNA-binding protein, and its interactome provides a link to neural development and microtubule assembly. Cell. 2014;158:368–82. https://doi.org/10.1016/j.cell.2014.05.042 .', 'ArticleIdList': [StringElement('10.1016/j.cell.2014.05.042', attributes={'IdType': 'doi'}), StringElement('25036633', attributes={'IdType': 'pubmed'}), StringElement('4133101', attributes={'IdType': 'pmc'})]}, {'Citation': 'Clevers H, Nusse R. Wnt/B-catenin signaling and disease. Cell. 2012;149:1192–205. https://doi.org/10.1016/j.cell.2012.05.012 .', 'ArticleIdList': [StringElement('10.1016/j.cell.2012.05.012', attributes={'IdType': 'doi'}), StringElement('22682243', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Onouchi T, Kobayashi K, Sakai K, Shimomura A, Smits R, Sumi-Ichinose C, et al. Targeted deletion of the C-terminus of the mouse adenomatous polyposis coli tumor suppressor results in neurologic phenotypes related to schizophrenia. Mol Brain. 2014;7:21. https://doi.org/10.1186/1756-6606-7-21 .', 'ArticleIdList': [StringElement('10.1186/1756-6606-7-21', attributes={'IdType': 'doi'}), StringElement('24678719', attributes={'IdType': 'pubmed'}), StringElement('3986642', attributes={'IdType': 'pmc'})]}, {'Citation': 'Mohn JL, Alexander J, Pirone A, Palka CD, Lee SY, Mebane L, et al. Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities. Mol Psychiatry. 2014;19:1133–42. https://doi.org/10.1038/mp.2014.61 .', 'ArticleIdList': [StringElement('10.1038/mp.2014.61', attributes={'IdType': 'doi'}), StringElement('24934177', attributes={'IdType': 'pubmed'}), StringElement('4317257', attributes={'IdType': 'pmc'})]}, {'Citation': 'Levitt AJ, Rodin G, Cohen Z, Berk T. Coping styles, psychopathology and intellectual performance in patients with familial adenomatous polyposis. Gen Hosp Psychiatry. 1992;14:61–8. https://doi.org/10.1016/0163-8343(92)90027-8 .', 'ArticleIdList': [StringElement('10.1016/0163-8343(92)90027-8', attributes={'IdType': 'doi'}), StringElement('1309713', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Heald B, Moran R, Milas M, Burke C, Eng C. Familial adenomatous polyposis in a patient with unexplained mental retardation. Nat Clin Pract Neurol. 2007;3:694–700. https://doi.org/10.1038/ncpneuro0658 .', 'ArticleIdList': [StringElement('10.1038/ncpneuro0658', attributes={'IdType': 'doi'}), StringElement('18046442', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Barber JC, Ellis KH, Bowles LV, Delhanty JD, Ede RF, Male BM, et al. Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion. J Med Genet. 1994;31:312–6. https://doi.org/10.1136/jmg.31.4.312 .', 'ArticleIdList': [StringElement('10.1136/jmg.31.4.312', attributes={'IdType': 'doi'}), StringElement('8071957', attributes={'IdType': 'pubmed'}), StringElement('1049804', attributes={'IdType': 'pmc'})]}, {'Citation': 'Cross I, Delhanty J, Chapman P, Bowles LV, Griffin D, Wolstenholme J, et al. An intrachromosomal insertion causing 5q22 deletion and familial adenomatous polyposis coli in two generations. J Med Genet. 1992;29:175–9. https://doi.org/10.1136/jmg.29.3.175 .', 'ArticleIdList': [StringElement('10.1136/jmg.29.3.175', attributes={'IdType': 'doi'}), StringElement('1313112', attributes={'IdType': 'pubmed'}), StringElement('1015892', attributes={'IdType': 'pmc'})]}, {'Citation': 'Finch R, Moore HG, Lindor N, Jalal SM, Markowitz A, Suresh J, et al. Familial adenomatous polyposis and mental retardation caused by a de novo chromosomal deletion at 5q15-q22: report of a case. Dis Colon Rectum. 2005;48:2148–52. https://doi.org/10.1007/s10350-005-0177-7 .', 'ArticleIdList': [StringElement('10.1007/s10350-005-0177-7', attributes={'IdType': 'doi'}), StringElement('16228830', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hockey KA, Mulcahy MT, Montgomery P, Levitt S. Deletion of chromosome 5q and familial adenomatous polyposis. J Med Genet. 1989;26:61–2. https://doi.org/10.1136/jmg.26.1.61 .', 'ArticleIdList': [StringElement('10.1136/jmg.26.1.61', attributes={'IdType': 'doi'}), StringElement('2537430', attributes={'IdType': 'pubmed'}), StringElement('1015540', attributes={'IdType': 'pmc'})]}, {'Citation': 'Kobayashi T, Narahara K, Yokoyama Y, Ueyama S, Mohri O, Fujii T, et al. Gardner syndrome in a boy with interstitial deletion of the long arm of chromosome 5. Am J Med Genet. 1991;41:460–3. https://doi.org/10.1002/ajmg.1320410416 .', 'ArticleIdList': [StringElement('10.1002/ajmg.1320410416', attributes={'IdType': 'doi'}), StringElement('1776638', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lindgren V, Bryke CR, Ozcelik T, Yang-Feng TL, Francke U. Phenotypic, cytogenetic, and molecular studies of three patients with constitutional deletions of chromosome 5 in the region of the gene for familial adenomatous polyposis. Am J Hum Genet. 1992;50:988–97.', 'ArticleIdList': [StringElement('1315124', attributes={'IdType': 'pubmed'}), StringElement('1682619', attributes={'IdType': 'pmc'})]}, {'Citation': 'Hastings RJ, Svennevik EC, Setterfield B, Wells D, Delhanty JD, Mackinnon H. Deletion and duplication of the adenomatous polyposis coli gene resulting from an interchromosomal insertion involving 5(q22q23.3) in the father. J Med Genet. 2000;37:141–5. https://doi.org/10.1136/jmg.37.2.141'}, {'Citation': 'Raedle J, Friedl W, Engels H, Koenig R, Trojan J, Zeuzem S. A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation. Am J Gastroenterol. 2001;96:3016–20. https://doi.org/10.1111/j.1572-0241.2001.04674.x .', 'ArticleIdList': [StringElement('10.1111/j.1572-0241.2001.04674.x', attributes={'IdType': 'doi'}), StringElement('11693343', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ofner L, Raedle J, Windpassinger C, Schwarzbraun T, Kroisel PM, Wagner K, et al. Phenotypic and molecular characterisation of a de novo 5q deletion that includes the APC gene. J Hum Genet. 2006;51:141–6. https://doi.org/10.1007/s10038-005-0333-x .', 'ArticleIdList': [StringElement('10.1007/s10038-005-0333-x', attributes={'IdType': 'doi'}), StringElement('16365682', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Privitera F, Piccini F, Recalcati MP, Presi S, Mazzola S, Carrera P. APC-Related phenotypes and intellectual disability in 5q interstitial deletions: a new case and review of the literature. Genes. 2023;14:1505. https://doi.org/10.3390/genes14071505 .', 'ArticleIdList': [StringElement('10.3390/genes14071505', attributes={'IdType': 'doi'}), StringElement('37510409', attributes={'IdType': 'pubmed'}), StringElement('10379344', attributes={'IdType': 'pmc'})]}, {'Citation': 'Yamaguchi T, Koizumi K, Arai M, Tamura K, Iijima T, Horiguchi S, et al. A large deletion of chromosome 5q22.1–22.2 associated with sparse type of familial adenomatous polyposis: report of a case. Jpn J Clin Oncol. 2014;44:1243–7. https://doi.org/10.1093/jjco/hyu150 . Epub 2014 Oct 16'}, {'Citation': 'Mochel F, Rastetter A, Ceulemans B, Platzer K, Yang S, Shinde DN, et al. Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders. Brain. 2020;143:3564–73. https://doi.org/10.1093/brain/awaa346 .', 'ArticleIdList': [StringElement('10.1093/brain/awaa346', attributes={'IdType': 'doi'}), StringElement('33242881', attributes={'IdType': 'pubmed'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '4', 'Day': '14'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '10', 'Day': '9'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780213', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s13053-024-00297-1', attributes={'IdType': 'doi'}), StringElement('10.1186/s13053-024-00297-1', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('Alcohol', attributes={'MajorTopicYN': 'N'}), StringElement('Fetal', attributes={'MajorTopicYN': 'N'}), StringElement('Lung', attributes={'MajorTopicYN': 'N'}), StringElement('Pregnancy', attributes={'MajorTopicYN': 'N'}), StringElement('Sexual dimorphism', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780208', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '09'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s12931-025-03094-z', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1465-993X', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '26', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Respiratory research', 'ISOAbbreviation': 'Respir Res'}, 'ArticleTitle': 'Sexual dimorphism in lung transcriptomic adaptations in fetal alcohol spectrum disorders.', 'Pagination': {'StartPage': '6', 'MedlinePgn': '6'}, 'Abstract': {'AbstractText': [\"Current fetal alcohol spectrum disorders (FASD) studies primarily focus on alcohol's actions on the fetal brain although respiratory infections are a leading cause of morbidity/mortality in newborns. The limited studies examining the pulmonary adaptations in FASD demonstrate decreased surfactant protein A and alveolar macrophage phagocytosis, impaired differentiation, and increased risk of Group B streptococcal pneumonia with no study examining sexual dimorphism in adaptations. We hypothesized that developmental alcohol exposure in pregnancy will lead to sexually dimorphic fetal lung morphological and immune adaptations. Pregnant rats were orogastrically treated once daily with alcohol (4.5\\xa0g/kg, gestational day [GD] 4 to 10, peak BAC, 216\\xa0mg/dl; 6.0\\xa0g/kg, GD 11 to 20, peak BAC, 289\\xa0mg/dl) or 50% maltose dextrin (isocalorically matched pair-fed controls) to control for calories derived from ethanol. Male and female fetal lung RNA from a total of 20 dams were assessed using the TapeStation (Agilent) and Qubit RNA broad-range assay. Samples with RNA Integrity Numbers (RINs)\\u2009>\\u20098 were prepared using the NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB), xGen Broad-range RNA Library Prep (IDT), and xGen Normalase UDI Primer Plate 2 (IDT). Final libraries were checked for quality and quantity by Qubit hsDNA and LabChip. The samples were sequenced on the Illumina NovaSeq S4 Paired-end 150\\xa0bp. Fetal lung tissue were analyzed for histopathological assessments. Mean fetal weight, crown-rump length and placental efficiency of the alcohol-administered rats were significantly lower (P\\u2009<\\u20090.05) than the pair-fed control pups. Differentially expressed genes indicated a sex-linked gene regulation dichotomy with a significantly higher number of genes altered in the female fetal lungs compared to the male. Network analysis plot of downregulated genes in the females exposed to alcohol in utero showed a negative impact on T cell activation and regulation, T cell differentiation, decrease in CD8<sup>+</sup> T cell number etc. The most altered genes were Cd8b, Ccl25, Cd3e, Cd27, Cd247, Cd3d, Ccr9, Cd2, Cd8a and were decreased by a log2fold change of >\\u20092 (P\\u2009<\\u20090.05) in the female fetal lungs. KEGG analyses showed that male and female fetal lungs had downregulated genes associated with development and mitosis, whereas the females alone showed dysregulation of T cell genes. Comparison of gross appearance and histopathologic morphology showed that the developing lungs of both male and female fetal pups, displayed stunted differentiation, were relatively hypoplastic, and displayed a diminution of alveolar size and air spaces. Similarly, in both sexes, decreased alveolar capillarization was also evident in the alcohol-exposed fetal lungs. These data provide novel information in a growing area focused on alcohol effects on the offspring lung and its influence on appropriate fetal/neonatal immune responses and highlights the importance of examining sexual dimorphism in developmental adaptations.\"], 'CopyrightInformation': '© 2025. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Naik', 'ForeName': 'Vishal D', 'Initials': 'VD'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Millikin', 'ForeName': 'Dylan J', 'Initials': 'DJ'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Moussa', 'ForeName': 'Daniel', 'Initials': 'D'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Jiang', 'ForeName': 'Hong', 'Initials': 'H'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Carabulea', 'ForeName': 'Alexander L', 'Initials': 'AL'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Janeski', 'ForeName': 'Joseph D', 'Initials': 'JD'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}], 'Identifier': [], 'LastName': 'Ding', 'ForeName': 'Jiahui', 'Initials': 'J'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}, {'Identifier': [], 'Affiliation': 'Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.'}], 'Identifier': [], 'LastName': 'Chen', 'ForeName': 'Kang', 'Initials': 'K'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}, {'Identifier': [], 'Affiliation': 'Department of Biochemistry, Microbiology and Immunology, School of Medicine, Wayne State University, Detroit, MI, USA.'}], 'Identifier': [], 'LastName': 'Rodriguez-Garcia', 'ForeName': 'Marta', 'Initials': 'M'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Pathology, School of Medicine, Wayne State University, Detroit, MI, USA.'}], 'Identifier': [], 'LastName': 'Jaiman', 'ForeName': 'Sunil', 'Initials': 'S'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}, {'Identifier': [], 'Affiliation': 'Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA.'}], 'Identifier': [], 'LastName': 'Krawetz', 'ForeName': 'Stephen A', 'Initials': 'SA'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA.'}, {'Identifier': [], 'Affiliation': 'Department of Physiology, School of Medicine, Wayne State University, Detroit, MI, USA.'}], 'Identifier': [], 'LastName': 'Mor', 'ForeName': 'Gil', 'Initials': 'G'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, School of Medicine, Wayne State University, 275 E Hancock St, Rm 195, Detroit, MI, 48201, USA. hh1065@wayne.edu.'}, {'Identifier': [], 'Affiliation': 'Department of Physiology, School of Medicine, Wayne State University, Detroit, MI, USA. hh1065@wayne.edu.'}], 'Identifier': [], 'LastName': 'Ramadoss', 'ForeName': 'Jayanth', 'Initials': 'J'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': 'HL151497', 'Agency': 'National Institutes of Health', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'Respir Res', 'NlmUniqueID': '101090633', 'ISSNLinking': '1465-9921'}, 'CoiStatement': 'Declarations. Ethical approval: All experimental procedures were in accordance with National Institutes of Health guidelines (NIH Publication No. 85–23, revised 1996), with approval by the Animal Care and Use Committee at Wayne State University (Approval date, September 09. 2021, #IACUC-21-08-3925). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests. Clinical trial number: Not applicable.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Wozniak JR, Riley EP, Charness ME. Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder. Lancet Neurol. 2019;18:760–70.', 'ArticleIdList': [StringElement('31160204', attributes={'IdType': 'pubmed'}), StringElement('6995665', attributes={'IdType': 'pmc'}), StringElement('10.1016/S1474-4422(19)30150-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Caputo C, Wood E, Jabbour L. Impact of fetal alcohol exposure on body systems: a systematic review. Birth Defects Res Part C: Embryo Today: Reviews. 2016;108:174–80.', 'ArticleIdList': [StringElement('10.1002/bdrc.21129', attributes={'IdType': 'doi'})]}, {'Citation': 'Bertrand JFR, Weber MK, O’Connor M, Riley EP, Johnson KA, Cohen DE. National Task Force on FAS/FAE. Fetal alcohol syndrome: guidelines for referral and diagnosis. Atlanta, GA: Centers for Disease Control and Prevention; 2004.'}, {'Citation': 'Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Global Health. 2017;5:e290–9.', 'ArticleIdList': [StringElement('28089487', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S2214-109X(17)30021-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Popova S, Lange S, Probst C, Gmel G, Rehm J. Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder. Biochem Cell Biol. 2018;96:237–40.', 'ArticleIdList': [StringElement('28834683', attributes={'IdType': 'pubmed'}), StringElement('10.1139/bcb-2017-0077', attributes={'IdType': 'doi'})]}, {'Citation': 'Popova S, Charness ME, Burd L, Crawford A, Hoyme HE, Mukherjee RA, Riley EP, Elliott EJ. Fetal alcohol spectrum disorders. Nat Reviews Disease Primers. 2023;9:11.', 'ArticleIdList': [StringElement('36823161', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41572-023-00420-x', attributes={'IdType': 'doi'})]}, {'Citation': 'D’Alessandro S, Carter L, Webster C. Binge drinking: a review and research agenda. J Consumer Behav. 2023;22:177–98.', 'ArticleIdList': [StringElement('10.1002/cb.2102', attributes={'IdType': 'doi'})]}, {'Citation': 'Mattson SN, Bernes GA, Doyle LR. Fetal Alcohol Spectrum disorders: a review of the Neurobehavioral deficits Associated with prenatal Alcohol exposure. Alcohol Clin Exp Res. 2019;43:1046–62.', 'ArticleIdList': [StringElement('30964197', attributes={'IdType': 'pubmed'}), StringElement('6551289', attributes={'IdType': 'pmc'}), StringElement('10.1111/acer.14040', attributes={'IdType': 'doi'})]}, {'Citation': 'May PA, Chambers CD, Kalberg WO, Zellner J, Feldman H, Buckley D, Kopald D, Hasken JM, Xu R, Honerkamp-Smith G. Prevalence of fetal alcohol spectrum disorders in 4 US communities. JAMA. 2018;319:474–82.', 'ArticleIdList': [StringElement('29411031', attributes={'IdType': 'pubmed'}), StringElement('5839298', attributes={'IdType': 'pmc'}), StringElement('10.1001/jama.2017.21896', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier TW, Drews-Botsch C, Falek A, Coles C, Brown LAS. Maternal alcohol abuse and neonatal infection. Alcoholism: Clin Experimental Res. 2005;29:1035–43.', 'ArticleIdList': [StringElement('10.1097/01.ALC.0000167956.28160.5E', attributes={'IdType': 'doi'})]}, {'Citation': 'Libster R, Ferolla M, Hijano F, Acosta DR, Erviti PL, Polack A, Network FP. Alcohol during pregnancy worsens acute respiratory infections in children. Acta Paediatr. 2015;104:e494–9.', 'ArticleIdList': [StringElement('26249835', attributes={'IdType': 'pubmed'}), StringElement('10.1111/apa.13148', attributes={'IdType': 'doi'})]}, {'Citation': 'Vilcins D, Blake TL, Sly PD, Saffery R, Ponsonby AL, Burgner D, Tang ML, Reid N, Group BISI. Effects of prenatal alcohol exposure on infant lung function, wheeze, and respiratory infections in Australian children. Alcohol: Clin Experimental Res. 2023;47:2278–87.'}, {'Citation': 'Gray D, Willemse L, Visagie A, Czövek D, Nduru P, Vanker A, Stein DJ, Koen N, Sly PD, Hantos Z. Determinants of early-life lung function in African infants. Thorax. 2017;72:445–50.', 'ArticleIdList': [StringElement('27856821', attributes={'IdType': 'pubmed'}), StringElement('10.1136/thoraxjnl-2015-207401', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier TW. Prenatal Alcohol exposure and the developing Immune System. Alcohol Res. 2015;37:279–85.', 'ArticleIdList': [StringElement('26695750', attributes={'IdType': 'pubmed'}), StringElement('4590623', attributes={'IdType': 'pmc'})]}, {'Citation': 'Inselman LS, Fisher SE, Spencer H, Atkinson M. Effect of intrauterine ethanol exposure on fetal lung growth. Pediatr Res. 1985;19:12–4.', 'ArticleIdList': [StringElement('2578634', attributes={'IdType': 'pubmed'}), StringElement('10.1203/00006450-198501000-00004', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang X, Gomutputra P, Wolgemuth DJ, Baxi L. Effects of acute alcohol intoxication in the second trimester of pregnancy on development of the murine fetal lung. Am J Obstet Gynecol. 2007;197:e269261–264.', 'ArticleIdList': [StringElement('10.1016/j.ajog.2007.06.031', attributes={'IdType': 'doi'})]}, {'Citation': 'Lazic T, Sow FB, Van Geelen A, Meyerholz DK, Gallup JM, Ackermann MR. Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung. Alcohol. 2011;45:673–80.', 'ArticleIdList': [StringElement('21163613', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.alcohol.2010.11.001', attributes={'IdType': 'doi'})]}, {'Citation': 'Sozo F, Vela M, Stokes V, Kenna K, Meikle PJ, De Matteo R, Walker D, Brien J, Bocking A, Harding R. Effects of prenatal ethanol exposure on the lungs of postnatal lambs. Am J Physiol Lung Cell Mol Physiol. 2011;300:L139–147.', 'ArticleIdList': [StringElement('21036920', attributes={'IdType': 'pubmed'}), StringElement('10.1152/ajplung.00195.2010', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier TW, Ping XD, Harris FL, Wong M, Elbahesh H, Brown LA. Fetal alcohol exposure impairs alveolar macrophage function via decreased glutathione availability. Pediatr Res. 2005;57:76–81.', 'ArticleIdList': [StringElement('15531743', attributes={'IdType': 'pubmed'}), StringElement('10.1203/01.PDR.0000149108.44152.D3', attributes={'IdType': 'doi'})]}, {'Citation': 'Ping XD, Harris FL, Brown LA, Gauthier TW. In vivo dysfunction of the term alveolar macrophage after in utero ethanol exposure. Alcohol Clin Exp Res. 2007;31:308–16.', 'ArticleIdList': [StringElement('17250624', attributes={'IdType': 'pubmed'}), StringElement('10.1111/j.1530-0277.2006.00306.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier TW, Ping XD, Gabelaia L, Brown LA. Delayed neonatal lung macrophage differentiation in a mouse model of in utero ethanol exposure. Am J Physiol Lung Cell Mol Physiol. 2010;299:L8–16.', 'ArticleIdList': [StringElement('20382747', attributes={'IdType': 'pubmed'}), StringElement('2904088', attributes={'IdType': 'pmc'}), StringElement('10.1152/ajplung.90609.2008', attributes={'IdType': 'doi'})]}, {'Citation': 'Hause AM, Avadhanula V, Maccato ML, Pinell PM, Bond N, Santarcangelo P, Ferlic-Stark L, Munoz FM, Piedra PA. A cross-sectional surveillance study of the frequency and etiology of acute respiratory illness among pregnant women. J Infect Dis. 2018;218:528–35.', 'ArticleIdList': [StringElement('29741642', attributes={'IdType': 'pubmed'}), StringElement('10.1093/infdis/jiy167', attributes={'IdType': 'doi'})]}, {'Citation': 'Klein SL, Hodgson A, Robinson DP. Mechanisms of sex disparities in influenza pathogenesis. J Leukoc Biol. 2012;92:67–73.', 'ArticleIdList': [StringElement('22131346', attributes={'IdType': 'pubmed'}), StringElement('4046247', attributes={'IdType': 'pmc'}), StringElement('10.1189/jlb.0811427', attributes={'IdType': 'doi'})]}, {'Citation': 'Davis-Anderson KL, Wesseling H, Siebert LM, Lunde-Young ER, Naik VD, Steen H, Ramadoss J. Fetal regional brain protein signature in FASD rat model. Reprod Toxicol. 2018;76:84–92.', 'ArticleIdList': [StringElement('29408587', attributes={'IdType': 'pubmed'}), StringElement('5834402', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.reprotox.2018.01.004', attributes={'IdType': 'doi'})]}, {'Citation': 'Subramanian K, Naik VD, Sathishkumar K, Yallampalli C, Saade GR, Hankins GD, Ramadoss J. Chronic binge alcohol exposure during pregnancy impairs rat maternal uterine vascular function. Alcohol Clin Exp Res. 2014;38:1832–8.', 'ArticleIdList': [StringElement('24962648', attributes={'IdType': 'pubmed'}), StringElement('4107157', attributes={'IdType': 'pmc'}), StringElement('10.1111/acer.12431', attributes={'IdType': 'doi'})]}, {'Citation': 'Church MW, Gerkin KP. Hearing disorders in children with fetal alcohol syndrome: findings from case reports. Pediatrics. 1988;82:147–54.', 'ArticleIdList': [StringElement('3399287', attributes={'IdType': 'pubmed'}), StringElement('10.1542/peds.82.2.147', attributes={'IdType': 'doi'})]}, {'Citation': 'Cudd TA, Chen W-JA, West JR. Fetal and maternal thyroid hormone responses to ethanol exposure during the third trimester equivalent of Gestation in Sheep. Alcoholism: Clin Experimental Res. 2002;26:53–8.', 'ArticleIdList': [StringElement('10.1111/j.1530-0277.2002.tb02431.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Thomas JD, Sather TM, Whinery LA. Voluntary exercise influences behavioral development in rats exposed to alcohol during the neonatal brain growth spurt. Behav Neurosci. 2008;122:1264–73.', 'ArticleIdList': [StringElement('19045946', attributes={'IdType': 'pubmed'}), StringElement('3164868', attributes={'IdType': 'pmc'}), StringElement('10.1037/a0013271', attributes={'IdType': 'doi'})]}, {'Citation': 'Team RC. R: a language and environment for statistical computing. MSOR Connections 2014, 1.'}, {'Citation': 'Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–40.', 'ArticleIdList': [StringElement('19910308', attributes={'IdType': 'pubmed'}), StringElement('10.1093/bioinformatics/btp616', attributes={'IdType': 'doi'})]}, {'Citation': 'Valero-Mora PM. ggplot2: elegant graphics for data analysis. J Stat Softw Book Reviews. 2010;35:1–3.'}, {'Citation': 'Koopmans F, van Nierop P, Andres-Alonso M, Byrnes A, Cijsouw T, Coba MP, Cornelisse LN, Farrell RJ, Goldschmidt HL, Howrigan DP, et al. SynGO: an Evidence-Based, Expert-Curated Knowledge Base for the synapse. Neuron. 2019;103:217–e234214.', 'ArticleIdList': [StringElement('31171447', attributes={'IdType': 'pubmed'}), StringElement('6764089', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.neuron.2019.05.002', attributes={'IdType': 'doi'})]}, {'Citation': 'Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R Package for comparing Biological themes among Gene clusters. OMICS. 2012;16:284–7.', 'ArticleIdList': [StringElement('22455463', attributes={'IdType': 'pubmed'}), StringElement('3339379', attributes={'IdType': 'pmc'}), StringElement('10.1089/omi.2011.0118', attributes={'IdType': 'doi'})]}, {'Citation': 'Vedi M, Smith JR, Thomas Hayman G, Tutaj M, Brodie KC, De Pons JL, Demos WM, Gibson AC, Kaldunski ML, Lamers L, et al. 2022 updates to the rat genome database: a findable, accessible, interoperable, and Reusable (FAIR) resource. Genetics. 2023;224:iyad042.', 'ArticleIdList': [StringElement('36930729', attributes={'IdType': 'pubmed'}), StringElement('10474928', attributes={'IdType': 'pmc'}), StringElement('10.1093/genetics/iyad042', attributes={'IdType': 'doi'})]}, {'Citation': 'Wickham H, François R. dplyr: A grammar of data manipulation. 2014.'}, {'Citation': 'Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.', 'ArticleIdList': [StringElement('10592173', attributes={'IdType': 'pubmed'}), StringElement('102409', attributes={'IdType': 'pmc'}), StringElement('10.1093/nar/28.1.27', attributes={'IdType': 'doi'})]}, {'Citation': 'Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics. 2009;10:161.', 'ArticleIdList': [StringElement('19473525', attributes={'IdType': 'pubmed'}), StringElement('2696452', attributes={'IdType': 'pmc'}), StringElement('10.1186/1471-2105-10-161', attributes={'IdType': 'doi'})]}, {'Citation': 'Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR. Ma’ayan A: Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.', 'ArticleIdList': [StringElement('23586463', attributes={'IdType': 'pubmed'}), StringElement('3637064', attributes={'IdType': 'pmc'}), StringElement('10.1186/1471-2105-14-128', attributes={'IdType': 'doi'})]}, {'Citation': 'Smith CL, Eppig JT. The mammalian phenotype ontology: enabling robust annotation and comparative analysis. Wiley Interdiscip Rev Syst Biol Med. 2009;1:390–9.', 'ArticleIdList': [StringElement('20052305', attributes={'IdType': 'pubmed'}), StringElement('2801442', attributes={'IdType': 'pmc'}), StringElement('10.1002/wsbm.44', attributes={'IdType': 'doi'})]}, {'Citation': 'Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25:25–9.', 'ArticleIdList': [StringElement('10802651', attributes={'IdType': 'pubmed'}), StringElement('3037419', attributes={'IdType': 'pmc'}), StringElement('10.1038/75556', attributes={'IdType': 'doi'})]}, {'Citation': 'The Gene Ontology C, Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, Ebert D, Feuermann M, Gaudet P, Harris NL, et al. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224:iyad031.', 'ArticleIdList': [StringElement('10.1093/genetics/iyad031', attributes={'IdType': 'doi'})]}, {'Citation': 'Apostol AC, Jensen KD, Beaudin AE. Training the fetal immune system through maternal inflammation—a layered hygiene hypothesis. Front Immunol. 2020;11:514736.', 'ArticleIdList': [StringElement('10.3389/fimmu.2020.00123', attributes={'IdType': 'doi'})]}, {'Citation': 'Shi L, Tu N, Patterson PH. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int J Dev Neurosci. 2005;23:299–305.', 'ArticleIdList': [StringElement('15749254', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ijdevneu.2004.05.005', attributes={'IdType': 'doi'})]}, {'Citation': 'Battle YL, Martin BC, Dorfman JH, Miller LS. Seasonality and infectious disease in schizophrenia: the birth hypothesis revisited. J Psychiatr Res. 1999;33:501–9.', 'ArticleIdList': [StringElement('10628526', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S0022-3956(99)00022-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Scott NM, Hodyl NA, Osei-Kumah A, Stark MJ, Smith R, Clifton VL. The presence of maternal asthma during pregnancy suppresses the placental pro-inflammatory response to an immune challenge in vitro. Placenta. 2011;32:454–61.', 'ArticleIdList': [StringElement('21453968', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.placenta.2011.03.004', attributes={'IdType': 'doi'})]}, {'Citation': 'Lotvall J, Ekerljung L, Lundback B. Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study. Respir Res. 2010;11:163.', 'ArticleIdList': [StringElement('21110834', attributes={'IdType': 'pubmed'}), StringElement('3004848', attributes={'IdType': 'pmc'}), StringElement('10.1186/1465-9921-11-163', attributes={'IdType': 'doi'})]}, {'Citation': 'Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, Sharpe AH, Umetsu DT, Dekruyff RH. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol. 2010;3:81–91.', 'ArticleIdList': [StringElement('19741598', attributes={'IdType': 'pubmed'}), StringElement('10.1038/mi.2009.112', attributes={'IdType': 'doi'})]}, {'Citation': 'Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ: Can Med Association J = J de l’Association medicale canadienne. 2009;181:E181–190.', 'ArticleIdList': [StringElement('10.1503/cmaj.080612', attributes={'IdType': 'doi'})]}, {'Citation': 'Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009;15:410–6.', 'ArticleIdList': [StringElement('19330007', attributes={'IdType': 'pubmed'}), StringElement('2789255', attributes={'IdType': 'pmc'}), StringElement('10.1038/nm.1946', attributes={'IdType': 'doi'})]}, {'Citation': 'Borrego LM, Arroz MJ, Videira P, Martins C, Guimaraes H, Nunes G, Papoila AL, Trindade H. Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze. Clin Exp Allergy. 2009;39:1160–9.', 'ArticleIdList': [StringElement('19438590', attributes={'IdType': 'pubmed'}), StringElement('10.1111/j.1365-2222.2009.03253.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Cappelletti M, Della Bella S, Ferrazzi E, Mavilio D, Divanovic S. Inflammation and preterm birth. J Leukoc Biol. 2016;99:67–78.', 'ArticleIdList': [StringElement('26538528', attributes={'IdType': 'pubmed'}), StringElement('10.1189/jlb.3MR0615-272RR', attributes={'IdType': 'doi'})]}, {'Citation': 'Maritz GS, Cock CA, Louey S, Joyce BJ, Albuquerque CA, Harding R. Effects of fetal growth restriction on lung development before and after birth: a morphometric analysis. Pediatr Pulmonol. 2001;32:201–10.', 'ArticleIdList': [StringElement('11536449', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ppul.1109', attributes={'IdType': 'doi'})]}, {'Citation': 'Maritz GS, Cock ML, Louey S, Suzuki K, Harding R. Fetal growth restriction has long-term effects on postnatal lung structure in sheep. Pediatr Res. 2004;55:287–95.', 'ArticleIdList': [StringElement('14630984', attributes={'IdType': 'pubmed'}), StringElement('10.1203/01.PDR.0000106314.99930.65', attributes={'IdType': 'doi'})]}, {'Citation': 'Johnson C, Havstad S, Ownby D. Children’s respiratory and Environmental Workgroup in the ECHO Consortium. Pediatric Asthma incidence rates in the United States from 1980 to 2017. J Allergy Clin Immunol. 2021;148:1270–80.', 'ArticleIdList': [StringElement('33964299', attributes={'IdType': 'pubmed'}), StringElement('8631308', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.jaci.2021.04.027', attributes={'IdType': 'doi'})]}, {'Citation': 'Pignataro F, Bonini M, Forgione A, Melandri S, Usmani O. Asthma and gender: the female lung. Pharmacol Res. 2017;119:384–90.', 'ArticleIdList': [StringElement('28238829', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.phrs.2017.02.017', attributes={'IdType': 'doi'})]}, {'Citation': 'Taveira-DaSilva AM, Moss J. Optimizing treatments for lymphangioleiomyomatosis. Expert Rev Respir Med. 2012;6:267–76.', 'ArticleIdList': [StringElement('22788941', attributes={'IdType': 'pubmed'}), StringElement('3429940', attributes={'IdType': 'pmc'}), StringElement('10.1586/ers.12.26', attributes={'IdType': 'doi'})]}, {'Citation': 'Townsend EA, Miller VM, Prakash Y. Sex differences and sex steroids in lung health and disease. Endocr Rev. 2012;33:1–47.', 'ArticleIdList': [StringElement('22240244', attributes={'IdType': 'pubmed'}), StringElement('3365843', attributes={'IdType': 'pmc'}), StringElement('10.1210/er.2010-0031', attributes={'IdType': 'doi'})]}, {'Citation': 'Vink NM, Postma DS, Schouten JP, Rosmalen JG, Boezen HM. Gender differences in asthma development and remission during transition through puberty: the TRacking adolescents’ individual lives Survey (TRAILS) study. J Allergy Clin Immunol. 2010;126:498–504. e496.', 'ArticleIdList': [StringElement('20816186', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.jaci.2010.06.018', attributes={'IdType': 'doi'})]}, {'Citation': 'Lachowicz-Scroggins ME, Vuga LJ, Laposky AD, Brown M, Banerjee K, Croxton TL, Kiley JP. The intersection of women’s health, lung health, and disease. Volume 321. American Physiological Society Rockville, MD. 2021. p. L624.'}, {'Citation': 'Zein JG, Erzurum SC. Asthma is different in women. Curr Allergy Asthma Rep. 2015;15:1–10.', 'ArticleIdList': [StringElement('10.1007/s11882-015-0528-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Baines KJ, West RC. Sex differences in innate and adaptive immunity impact fetal, placental, and maternal health. Biol Reprod. 2023;109:256–70.', 'ArticleIdList': [StringElement('37418168', attributes={'IdType': 'pubmed'}), StringElement('10.1093/biolre/ioad072', attributes={'IdType': 'doi'})]}, {'Citation': 'Streissguth AP. Sex differences in prenatal alcohol abuse in humans. 2012.'}, {'Citation': 'Flannigan K, Poole N, Cook J, Unsworth K. Sex-related differences among individuals assessed for fetal alcohol spectrum disorder in Canada. Alcohol: Clin Experimental Res. 2023;47:613–23.'}, {'Citation': 'Paolozza A, Munn R, Munoz DP, Reynolds JN. Eye movements reveal sexually dimorphic deficits in children with fetal alcohol spectrum disorder. Front NeuroSci. 2015;9:76.', 'ArticleIdList': [StringElement('25814922', attributes={'IdType': 'pubmed'}), StringElement('4356081', attributes={'IdType': 'pmc'}), StringElement('10.3389/fnins.2015.00076', attributes={'IdType': 'doi'})]}, {'Citation': 'Candelaria-Cook FT, Schendel ME, Romero LL, Cerros C, Hill DE, Stephen JM. Sex-specific differences in Resting Oscillatory Dynamics in children with prenatal Alcohol exposure. Neuroscience. 2024;543:121–36.', 'ArticleIdList': [StringElement('38387734', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.neuroscience.2024.02.016', attributes={'IdType': 'doi'})]}, {'Citation': 'Bake S, Pinson MR, Pandey S, Chambers JP, Mota R, Fairchild AE, Miranda RC, Sohrabji F. Prenatal alcohol-induced sex differences in immune, metabolic and neurobehavioral outcomes in adult rats. Brain Behav Immun. 2021;98:86–100.', 'ArticleIdList': [StringElement('34390803', attributes={'IdType': 'pubmed'}), StringElement('8591773', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.bbi.2021.08.207', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang X, Gomutputra P, Wolgemuth DJ, Baxi L. Effects of acute alcohol intoxication in the second trimester of pregnancy on development of the murine fetal lung. Am J Obstet Gynecol. 2007;197:269. e261-269. e264.', 'ArticleIdList': [StringElement('10.1016/j.ajog.2007.06.031', attributes={'IdType': 'doi'})]}, {'Citation': 'Lazic T, Wyatt TA, Matic M, Meyerholz DK, Grubor B, Gallup JM, Kersting KW, Imerman PM, Almeida-De-Macedo M, Ackermann MR. Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia. Alcohol. 2007;41:347–55.', 'ArticleIdList': [StringElement('17889311', attributes={'IdType': 'pubmed'}), StringElement('2083706', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.alcohol.2007.07.006', attributes={'IdType': 'doi'})]}, {'Citation': 'Sozo F, O’Day L, Maritz G, Kenna K, Stacy V, Brew N, Walker D, Bocking A, Brien J, Harding R. Repeated ethanol exposure during late gestation alters the maturation and innate immune status of the ovine fetal lung. Am J Physiology-Lung Cell Mol Physiol. 2009;296:L510–8.', 'ArticleIdList': [StringElement('10.1152/ajplung.90532.2008', attributes={'IdType': 'doi'})]}, {'Citation': 'McGill J, Meyerholz DK, Edsen-Moore M, Young B, Coleman RA, Schlueter AJ, Waldschmidt TJ, Cook RT, Legge KL. Fetal exposure to ethanol has long-term effects on the severity of influenza virus infections. J Immunol. 2009;182:7803–8.', 'ArticleIdList': [StringElement('19494304', attributes={'IdType': 'pubmed'}), StringElement('10.4049/jimmunol.0803881', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier TW, Ping X-D, Harris FL, Wong M, Elbahesh H, Brown LAS. Fetal alcohol exposure impairs alveolar macrophage function via decreased glutathione availability. Pediatr Res. 2005;57:76–81.', 'ArticleIdList': [StringElement('15531743', attributes={'IdType': 'pubmed'}), StringElement('10.1203/01.PDR.0000149108.44152.D3', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier TW, Young PA, Gabelaia L, Tang SM, Ping XD, Harris FL, Brown LAS. In utero ethanol exposure impairs defenses against experimental group B streptococcus in the term Guinea pig lung. Alcoholism: Clin Experimental Res. 2009;33:300–6.', 'ArticleIdList': [StringElement('10.1111/j.1530-0277.2008.00833.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Ping XD, Harris FL, Brown LAS, Gauthier TW. In vivo dysfunction of the term alveolar macrophage after in utero ethanol exposure. Alcoholism: Clin Experimental Res. 2007;31:308–16.', 'ArticleIdList': [StringElement('10.1111/j.1530-0277.2006.00306.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Reid N, Moritz KM, Akison LK. Adverse health outcomes associated with fetal alcohol exposure: a systematic review focused on immune-related outcomes. Pediatr Allergy Immunol. 2019;30:698–707.', 'ArticleIdList': [StringElement('31215695', attributes={'IdType': 'pubmed'}), StringElement('10.1111/pai.13099', attributes={'IdType': 'doi'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '5', 'Day': '13'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '1'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780208', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s12931-025-03094-z', attributes={'IdType': 'doi'}), StringElement('10.1186/s12931-025-03094-z', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('PVS1', attributes={'MajorTopicYN': 'N'}), StringElement('SpliceAI', attributes={'MajorTopicYN': 'N'}), StringElement('Splicing', attributes={'MajorTopicYN': 'N'}), StringElement('TP53', attributes={'MajorTopicYN': 'N'}), StringElement('VCEP specifications', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780207', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '09'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s40246-024-00714-5', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1479-7364', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '19', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Human genomics', 'ISOAbbreviation': 'Hum Genomics'}, 'ArticleTitle': 'Exploring the role of splicing in TP53 variant pathogenicity through predictions and minigene assays.', 'Pagination': {'StartPage': '2', 'MedlinePgn': '2'}, 'Abstract': {'AbstractText': [StringElement('TP53 variant classification benefits from the availability of large-scale functional data for missense variants generated using cDNA-based assays. However, absence of comprehensive splicing assay data for TP53 confounds the classification of the subset of predicted missense and synonymous variants that are also predicted to alter splicing. Our study aimed to generate and apply splicing assay data for a prioritised group of 59 TP53 predicted missense or synonymous variants that are also predicted to affect splicing by either SpliceAI or MaxEntScan.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'BACKGROUND'}), StringElement('We conducted splicing analyses using a minigene construct containing TP53 exons 2 to 9 transfected into human breast cancer SKBR3 cells, and compared results against different splice prediction methods, including correlation with the SpliceAI-10k calculator. We additionally applied the splicing results for TP53 variant classification using an approach consistent with the ClinGen Sequence Variant Interpretation Splicing Subgroup recommendations.', attributes={'Label': 'METHODS', 'NlmCategory': 'METHODS'}), StringElement('Aberrant transcript profile consistent with loss of function, and for which a PVS1 (RNA) code would be assigned, was observed for 42 (71%) of prioritised variants, of which aberrant transcript expression was over 50% for 26 variants, and over 80% for 15 variants. Data supported the use of SpliceAI\\u2009≥\\u20090.2 cutoff for predicted splicing impact of TP53 variants. Prediction of aberration types using SpliceAI-10k calculator generally aligned with the corresponding assay results, though maximum SpliceAI score did not accurately predict level of aberrant expression. Application of the observed splicing results was used to reclassify 27/59 (46%) test variants as (likely) pathogenic or (likely) benign.', attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('In conclusion, this study enhances the integration of splicing predictions and provides splicing assay data for exonic variants to support TP53 germline classification.', attributes={'Label': 'CONCLUSIONS', 'NlmCategory': 'CONCLUSIONS'})], 'CopyrightInformation': '© 2025. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Population Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.'}], 'Identifier': [], 'LastName': 'Fortuno', 'ForeName': 'Cristina', 'Initials': 'C'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Splicing and Genetic Susceptibility to Cancer, Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas - Universidad de Valladolid (CSIC-UVa), 47003, Valladolid, Spain.'}], 'Identifier': [], 'LastName': 'Llinares-Burguet', 'ForeName': 'Inés', 'Initials': 'I'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Population Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.'}], 'Identifier': [], 'LastName': 'Canson', 'ForeName': 'Daffodil M', 'Initials': 'DM'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.'}], 'Identifier': [], 'LastName': 'de la Hoya', 'ForeName': 'Miguel', 'Initials': 'M'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Splicing and Genetic Susceptibility to Cancer, Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas - Universidad de Valladolid (CSIC-UVa), 47003, Valladolid, Spain.'}], 'Identifier': [], 'LastName': 'Bueno-Martínez', 'ForeName': 'Elena', 'Initials': 'E'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Splicing and Genetic Susceptibility to Cancer, Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas - Universidad de Valladolid (CSIC-UVa), 47003, Valladolid, Spain.'}], 'Identifier': [], 'LastName': 'Sanoguera-Miralles', 'ForeName': 'Lara', 'Initials': 'L'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Population Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia.'}], 'Identifier': [], 'LastName': 'Caldes', 'ForeName': 'Sonsoles', 'Initials': 'S'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.'}, {'Identifier': [], 'Affiliation': 'Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.'}], 'Identifier': [], 'LastName': 'James', 'ForeName': 'Paul A', 'Initials': 'PA'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Splicing and Genetic Susceptibility to Cancer, Instituto de Biomedicina y Genética Molecular de Valladolid (IBGM), Consejo Superior de Investigaciones Científicas - Universidad de Valladolid (CSIC-UVa), 47003, Valladolid, Spain.'}], 'Identifier': [], 'LastName': 'Velasco-Sampedro', 'ForeName': 'Eladio A', 'Initials': 'EA'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Population Health Program, QIMR Berghofer Medical Research Institute, Herston, QLD, 4006, Australia. Amanda.Spurdle@qimrberghofer.edu.au.'}, {'Identifier': [], 'Affiliation': 'Faculty of Medicine, The University of Queensland, Brisbane, QLD, 4006, Australia. Amanda.Spurdle@qimrberghofer.edu.au.'}], 'Identifier': [], 'LastName': 'Spurdle', 'ForeName': 'Amanda B', 'Initials': 'AB'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': 'IIRS-21-102', 'Agency': 'National Breast Cancer Foundation', 'Country': ''}, {'GrantID': 'APP177524', 'Agency': 'National Health and Medical Research Council', 'Country': ''}, {'GrantID': 'APP177524', 'Agency': 'National Health and Medical Research Council', 'Country': ''}, {'GrantID': 'ISCIII (PI20/00110)', 'Agency': 'Spanish Ministry of Science and Innovation, Acción Estratégica en Salud 2019', 'Country': ''}, {'GrantID': 'ISCIII (PI24/00267)', 'Agency': 'Spanish Ministry of Science and Innovation, Acción Estratégica en Salud 2024', 'Country': ''}, {'GrantID': 'ISCIII (PI23/00047)', 'Agency': 'Spanish Ministry of Science and Innovation, Acción Estratégica en Salud 2023', 'Country': ''}, {'GrantID': 'ISCIII (PI23/00047)', 'Agency': 'Spanish Ministry of Science and Innovation, Acción Estratégica en Salud 2023', 'Country': ''}, {'GrantID': 'ISCIII (PI23/00047)', 'Agency': 'Spanish Ministry of Science and Innovation, Acción Estratégica en Salud 2023', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'Hum Genomics', 'NlmUniqueID': '101202210', 'ISSNLinking': '1473-9542'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: This project has been approved by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee (HREC) under QIMR HREC Approval P1051. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Fortuno C, Feng BJ, Carroll C, Innella G, Kohlmann W, Lázaro C, et al. Cancer risks associated with TP53 pathogenic variants: maximum likelihood analysis of extended pedigrees for diagnosis of first cancers beyond the Li-fraumeni syndrome spectrum. JCO Precis Oncol. 2024;8: e2300453.', 'ArticleIdList': [StringElement('10.1200/PO.23.00453', attributes={'IdType': 'doi'}), StringElement('38412388', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023;110(7):1046–67.', 'ArticleIdList': [StringElement('10.1016/j.ajhg.2023.06.002', attributes={'IdType': 'doi'}), StringElement('37352859', attributes={'IdType': 'pubmed'}), StringElement('10357475', attributes={'IdType': 'pmc'})]}, {'Citation': 'Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176(3):535-48.e24.', 'ArticleIdList': [StringElement('10.1016/j.cell.2018.12.015', attributes={'IdType': 'doi'}), StringElement('30661751', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Eng L, Coutinho G, Nahas S, Yeo G, Tanouye R, Babaei M, et al. Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Hum Mutat. 2004;23(1):67–76.', 'ArticleIdList': [StringElement('10.1002/humu.10295', attributes={'IdType': 'doi'}), StringElement('14695534', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol. 2004;11(2–3):377–94.', 'ArticleIdList': [StringElement('10.1089/1066527041410418', attributes={'IdType': 'doi'}), StringElement('15285897', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Fortuno C, James PA, Young EL, Feng B, Olivier M, Pesaran T, et al. Improved, ACMG-Compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants. Human Mutation. 2018.'}, {'Citation': 'Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA. 2003;100(14):8424–9.', 'ArticleIdList': [StringElement('10.1073/pnas.1431692100', attributes={'IdType': 'doi'}), StringElement('12826609', attributes={'IdType': 'pubmed'}), StringElement('166245', attributes={'IdType': 'pmc'})]}, {'Citation': 'Giacomelli AO, Yang X, Lintner RE, McFarland JM, Duby M, Kim J, et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat Genet. 2018;50(10):1381–7.', 'ArticleIdList': [StringElement('10.1038/s41588-018-0204-y', attributes={'IdType': 'doi'}), StringElement('30224644', attributes={'IdType': 'pubmed'}), StringElement('6168352', attributes={'IdType': 'pmc'})]}, {'Citation': 'Palmisano A, Vural S, Zhao Y, Sonkin D. MutSpliceDB: A database of splice sites variants with RNA-seq based evidence on effects on splicing. Hum Mutat. 2021;42(4):342–5.', 'ArticleIdList': [StringElement('10.1002/humu.24185', attributes={'IdType': 'doi'}), StringElement('33600011', attributes={'IdType': 'pubmed'}), StringElement('9867871', attributes={'IdType': 'pmc'})]}, {'Citation': 'Sullivan PJ, Quinn JMW, Wu W, Pinese M, Cowley MJ. SpliceVarDB: a comprehensive database of experimentally validated human splicing variants. Am J Hum Genet. 2024;111(10):2164–75.', 'ArticleIdList': [StringElement('10.1016/j.ajhg.2024.08.002', attributes={'IdType': 'doi'}), StringElement('39226898', attributes={'IdType': 'pubmed'}), StringElement('11480807', attributes={'IdType': 'pmc'})]}, {'Citation': 'Shamsani J, Kazakoff SH, Armean IM, McLaren W, Parsons MT, Thompson BA, et al. A plugin for the Ensembl Variant Effect Predictor that uses MaxEntScan to predict variant spliceogenicity. Bioinformatics. 2019;35(13):2315–7.', 'ArticleIdList': [StringElement('10.1093/bioinformatics/bty960', attributes={'IdType': 'doi'}), StringElement('30475984', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Canson DM, Llinares-Burguet I, Fortuno C, Sanoguera-Miralles L, Bueno-Martínez E, de la Hoya M, et al. TP53 minigene analysis of 161 sequence changes provides evidence for role of spatial constraint and regulatory elements on variant-induced splicing impact. bioRxiv. 2024:2024.10.07.617118.'}, {'Citation': 'Acedo A, Hernández-Moro C, Curiel-García Á, Díez-Gómez B, Velasco EA. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons. Hum Mutat. 2015;36(2):210–21.', 'ArticleIdList': [StringElement('10.1002/humu.22725', attributes={'IdType': 'doi'}), StringElement('25382762', attributes={'IdType': 'pubmed'}), StringElement('4371643', attributes={'IdType': 'pmc'})]}, {'Citation': 'Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, et al. A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation. Mol Cell. 2018;71(1):178–90.', 'ArticleIdList': [StringElement('10.1016/j.molcel.2018.06.012', attributes={'IdType': 'doi'}), StringElement('29979965', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Parsons MT, de la Hoya M, Richardson ME, Tudini E, Anderson M, Berkofsky-Fessler W, et al. Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 variant curation expert panel. Am J Hum Genet. 2024;111(9):2044–58.', 'ArticleIdList': [StringElement('10.1016/j.ajhg.2024.07.013', attributes={'IdType': 'doi'}), StringElement('39142283', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Canson DM, Davidson AL, de la Hoya M, Parsons MT, Glubb DM, Kondrashova O, et al. SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletion. Bioinformatics. 2023;39(4).'}, {'Citation': 'de Andrade KC, Lee EE, Tookmanian EM, Kesserwan CA, Manfredi JJ, Hatton JN, et al. The TP53 database: transition from the international agency for research on cancer to the US National Cancer Institute. Cell Death Differ. 2022;29(5):1071–3.', 'ArticleIdList': [StringElement('10.1038/s41418-022-00976-3', attributes={'IdType': 'doi'}), StringElement('35352025', attributes={'IdType': 'pubmed'}), StringElement('9090805', attributes={'IdType': 'pmc'})]}, {'Citation': 'Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–43.', 'ArticleIdList': [StringElement('10.1038/s41586-020-2308-7', attributes={'IdType': 'doi'}), StringElement('32461654', attributes={'IdType': 'pubmed'}), StringElement('7334197', attributes={'IdType': 'pmc'})]}, {'Citation': 'Chang MT, Bhattarai TS, Schram AM, Bielski CM, Donoghue MTA, Jonsson P, et al. Accelerating discovery of functional mutant alleles in cancer. Cancer Discov. 2018;8(2):174–83.', 'ArticleIdList': [StringElement('10.1158/2159-8290.CD-17-0321', attributes={'IdType': 'doi'}), StringElement('29247016', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Fortuno C, McGoldrick K, Pesaran T, Dolinsky J, Hoang L, Weitzel JN, et al. Suspected clonal hematopoiesis as a natural functional assay of TP53 germline variant pathogenicity. Genet Med. 2022;24(3):673–80.', 'ArticleIdList': [StringElement('10.1016/j.gim.2021.10.018', attributes={'IdType': 'doi'}), StringElement('34906512', attributes={'IdType': 'pubmed'})]}, {'Citation': 'de Sainte Agathe JM, Filser M, Isidor B, Besnard T, Gueguen P, Perrin A, et al. SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation. Hum Genomics. 2023;17(1):7.', 'ArticleIdList': [StringElement('10.1186/s40246-023-00451-1', attributes={'IdType': 'doi'}), StringElement('36765386', attributes={'IdType': 'pubmed'}), StringElement('9912651', attributes={'IdType': 'pmc'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '21'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '21'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '11', 'Day': '15'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '12', 'Day': '23'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780207', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s40246-024-00714-5', attributes={'IdType': 'doi'}), StringElement('10.1186/s40246-024-00714-5', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('Bone sarcoma', attributes={'MajorTopicYN': 'N'}), StringElement('Compress', attributes={'MajorTopicYN': 'N'}), StringElement('Implant failure', attributes={'MajorTopicYN': 'N'}), StringElement('Megaprosthesis', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780205', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '09'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s13256-024-05012-1', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1752-1947', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '19', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Journal of medical case reports', 'ISOAbbreviation': 'J Med Case Rep'}, 'ArticleTitle': 'Implant failure of the Compress prosthesis: a case report.', 'Pagination': {'StartPage': '6', 'MedlinePgn': '6'}, 'Abstract': {'AbstractText': [StringElement('The Compress is designed to achieve bone formation and stability by applying pressure at the bone-implant interface, minimizing the likelihood of aseptic loosening, which is a complication of stem implants. Herein, we report two cases of implant failure using the Compress.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'BACKGROUND'}), StringElement('Case 1 describes a 36\\xa0year-old Japanese man who underwent extraarticular tumor resection, Compress arthroplasty, and reconstruction with a gastrocnemius flap after preoperative chemotherapy for a secondary malignant giant cell tumor in the right distal femur. Postoperatively, partial weight-bearing was started at 6\\xa0weeks, and full weight-bearing was allowed at 10\\xa0weeks. One year after the surgery, a fall caused implant failure. No bone formation at the implant-bone interface was observed on radiographs immediately prior to the failure. Bone formation was achieved at the interface 1\\xa0year after revision arthroplasty, and the patient was able to walk unassisted with a brace. Case 2 describes a 14\\xa0year-old Japanese boy who underwent wide surgical resection of osteosarcoma in the left tibia, Compress arthroplasty, and reconstruction with a gastrocnemius flap after preoperative chemotherapy. The postoperative weight-bearing schedule was the same as that of case 1. One year after the surgery, the patient experienced implant failure. A revision arthroplasty was performed. One year after revision surgery, the patient was able to walk unassisted.', attributes={'Label': 'CASE PRESENTATION', 'NlmCategory': 'METHODS'}), StringElement('Although the risk factors for Compress failure remain unknown, it is important to consider patient characteristics that may inhibit bone formation, implant selection, postoperative loading timing, and radiographs of bone formation at the implant interface when using the Compress.', attributes={'Label': 'CONCLUSION', 'NlmCategory': 'CONCLUSIONS'})], 'CopyrightInformation': '© 2025. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan.'}], 'Identifier': [], 'LastName': 'Koike', 'ForeName': 'Hiroshi', 'Initials': 'H'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan. k-ikuta@med.nagoya-u.ac.jp.'}], 'Identifier': [], 'LastName': 'Ikuta', 'ForeName': 'Kunihiro', 'Initials': 'K'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Advanced Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan.'}], 'Identifier': [], 'LastName': 'Urakawa', 'ForeName': 'Hiroshi', 'Initials': 'H'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Rare Cancer Center, Nagoya University Hospital, 65 Tsurumai, Showa Nagoya, Aichi, 466-8550, Japan.'}], 'Identifier': [], 'LastName': 'Sakai', 'ForeName': 'Tomohisa', 'Initials': 'T'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan.'}], 'Identifier': [], 'LastName': 'Fujito', 'ForeName': 'Takeo', 'Initials': 'T'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Rehabilitation Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan.'}], 'Identifier': [], 'LastName': 'Nishida', 'ForeName': 'Yoshihiro', 'Initials': 'Y'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya University Hospital, 65 Tsurumai, Showa, Nagoya, Aichi, 466-8550, Japan.'}], 'Identifier': [], 'LastName': 'Imagama', 'ForeName': 'Shiro', 'Initials': 'S'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'J Med Case Rep', 'NlmUniqueID': '101293382', 'ISSNLinking': '1752-1947'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: The study was approved by the Ethics Committee at our hospital (2015-03586850), and informed consent was obtained from all patients. It has adhered to any reporting/ethical guidelines. Consent for publication: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. Competing interests: Shiro Imagama has received grants from Zimmer-Biomet. The other authors declare no financial disclosures.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Ahlmann ER, Menendez LR, Kermani C, Gotha H. Survivorship and clinical outcome of modular endoprosthetic reconstruction for neoplastic disease of the lower limb. J Bone Joint Surg Am. 2006;88:790–5. https://doi.org/10.1302/0301-620X.88B6.17519 .', 'ArticleIdList': [StringElement('10.1302/0301-620X.88B6.17519', attributes={'IdType': 'doi'})]}, {'Citation': 'Kawai A, Muschler GF, Lane JM, Otis JC, Healey JH. Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur: medium to long-term results. J Bone Joint Surg Am. 1998;80:636–47. https://doi.org/10.2106/00004623-199805000-00004 .', 'ArticleIdList': [StringElement('10.2106/00004623-199805000-00004', attributes={'IdType': 'doi'}), StringElement('9611024', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kinkel S, Lehner B, Kleinhans JA, Jakubowitz E, Ewerbeck V, Heisel C. Medium to long-term results after reconstruction of bone defects at the knee with tumor endoprostheses. J Surg Oncol. 2010;101:166–9. https://doi.org/10.1002/jso.21441 .', 'ArticleIdList': [StringElement('10.1002/jso.21441', attributes={'IdType': 'doi'}), StringElement('19924724', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Morgan HD, Cizik AM, Leopold SS, Hawkins DS, Conrad EU. Survival of tumor megaprostheses replacements about the knee. Clin Orthop Relat Res. 2006;450:39–45. https://doi.org/10.1097/01.blo.0000229330.14029.0d .', 'ArticleIdList': [StringElement('10.1097/01.blo.0000229330.14029.0d', attributes={'IdType': 'doi'}), StringElement('16906094', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Pala E, Trovarelli G, Calabrò T, Angelini A, Abati CN, Ruggieri P. Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis. Clin Orthop Relat Res. 2015;473:891–9. https://doi.org/10.1007/s11999-014-3699-2 .', 'ArticleIdList': [StringElement('10.1007/s11999-014-3699-2', attributes={'IdType': 'doi'}), StringElement('24874116', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Healey JH, Morris CD, Athanasian EA, Boland PJ. Compress<sup>®</sup> knee arthroplasty has 80% 10\\xa0year survivorship and novel forms of bone failure knee. Clin Orthop Relat Res. 2013;471:774–83. https://doi.org/10.1007/s11999-012-2635-6 .', 'ArticleIdList': [StringElement('10.1007/s11999-012-2635-6', attributes={'IdType': 'doi'}), StringElement('23054526', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kagan R, Adams J, Schulman C, Laursen R, Espana K, Yoo J, et\\xa0al. What factors are associated with failure of compressive osseointegration fixation? Clin Orthop Relat Res. 2017;475:698–704. https://doi.org/10.1007/s11999-016-4764-9 .', 'ArticleIdList': [StringElement('10.1007/s11999-016-4764-9', attributes={'IdType': 'doi'}), StringElement('26926774', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zimel MN, Farfalli GL, Zindman AM, Riedel ER, Morris CD, Boland PJ, et\\xa0al. Revision distal femoral arthroplasty with the compress<sup>®</sup> prosthesis has a low rate of mechanical failure at 10 years. Clin Orthop Relat Res. 2016;474:528–36. https://doi.org/10.1007/s11999-015-4552-y .', 'ArticleIdList': [StringElement('10.1007/s11999-015-4552-y', attributes={'IdType': 'doi'}), StringElement('26394638', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Goldman LH, Morse LJ, O’Donnell RJ, Wustrack RL. How often does spindle failure occur in compressive osseointegration endoprostheses for oncologic reconstruction? Clin Orthop Relat Res. 2016;474:1714–23. https://doi.org/10.1007/s11999-016-4839-7 .', 'ArticleIdList': [StringElement('10.1007/s11999-016-4839-7', attributes={'IdType': 'doi'}), StringElement('27106130', attributes={'IdType': 'pubmed'}), StringElement('4887378', attributes={'IdType': 'pmc'})]}, {'Citation': 'Yilmaz M, Sørensen MS, Sæbye C, Baad-Hansen T, Petersen MM. Long-term results of the Global Modular Replacement System tumor prosthesis for reconstruction after limb-sparing bone resections in orthopedic oncologic conditions: Results from a national cohort. J Surg Oncol. 2019;120:183–92. https://doi.org/10.1002/jso.25490 .', 'ArticleIdList': [StringElement('10.1002/jso.25490', attributes={'IdType': 'doi'}), StringElement('31042011', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, et\\xa0al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011;93:418–29. https://doi.org/10.2106/JBJS.J.00834 .', 'ArticleIdList': [StringElement('10.2106/JBJS.J.00834', attributes={'IdType': 'doi'}), StringElement('21368074', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Carlisle E, Steadman P, Lowe M, Rowell P, Sommerville S. What factors are associated with stem breakage in distal femoral endoprosthetic replacements undertaken for primary bone tumors? Clin Orthop Relat Res. 2023. https://doi.org/10.1097/CORR.0000000000002746 .', 'ArticleIdList': [StringElement('10.1097/CORR.0000000000002746', attributes={'IdType': 'doi'}), StringElement('37368003', attributes={'IdType': 'pubmed'}), StringElement('10566930', attributes={'IdType': 'pmc'})]}, {'Citation': 'Groundland J, Brown JM, Monument M, Bernthal N, Jones KB, Randall RL. What are the long-term surgical outcomes of compressive endoprosthetic osseointegration of the femur with a minimum 10\\xa0year follow-up period? Clin Orthop Relat Res. 2022;480:539–48. https://doi.org/10.1097/CORR.0000000000001979 .', 'ArticleIdList': [StringElement('10.1097/CORR.0000000000001979', attributes={'IdType': 'doi'}), StringElement('34559734', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Tyler WK, Healey JH, Morris CD, Boland PJ, O’Donnell RJ. Compress<sup>®</sup> periprosthetic fractures: interface stability and ease of revision. Clin Orthop Relat Res. 2009;467:2800–3280. https://doi.org/10.1007/s11999-009-0946-z .', 'ArticleIdList': [StringElement('10.1007/s11999-009-0946-z', attributes={'IdType': 'doi'}), StringElement('19565305', attributes={'IdType': 'pubmed'}), StringElement('2758988', attributes={'IdType': 'pmc'})]}, {'Citation': 'MAUDE—manufacturer and user facility device experience. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/search.cfm . Accessed 29 Nov 2023.'}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '22'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '22'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '10', 'Day': '16'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '11', 'Day': '15'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '0'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780205', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s13256-024-05012-1', attributes={'IdType': 'doi'}), StringElement('10.1186/s13256-024-05012-1', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('CASP5', attributes={'MajorTopicYN': 'N'}), StringElement('Clear cell renal cell carcinoma', attributes={'MajorTopicYN': 'N'}), StringElement('Immune infiltration landscape', attributes={'MajorTopicYN': 'N'}), StringElement('PANoptosis', attributes={'MajorTopicYN': 'N'}), StringElement('Risk model', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': [], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780201', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '08'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '08'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s12935-024-03630-9', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1475-2867', attributes={'IssnType': 'Print'}), 'JournalIssue': DictElement({'Volume': '25', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '08'}}, attributes={'CitedMedium': 'Print'}), 'Title': 'Cancer cell international', 'ISOAbbreviation': 'Cancer Cell Int'}, 'ArticleTitle': 'CASP5 associated with PANoptosis promotes tumorigenesis and progression of clear cell renal cell carcinoma.', 'Pagination': {'StartPage': '8', 'MedlinePgn': '8'}, 'Abstract': {'AbstractText': ['Clear cell renal cell carcinoma (ccRCC) is a globally severe cancer with an unfavorable prognosis. PANoptosis, a form of cell death regulated by PANoptosomes, plays a role in numerous cancer types. However, the specific roles of genes associated with PANoptosis in the development and advancement of ccRCC remain unclear. Our study developed a risk model utilizing three PANoptosis-associated genes (Caspase\\xa04 (CASP4), TLR3, and CASP5). This model demonstrated a high degree of precision in predicting the prognosis for patients with ccRCC. ccRCC patients in the high-risk group had the strongest immune cell activity, experiencing immune evasion, and might potentially derive advantages from treatment involving combined immune checkpoint inhibitors. CASP5 was highly expressed in ccRCC tissues by RT-qPCR, western blotting, and immunofluorescence. Stable CASP5 knockdown cell lines were constructed by lentivirus in vitro transfection technique. Reducing CASP5 level suppressed the growth, migration, and invasion of ccRCC cells, while encouraging cell apoptosis. In addition, the results of in vivo tumorigenesis experiments showed that down-regulating CASP5 expression inhibited the tumorigenic ability of 786-O cells. Together, the innovative risk model using PANoptosis-associated genes effectively forecasts the tumor microenvironment and survival rates for ccRCC, offering a novel approach to the early, precise diagnosis of ccRCC and the advancement of personalized treatment strategies.'], 'CopyrightInformation': '© 2024. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute for Genome Engineered Animal Models of Human Diseases, National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, 9 West Section Lvshun South Road, Dalian, 116044, China.'}], 'Identifier': [], 'LastName': 'Yang', 'ForeName': 'Kangkang', 'Initials': 'K'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Clinical Laboratory, Central Hospital of Dalian University of Technology, 826 Southwest Road, Dalian, 116033, China.'}], 'Identifier': [], 'LastName': 'Wang', 'ForeName': 'Yushuang', 'Initials': 'Y'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, 9 West Section Lvshun South Road, Dalian, 116044, China.'}], 'Identifier': [], 'LastName': 'Jian', 'ForeName': 'Yuli', 'Initials': 'Y'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Clinical Laboratory, Central Hospital of Dalian University of Technology, 826 Southwest Road, Dalian, 116033, China.'}], 'Identifier': [], 'LastName': 'Wang', 'ForeName': 'Bo', 'Initials': 'B'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Urology, Central Hospital of Dalian University of Technology, 826 Southwest Road, Dalian, 116033, China.'}], 'Identifier': [], 'LastName': 'Du', 'ForeName': 'Hao', 'Initials': 'H'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Pharmaceutical sciences, Massachusetts College of Pharmacy and Health Science University, 179 Longwood Avenue, Boston, Massachusetts, 02115, USA.'}], 'Identifier': [], 'LastName': 'Xia', 'ForeName': 'Yuqing', 'Initials': 'Y'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Obstetrics and Gynecology, The Second Hospital of Dalian Medical University, 467 Zhongshan Road, Dalian, 116023, China.'}], 'Identifier': [], 'LastName': 'Bi', 'ForeName': 'Jianlei', 'Initials': 'J'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute for Genome Engineered Animal Models of Human Diseases, National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, 9 West Section Lvshun South Road, Dalian, 116044, China.'}], 'Identifier': [], 'LastName': 'Guo', 'ForeName': 'Meihua', 'Initials': 'M'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Clinical Laboratory, Central Hospital of Dalian University of Technology, 826 Southwest Road, Dalian, 116033, China. postlizhi@126.com.'}], 'Identifier': [], 'LastName': 'Li', 'ForeName': 'Zhi', 'Initials': 'Z'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Institute for Genome Engineered Animal Models of Human Diseases, National Center of Genetically Engineered Animal Models for International Research, Dalian Medical University, 9 West Section Lvshun South Road, Dalian, 116044, China. ningwang1990328@163.com.'}], 'Identifier': [], 'LastName': 'Wang', 'ForeName': 'Ning', 'Initials': 'N'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': 'No.2022ZXYG23', 'Agency': 'Dalian life and health field guidance program project', 'Country': ''}, {'GrantID': 'No.508027', 'Agency': 'Youth Talent Cultivation Fund Project of Dalian Medical University', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'Cancer Cell Int', 'NlmUniqueID': '101139795', 'ISSNLinking': '1475-2867'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: The study was approved by the Ethics Committee of the Affiliated Central Hospital of Dalian University of Technology (Dalian Central Hospital) (No. YN2024-053-01). All the study subjects provided informed consent. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Linehan WM, Ricketts CJ. The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications. Nat Reviews Urol. 2019;16(9):539–52.', 'ArticleIdList': [StringElement('10.1038/s41585-019-0211-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354–66.', 'ArticleIdList': [StringElement('10.1056/NEJMra1601333', attributes={'IdType': 'doi'}), StringElement('28121507', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356(2):115–24.', 'ArticleIdList': [StringElement('10.1056/NEJMoa065044', attributes={'IdType': 'doi'}), StringElement('17215529', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wan X, Zhang Y, Tan C, Zeng X, Peng L. First-line Nivolumab Plus Ipilimumab vs Sunitinib for metastatic renal cell carcinoma: a cost-effectiveness analysis. JAMA Oncol. 2019;5(4):491–6.', 'ArticleIdList': [StringElement('6459127', attributes={'IdType': 'pmc'}), StringElement('10.1001/jamaoncol.2018.7086', attributes={'IdType': 'doi'}), StringElement('30789633', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hahn AW, Klaassen Z, Agarwal N, Haaland B, Esther J, Ye XY, Wang X, Pal SK, Wallis CJD. First-line treatment of metastatic renal cell carcinoma: a systematic review and network Meta-analysis. Eur Urol Oncol. 2019;2(6):708–15.', 'ArticleIdList': [StringElement('10.1016/j.euo.2019.09.002', attributes={'IdType': 'doi'}), StringElement('31588018', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol. 2009;9(5):353–63.', 'ArticleIdList': [StringElement('2818721', attributes={'IdType': 'pmc'}), StringElement('10.1038/nri2545', attributes={'IdType': 'doi'}), StringElement('19365408', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18(5):1106–21.', 'ArticleIdList': [StringElement('8008022', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41423-020-00630-3', attributes={'IdType': 'doi'}), StringElement('33785842', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and Pyroptosis. Annu Rev Immunol. 2020;38:567–95.', 'ArticleIdList': [StringElement('7190443', attributes={'IdType': 'pmc'}), StringElement('10.1146/annurev-immunol-073119-095439', attributes={'IdType': 'doi'}), StringElement('32017655', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, et al. Molecular mechanisms of cell death: recommendations of the nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486–541.', 'ArticleIdList': [StringElement('5864239', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41418-017-0012-4', attributes={'IdType': 'doi'}), StringElement('29362479', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Häcker G. Apoptosis in infection. Microbes Infect. 2018;20(9–10):552–9.', 'ArticleIdList': [StringElement('10.1016/j.micinf.2017.10.006', attributes={'IdType': 'doi'}), StringElement('29109017', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022;232:108010.', 'ArticleIdList': [StringElement('10.1016/j.pharmthera.2021.108010', attributes={'IdType': 'doi'}), StringElement('34619283', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Christgen S, Zheng M, Kesavardhana S, Karki R, Malireddi RKS, Banoth B, Place DE, Briard B, Sharma BR, Tuladhar S, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:237.', 'ArticleIdList': [StringElement('7274033', attributes={'IdType': 'pmc'}), StringElement('10.3389/fcimb.2020.00237', attributes={'IdType': 'doi'}), StringElement('32547960', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Karki R, Lee S, Mall R, Pandian N, Wang Y, Sharma BR, Malireddi RS, Yang D, Trifkovic S, Steele JA, et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol. 2022;7(74):eabo6294.', 'ArticleIdList': [StringElement('10.1126/sciimmunol.abo6294', attributes={'IdType': 'doi'}), StringElement('35587515', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Samir P, Malireddi RKS, Kanneganti TD. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis). Frontiers in cellular and infection microbiology 2020, 10:238.'}, {'Citation': 'Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, Tuladhar S, Mummareddy H, Burton AR, Vogel P et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight 2020, 5(12).'}, {'Citation': 'Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin Immunol (Orlando Fla). 2022;238:109019.', 'ArticleIdList': [StringElement('10.1016/j.clim.2022.109019', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang X, Sun R, Chan S, Meng L, Xu Y, Zuo X, Wang Z, Hu X, Han Q, Dai L, et al. PANoptosis-based molecular clustering and prognostic signature predicts patient survival and immune landscape in colon cancer. Front Genet. 2022;13:955355.', 'ArticleIdList': [StringElement('9515384', attributes={'IdType': 'pmc'}), StringElement('10.3389/fgene.2022.955355', attributes={'IdType': 'doi'}), StringElement('36186438', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–95.', 'ArticleIdList': [StringElement('10.1016/j.immuni.2013.10.003', attributes={'IdType': 'doi'}), StringElement('24138885', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.', 'ArticleIdList': [StringElement('4739640', attributes={'IdType': 'pmc'}), StringElement('10.1038/nmeth.3337', attributes={'IdType': 'doi'}), StringElement('25822800', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.', 'ArticleIdList': [StringElement('10.1038/ncomms3612', attributes={'IdType': 'doi'}), StringElement('24113773', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhou LZ, Xiao HQ, Chen J. Mismatch repair gene MSH6 correlates with the prognosis, immune status and immune checkpoint inhibitors response of endometrial cancer. Front Immunol. 2024;15:1302797.', 'ArticleIdList': [StringElement('10881679', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2024.1302797', attributes={'IdType': 'doi'}), StringElement('38390329', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wei C, Chen M, Deng W, Bie L, Ma Y, Zhang C, Liu K, Shen W, Wang S, Yang C et al. Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes. Brief Bioinform 2022, 23(1).'}, {'Citation': 'Williamson TJ, Pearson JR, Ischia J, Bolton DM, Lawrentschuk N. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma. BJU Int. 2016;117(4):555–62.', 'ArticleIdList': [StringElement('10.1111/bju.13384', attributes={'IdType': 'doi'}), StringElement('26617405', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005;353(23):2477–90.', 'ArticleIdList': [StringElement('10.1056/NEJMra043172', attributes={'IdType': 'doi'}), StringElement('16339096', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J, Ficarra V. Renal cell carcinoma. Nat Reviews Disease Primers. 2017;3:17009.', 'ArticleIdList': [StringElement('10.1038/nrdp.2017.9', attributes={'IdType': 'doi'}), StringElement('28276433', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297(1):26–38.', 'ArticleIdList': [StringElement('7811275', attributes={'IdType': 'pmc'}), StringElement('10.1111/imr.12909', attributes={'IdType': 'doi'}), StringElement('32729116', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Ketelut-Carneiro N, Fitzgerald KA. Apoptosis, pyroptosis, and Necroptosis-Oh my! The many ways a cell can die. J Mol Biol. 2022;434(4):167378.', 'ArticleIdList': [StringElement('10.1016/j.jmb.2021.167378', attributes={'IdType': 'doi'}), StringElement('34838807', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Giraldo NA, Becht E, Pagès F, Skliris G, Verkarre V, Vano Y, Mejean A, Saint-Aubert N, Lacroix L, Natario I, et al. Orchestration and Prognostic significance of Immune checkpoints in the Microenvironment of primary and metastatic renal cell Cancer. Clin cancer Research: Official J Am Association Cancer Res. 2015;21(13):3031–40.', 'ArticleIdList': [StringElement('10.1158/1078-0432.CCR-14-2926', attributes={'IdType': 'doi'})]}, {'Citation': 'Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res. 2001;61(13):5132–6.', 'ArticleIdList': [StringElement('11431351', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Dai S, Zeng H, Liu Z, Jin K, Jiang W, Wang Z, Lin Z, Xiong Y, Wang J, Chang Y et al. Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma. J Immunother Cancer 2021, 9(2).'}, {'Citation': 'Hatzioannou A, Boumpas A, Papadopoulou M, Papafragkos I, Varveri A, Alissafi T, Verginis P. Regulatory T cells in autoimmunity and Cancer: a duplicitous lifestyle. Front Immunol. 2021;12:731947.', 'ArticleIdList': [StringElement('8446642', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2021.731947', attributes={'IdType': 'doi'}), StringElement('34539668', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Sanfrancesco JM, Cheng L. Complexity of the genomic landscape of renal cell carcinoma: implications for targeted therapy and precision immuno-oncology. Crit Rev Oncol/Hematol. 2017;119:23–8.', 'ArticleIdList': [StringElement('10.1016/j.critrevonc.2017.09.011', attributes={'IdType': 'doi'}), StringElement('29065981', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Sci (New York NY). 2015;348(6230):74–80.', 'ArticleIdList': [StringElement('10.1126/science.aaa6204', attributes={'IdType': 'doi'})]}, {'Citation': 'Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. Recent advances in targeting CD8 T-Cell immunity for more effective Cancer immunotherapy. Front Immunol. 2018;9:14.', 'ArticleIdList': [StringElement('5786548', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2018.00014', attributes={'IdType': 'doi'}), StringElement('29403496', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, et al. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. N Engl J Med. 2018;378(14):1277–90.', 'ArticleIdList': [StringElement('5972549', attributes={'IdType': 'pmc'}), StringElement('10.1056/NEJMoa1712126', attributes={'IdType': 'doi'}), StringElement('29562145', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Krause K, Caution K, Badr A, Hamilton K, Saleh A, Patel K, Seveau S, Hall-Stoodley L, Hegazi R, Zhang X, et al. CASP4/caspase-11 promotes autophagosome formation in response to bacterial infection. Autophagy. 2018;14(11):1928–42.', 'ArticleIdList': [StringElement('6152495', attributes={'IdType': 'pmc'}), StringElement('10.1080/15548627.2018.1491494', attributes={'IdType': 'doi'}), StringElement('30165781', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Meng L, Tian Z, Long X, Diao T, Hu M, Wang M, Zhang W, Zhang Y, Wang J, He Y. Caspase 4 overexpression as a prognostic marker in Clear Cell Renal Cell Carcinoma: a study based on the Cancer Genome Atlas Data Mining. Front Genet. 2020;11:600248.', 'ArticleIdList': [StringElement('10.3389/fgene.2020.600248', attributes={'IdType': 'doi'}), StringElement('33584797', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Fu L, Bao J, Li J, Li Q, Lin H, Zhou Y, Li J, Yan Y, Langston ME, Sun T, et al. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma. Front Immunol. 2022;13:1021935.', 'ArticleIdList': [StringElement('9561249', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2022.1021935', attributes={'IdType': 'doi'}), StringElement('36248876', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chen Y, Liu Y, Wang M. Identification of a pyroptosis-related gene signature and effect of silencing the CHMP4C and CASP4 in pancreatic adenocarcinoma. Int J Gen Med. 2022;15:3199–213.', 'ArticleIdList': [StringElement('8943832', attributes={'IdType': 'pmc'}), StringElement('10.2147/IJGM.S353849', attributes={'IdType': 'doi'}), StringElement('35342302', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Morikawa T, Sugiyama A, Kume H, Ota S, Kashima T, Tomita K, Kitamura T, Kodama T, Fukayama M, Aburatani H. Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin cancer Research: Official J Am Association Cancer Res. 2007;13(19):5703–9.', 'ArticleIdList': [StringElement('10.1158/1078-0432.CCR-07-0603', attributes={'IdType': 'doi'})]}, {'Citation': 'Liao G, Lv J, Ji A, Meng S, Chen C. TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment. Journal of oncology 2021, 2021:3336770.'}, {'Citation': 'Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et al. Apoptosis and cancer: mutations within caspase genes. J Med Genet. 2009;46(8):497–510.', 'ArticleIdList': [StringElement('10.1136/jmg.2009.066944', attributes={'IdType': 'doi'}), StringElement('19505876', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Han JH, Tweedell RE, Kanneganti TD. Evaluation of caspase activation to assess Innate Immune Cell Death. J Visualized Experiments: JoVE 2023(191).'}, {'Citation': 'Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, Shao F. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–5.', 'ArticleIdList': [StringElement('10.1038/nature15514', attributes={'IdType': 'doi'}), StringElement('26375003', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666–71.', 'ArticleIdList': [StringElement('10.1038/nature15541', attributes={'IdType': 'doi'}), StringElement('26375259', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, Hu L, Shao F. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187–92.', 'ArticleIdList': [StringElement('10.1038/nature13683', attributes={'IdType': 'doi'}), StringElement('25119034', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Gemma A, Takenaka K, Hosoya Y, Matuda K, Seike M, Kurimoto F, Ono Y, Uematsu K, Takeda Y, Hibino S et al. Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. European journal of cancer (Oxford, England: 1990) 2001, 37(12):1554–1561.'}, {'Citation': 'Zhong M, Wang X, Zhu E, Gong L, Fei L, Zhao L, Wu K, Tang C, Zhang L, Wang Z, et al. Analysis of pyroptosis-related Immune signatures and Identification of pyroptosis-related LncRNA prognostic signature in Clear Cell Renal Cell Carcinoma. Front Genet. 2022;13:905051.', 'ArticleIdList': [StringElement('9277062', attributes={'IdType': 'pmc'}), StringElement('10.3389/fgene.2022.905051', attributes={'IdType': 'doi'}), StringElement('35846134', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang Y, Zhou J, Zhang N, Zhu Y, Zhong Y, Wang Z, Jin H, Wang X. A Novel defined PANoptosis-Related miRNA signature for Predicting the Prognosis and Immune characteristics in Clear Cell Renal Cell Carcinoma: a miRNA signature for the prognosis of ccRCC. Int J Mol Sci 2023, 24(11).'}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '22'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '22'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '9', 'Day': '6'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '12', 'Day': '29'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '8', 'Hour': '23', 'Minute': '59'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780201', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s12935-024-03630-9', attributes={'IdType': 'doi'}), StringElement('10.1186/s12935-024-03630-9', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('CTF1', attributes={'MajorTopicYN': 'N'}), StringElement('Glioma', attributes={'MajorTopicYN': 'N'}), StringElement('Immune microenvironment', attributes={'MajorTopicYN': 'N'}), StringElement('Prognosis', attributes={'MajorTopicYN': 'N'}), StringElement('Proliferation', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780198', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '08'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '09'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s40001-024-02192-w', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('2047-783X', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '30', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '09'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'European journal of medical research', 'ISOAbbreviation': 'Eur J Med Res'}, 'ArticleTitle': 'Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma.', 'Pagination': {'StartPage': '17', 'MedlinePgn': '17'}, 'Abstract': {'AbstractText': [StringElement('This study aimed to evaluate CTF1 expression in glioma, its relationship to patient prognosis and the tumor immune microenvironment, and effects on glioma phenotypes to identify a new therapeutic target for treating glioma precisely.', attributes={'Label': 'OBJECTIVE', 'NlmCategory': 'OBJECTIVE'}), StringElement('We initially assessed the expression of CTF1, a member of the IL-6 family, in glioma, using bioinformatics tools and publicly available databases. Furthermore, we examined the correlation between CTF1 expression and tumor prognosis, DNA methylation patterns, m6A-related genes, potential biological functions, the immune microenvironment, and genes associated with immune checkpoints. We also explored potential associations with drug sensitivity. To assess the impact on glioma cell proliferation and apoptosis, we employed various assays, including the Cell Counting Kit-8, colony formation assay, and flow cytometry.', attributes={'Label': 'METHODS', 'NlmCategory': 'METHODS'}), StringElement('CTF1 gene and protein expression were significantly elevated in glioma tissues, and correlated with malignancy and poor prognosis. CTF1 was an independent prognostic factor and negatively associated with DNA methylation. The involvement of CTF1 in m6A modifications contributed to glioma progression. Enrichment analysis revealed immune response pathways linked with CTF1 in glioma, including natural killer cell cytotoxicity, NOD-like receptor signaling, Toll-like receptor signaling, antigen processing, chemokine signaling, and cytokine receptor interactions. CTF1 expression correlated positively with pathways related to apoptosis, inflammation, proliferation, and epithelial-mesenchymal transition, and PI3K-AKT-mTOR signaling. Additionally, CTF1 expression was positively associated with macrophage, eosinophil, and neutrophil contents and immune checkpoint-related genes, but negatively associated with sensitivity to 14 drugs. In vitro experiments confirmed that CTF1 knockdown inhibited glioma cell proliferation and promoted apoptosis.', attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('This study identifies CTF1 as a significant independent prognostic factor that is closely associated with the tumor immune microenvironment in glioma. Additionally, reduced expression of CTF1 suppresses the proliferation and induces apoptosis of glioma cells in vitro. Consequently, CTF1 is a potentially promising novel therapeutic target for glioma treatment.', attributes={'Label': 'CONCLUSION', 'NlmCategory': 'CONCLUSIONS'})], 'CopyrightInformation': '© 2024. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}], 'Identifier': [], 'LastName': 'Cai', 'ForeName': 'Hongqing', 'Initials': 'H'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}], 'Identifier': [], 'LastName': 'Tian', 'ForeName': 'Shen', 'Initials': 'S'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}], 'Identifier': [], 'LastName': 'Liu', 'ForeName': 'Angsi', 'Initials': 'A'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'Identifier': [], 'Affiliation': \"Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, No 678 Furong Road, Economic and Technological Development Zone, Hefei, 230000, Anhui, People's Republic of China.\"}], 'Identifier': [], 'LastName': 'Xie', 'ForeName': 'Guanchao', 'Initials': 'G'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.'}, {'Identifier': [], 'Affiliation': \"Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, No 678 Furong Road, Economic and Technological Development Zone, Hefei, 230000, Anhui, People's Republic of China.\"}], 'Identifier': [], 'LastName': 'Zhang', 'ForeName': 'Hongsheng', 'Initials': 'H'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, No. 901 Hospital of the Chinese People's Liberation Army Logistic Support Force, No 424 Changjiang West Road, Shushan District, Hefei, Anhui, 230000, People's Republic of China. wxg18909696645@126.com.\"}], 'Identifier': [], 'LastName': 'Wu', 'ForeName': 'Xiaogang', 'Initials': 'X'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China. wanjinghai@sina.com.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wanjinghai@sina.com.'}, {'Identifier': [], 'Affiliation': \"Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, No 678 Furong Road, Economic and Technological Development Zone, Hefei, 230000, Anhui, People's Republic of China. wanjinghai@sina.com.\"}], 'Identifier': [], 'LastName': 'Wan', 'ForeName': 'Jinghai', 'Initials': 'J'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': \"Department of Neurosurgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, People's Republic of China. lisai19972022@163.com.\"}, {'Identifier': [], 'Affiliation': 'State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. lisai19972022@163.com.'}, {'Identifier': [], 'Affiliation': \"Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, No 678 Furong Road, Economic and Technological Development Zone, Hefei, 230000, Anhui, People's Republic of China. lisai19972022@163.com.\"}], 'Identifier': [], 'LastName': 'Li', 'ForeName': 'Sai', 'Initials': 'S'}, attributes={'ValidYN': 'Y', 'EqualContrib': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': '82103231', 'Agency': 'National Natural Science Foundation of China', 'Country': ''}, {'GrantID': '82072803', 'Agency': 'National Natural Science Foundation of China', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'Eur J Med Res', 'NlmUniqueID': '9517857', 'ISSNLinking': '0949-2321'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: This study did not require ethical approval since it was not directly involving the use of human or animal subjects. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329(7):574–87.', 'ArticleIdList': [StringElement('36809318', attributes={'IdType': 'pubmed'}), StringElement('11445779', attributes={'IdType': 'pmc'}), StringElement('10.1001/jama.2023.0023', attributes={'IdType': 'doi'})]}, {'Citation': 'Berger TR, Wen PY, Lang-Orsini M, Chukwueke UN. World Health Organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review. JAMA Oncol. 2022;8(10):1493–501.', 'ArticleIdList': [StringElement('36006639', attributes={'IdType': 'pubmed'}), StringElement('10.1001/jamaoncol.2022.2844', attributes={'IdType': 'doi'})]}, {'Citation': 'Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018;18(12):773–89.', 'ArticleIdList': [StringElement('30254251', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41577-018-0066-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Abdul-Ghani M, Suen C, Jiang B, Deng Y, Weldrick JJ, Putinski C, et al. Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart. Cell Res. 2017;27(10):1195–215.', 'ArticleIdList': [StringElement('28785017', attributes={'IdType': 'pubmed'}), StringElement('5630684', attributes={'IdType': 'pmc'}), StringElement('10.1038/cr.2017.87', attributes={'IdType': 'doi'})]}, {'Citation': 'Vlahodimitris I, Karangelis D, Moschaki M, Moyssakis I, Christodoulou KC, Perrea DN, et al. Cardiotrophin-1 in asymptomatic hypertensive patients with mild diastolic dysfunction: potential prognostic value in early stages of hypertensive heart disease. Cureus. 2023;15(10): e46516.', 'ArticleIdList': [StringElement('37927758', attributes={'IdType': 'pubmed'}), StringElement('10625173', attributes={'IdType': 'pmc'})]}, {'Citation': 'Ibarrola J, Garcia-Pena A, Matilla L, Bonnard B, Sadaba R, Arrieta V, et al. A new role for the aldosterone/mineralocorticoid receptor pathway in the development of mitral valve prolapse. Circ Res. 2020;127(3):e80–93.', 'ArticleIdList': [StringElement('32329663', attributes={'IdType': 'pubmed'}), StringElement('10.1161/CIRCRESAHA.119.316427', attributes={'IdType': 'doi'})]}, {'Citation': 'Martinez-Martinez E, Brugnolaro C, Ibarrola J, Ravassa S, Buonafine M, Lopez B, et al. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation. Hypertension. 2019;73(3):602–11.', 'ArticleIdList': [StringElement('30612490', attributes={'IdType': 'pubmed'}), StringElement('10.1161/HYPERTENSIONAHA.118.11874', attributes={'IdType': 'doi'})]}, {'Citation': 'Herencia C, Almaden Y, Ferrin G, Martinez-Romero R, de la Mata M, Ciria R, et al. Cardiotrophin-1 decreases liver apoptosis through calpastatin induction. J Surg Res. 2015;193(1):119–25.', 'ArticleIdList': [StringElement('25085703', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.jss.2014.06.056', attributes={'IdType': 'doi'})]}, {'Citation': 'Perretta-Tejedor N, Price KL, Jafree DJ, Pomeranz G, Kolatsi-Joannou M, Martinez-Salgado C, et al. Cardiotrophin-1 therapy reduces disease severity in a murine model of glomerular disease. Physiol Rep. 2024;12(13): e16129.', 'ArticleIdList': [StringElement('38955668', attributes={'IdType': 'pubmed'}), StringElement('11219243', attributes={'IdType': 'pmc'}), StringElement('10.14814/phy2.16129', attributes={'IdType': 'doi'})]}, {'Citation': 'Tian Y, Shao Q, Tang Y, Li X, Qi X, Jiang R, et al. HIF-1alpha regulates osteoclast activation and mediates osteogenesis during mandibular bone repair via CT-1. Oral Dis. 2022;28(2):428–41.', 'ArticleIdList': [StringElement('33274496', attributes={'IdType': 'pubmed'}), StringElement('10.1111/odi.13745', attributes={'IdType': 'doi'})]}, {'Citation': 'Abdelhaffez AS, Abd El-Aziz EA, Tohamy MB, Ahmed AM. N-acetyl cysteine can blunt metabolic and cardiovascular effects via downregulation of cardiotrophin-1 in rat model of fructose-induced metabolic syndrome. Arch Physiol Biochem. 2023;129(4):854–69.', 'ArticleIdList': [StringElement('33507837', attributes={'IdType': 'pubmed'}), StringElement('10.1080/13813455.2021.1876735', attributes={'IdType': 'doi'})]}, {'Citation': 'Huseynli Y, Kale I, Dizdar M, Muhcu M. Investigation of serum cardiotrophin-1 concentrations in pregnant women with gestational diabetes mellitus. Z Geburtshilfe Neonatol. 2024;228(4):355–62.', 'ArticleIdList': [StringElement('38122806', attributes={'IdType': 'pubmed'}), StringElement('10.1055/a-2210-4215', attributes={'IdType': 'doi'})]}, {'Citation': 'Zaporowska-Stachowiak I, Springer M, Stachowiak K, Oduah M, Sopata M, Wieczorowska-Tobis K, et al. Interleukin-6 family of cytokines in cancers. J Interferon Cytokine Res. 2024;44(2):45–59.', 'ArticleIdList': [StringElement('38232478', attributes={'IdType': 'pubmed'}), StringElement('10.1089/jir.2023.0103', attributes={'IdType': 'doi'})]}, {'Citation': 'Soler MF, Abaurrea A, Azcoaga P, Araujo AM, Caffarel MM. New perspectives in cancer immunotherapy: targeting IL-6 cytokine family. J Immunother Cancer. 2023;11(11): e007530.', 'ArticleIdList': [StringElement('37945321', attributes={'IdType': 'pubmed'}), StringElement('10649711', attributes={'IdType': 'pmc'}), StringElement('10.1136/jitc-2023-007530', attributes={'IdType': 'doi'})]}, {'Citation': 'Akkoc Y, Dalci K, Karakas HE, Erbil-Bilir S, Yalav O, Sakman G, et al. Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis. Autophagy. 2023;19(1):306–23.', 'ArticleIdList': [StringElement('35722965', attributes={'IdType': 'pubmed'}), StringElement('10.1080/15548627.2022.2090693', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang W, Wang S. The prognostic value of immune-related genes AZGP1, SLCO5A1, and CTF1 in Uveal melanoma. Front Oncol. 2022;12: 918230.', 'ArticleIdList': [StringElement('36052234', attributes={'IdType': 'pubmed'}), StringElement('9425775', attributes={'IdType': 'pmc'}), StringElement('10.3389/fonc.2022.918230', attributes={'IdType': 'doi'})]}, {'Citation': 'Gao L, Zhang L. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma. BMC Cancer. 2021;21(1):849.', 'ArticleIdList': [StringElement('34301211', attributes={'IdType': 'pubmed'}), StringElement('8299662', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12885-021-08462-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Armstrong TS, Dirven L, Arons D, Bates A, Chang SM, Coens C, et al. Glioma patient-reported outcome assessment in clinical care and research: a response assessment in neuro-oncology collaborative report. Lancet Oncol. 2020;21(2):e97–103.', 'ArticleIdList': [StringElement('32007210', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S1470-2045(19)30796-X', attributes={'IdType': 'doi'})]}, {'Citation': 'Turkalp Z, Karamchandani J, Das S. IDH mutation in glioma: new insights and promises for the future. JAMA Neurol. 2014;71(10):1319–25.', 'ArticleIdList': [StringElement('25155243', attributes={'IdType': 'pubmed'}), StringElement('10.1001/jamaneurol.2014.1205', attributes={'IdType': 'doi'})]}, {'Citation': 'Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372(26):2499–508.', 'ArticleIdList': [StringElement('26061753', attributes={'IdType': 'pubmed'}), StringElement('4489704', attributes={'IdType': 'pmc'}), StringElement('10.1056/NEJMoa1407279', attributes={'IdType': 'doi'})]}, {'Citation': 'Wick W, Weller M, van den Bent M, Sanson M, Weiler M, von Deimling A, et al. MGMT testing–the challenges for biomarker-based glioma treatment. Nat Rev Neurol. 2014;10(7):372–85.', 'ArticleIdList': [StringElement('24912512', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nrneurol.2014.100', attributes={'IdType': 'doi'})]}, {'Citation': 'Orsolic I, Carrier A, Esteller M. Genetic and epigenetic defects of the RNA modification machinery in cancer. Trends Genet. 2023;39(1):74–88.', 'ArticleIdList': [StringElement('36379743', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.tig.2022.10.004', attributes={'IdType': 'doi'})]}, {'Citation': 'Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379(6632):eaaw3835.', 'ArticleIdList': [StringElement('36758093', attributes={'IdType': 'pubmed'}), StringElement('10249049', attributes={'IdType': 'pmc'}), StringElement('10.1126/science.aaw3835', attributes={'IdType': 'doi'})]}, {'Citation': 'Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol. 2023;20(8):507–26.', 'ArticleIdList': [StringElement('37221357', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41571-023-00774-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Papanicolau-Sengos A, Aldape K. DNA methylation profiling: an emerging paradigm for cancer diagnosis. Annu Rev Pathol. 2022;17:295–321.', 'ArticleIdList': [StringElement('34736341', attributes={'IdType': 'pubmed'}), StringElement('10.1146/annurev-pathol-042220-022304', attributes={'IdType': 'doi'})]}, {'Citation': 'Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012–27.', 'ArticleIdList': [StringElement('34120771', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.tig.2021.05.002', attributes={'IdType': 'doi'})]}, {'Citation': 'Klutstein M, Nejman D, Greenfield R, Cedar H. DNA methylation in cancer and aging. Cancer Res. 2016;76(12):3446–50.', 'ArticleIdList': [StringElement('27256564', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-15-3278', attributes={'IdType': 'doi'})]}, {'Citation': 'Xu D, Cao M, Wang B, Bi X, Zhang H, Wu D, et al. Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas. Theranostics. 2023;13(5):1490–505.', 'ArticleIdList': [StringElement('37056564', attributes={'IdType': 'pubmed'}), StringElement('10086206', attributes={'IdType': 'pmc'}), StringElement('10.7150/thno.79874', attributes={'IdType': 'doi'})]}, {'Citation': 'Lopez-Bertoni H, Johnson A, Rui Y, Lal B, Sall S, Malloy M, et al. Sox2 induces glioblastoma cell stemness and tumor propagation by repressing TET2 and deregulating 5hmC and 5mC DNA modifications. Signal Transduct Target Ther. 2022;7(1):37.', 'ArticleIdList': [StringElement('35136034', attributes={'IdType': 'pubmed'}), StringElement('8826438', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41392-021-00857-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270–88.', 'ArticleIdList': [StringElement('32183948', attributes={'IdType': 'pubmed'}), StringElement('7141420', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ccell.2020.02.004', attributes={'IdType': 'doi'})]}, {'Citation': 'Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, et al. Molecular characterization and clinical relevance of m(6)A regulators across 33 cancer types. Mol Cancer. 2019;18(1):137.', 'ArticleIdList': [StringElement('31521193', attributes={'IdType': 'pubmed'}), StringElement('6744659', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-019-1066-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu M, Ruan X, Liu X, Dong W, Wang D, Yang C, et al. The mechanism of BUD13 m6A methylation mediated MBNL1-phosphorylation by CDK12 regulating the vasculogenic mimicry in glioblastoma cells. Cell Death Dis. 2022;13(12):1017.', 'ArticleIdList': [StringElement('36463205', attributes={'IdType': 'pubmed'}), StringElement('9719550', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-022-05426-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Li B, Zhao R, Qiu W, Pan Z, Zhao S, Qi Y, et al. The N(6)-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. Theranostics. 2022;12(14):6363–79.', 'ArticleIdList': [StringElement('36168628', attributes={'IdType': 'pubmed'}), StringElement('9475453', attributes={'IdType': 'pmc'}), StringElement('10.7150/thno.74600', attributes={'IdType': 'doi'})]}, {'Citation': 'Gu Y, Niu S, Wang Y, Duan L, Pan Y, Tong Z, et al. DMDRMR-mediated regulation of m6A-modified CDK4 by m6A reader IGF2BP3 drives ccRCC progression. Cancer Res. 2021;81(4):923–34.', 'ArticleIdList': [StringElement('33293428', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-20-1619', attributes={'IdType': 'doi'})]}, {'Citation': 'Song T, Hu Z, Zeng C, Luo H, Liu J. FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas. Heliyon. 2023;9(6): e16280.', 'ArticleIdList': [StringElement('37260902', attributes={'IdType': 'pubmed'}), StringElement('10227343', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.heliyon.2023.e16280', attributes={'IdType': 'doi'})]}, {'Citation': 'Han J, Yu X, Wang S, Wang Y, Liu Q, Xu H, et al. IGF2BP2 induces U251 glioblastoma cell chemoresistance by inhibiting FOXO1-mediated PID1 expression through stabilizing lncRNA DANCR. Front Cell Dev Biol. 2021;9: 659228.', 'ArticleIdList': [StringElement('35141227', attributes={'IdType': 'pubmed'}), StringElement('10.3389/fcell.2021.659228', attributes={'IdType': 'doi'})]}, {'Citation': 'Chen P, Xu J, Cui Z, Wu S, Xie T, Zhang X. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. Front Immunol. 2023;14:1071675.', 'ArticleIdList': [StringElement('36761737', attributes={'IdType': 'pubmed'}), StringElement('9905439', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2023.1071675', attributes={'IdType': 'doi'})]}, {'Citation': 'Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18(1):163.', 'ArticleIdList': [StringElement('31735169', attributes={'IdType': 'pubmed'}), StringElement('6859620', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-019-1082-3', attributes={'IdType': 'doi'})]}, {'Citation': 'de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403.', 'ArticleIdList': [StringElement('36917948', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ccell.2023.02.016', attributes={'IdType': 'doi'})]}, {'Citation': 'Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 2022;21(1):16.', 'ArticleIdList': [StringElement('35031058', attributes={'IdType': 'pubmed'}), StringElement('8759291', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-021-01485-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Grisaru-Tal S, Itan M, Klion AD, Munitz A. A new dawn for eosinophils in the tumour microenvironment. Nat Rev Cancer. 2020;20(10):594–607.', 'ArticleIdList': [StringElement('32678342', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41568-020-0283-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Ng MSF, Kwok I, Tan L, Shi C, Cerezo-Wallis D, Tan Y, et al. Deterministic reprogramming of neutrophils within tumors. Science. 2024;383(6679):eadf6493.', 'ArticleIdList': [StringElement('38207030', attributes={'IdType': 'pubmed'}), StringElement('11087151', attributes={'IdType': 'pmc'}), StringElement('10.1126/science.adf6493', attributes={'IdType': 'doi'})]}, {'Citation': 'Nguyen TN, Nguyen-Tran HH, Chen CY, Hsu T. IL6 and CCL18 mediate cross-talk between VHL-deficient kidney cells and macrophages during development of renal cell carcinoma. Cancer Res. 2022;82(15):2716–33.', 'ArticleIdList': [StringElement('35666812', attributes={'IdType': 'pubmed'}), StringElement('9662868', attributes={'IdType': 'pmc'}), StringElement('10.1158/0008-5472.CAN-21-3749', attributes={'IdType': 'doi'})]}, {'Citation': 'van Baarle L, De Simone V, Schneider L, Santhosh S, Abdurahiman S, Biscu F, et al. IL-1R signaling drives enteric glia–macrophage interactions in colorectal cancer. Nat Commun. 2024;15(1):6079.', 'ArticleIdList': [StringElement('39030280', attributes={'IdType': 'pubmed'}), StringElement('11271635', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-024-50438-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Gibney GT, Weiner LM, Atkins MB. Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet Oncol. 2016;17(12):e542–51.', 'ArticleIdList': [StringElement('27924752', attributes={'IdType': 'pubmed'}), StringElement('5702534', attributes={'IdType': 'pmc'}), StringElement('10.1016/S1470-2045(16)30406-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Abril-Rodriguez G, Ribas A. SnapShot: immune checkpoint inhibitors. Cancer Cell. 2017;31(6):848-e1.', 'ArticleIdList': [StringElement('10.1016/j.ccell.2017.05.010', attributes={'IdType': 'doi'})]}, {'Citation': 'Elliot TAE, Jennings EK, Lecky DAJ, Thawait N, Flores-Langarica A, Copland A, et al. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength. Immunity. 2021;54(11):2481-96 e6.', 'ArticleIdList': [StringElement('34534438', attributes={'IdType': 'pubmed'}), StringElement('8585507', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.immuni.2021.08.020', attributes={'IdType': 'doi'})]}, {'Citation': 'Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48(3):434–52.', 'ArticleIdList': [StringElement('29562194', attributes={'IdType': 'pubmed'}), StringElement('7116507', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.immuni.2018.03.014', attributes={'IdType': 'doi'})]}, {'Citation': 'Daubon T, Hemadou A, Romero Garmendia I, Saleh M. Glioblastoma immune landscape and the potential of new immunotherapies. Front Immunol. 2020;11: 585616.', 'ArticleIdList': [StringElement('33154756', attributes={'IdType': 'pubmed'}), StringElement('7591769', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2020.585616', attributes={'IdType': 'doi'})]}, {'Citation': 'Qi Y, Liu B, Sun Q, Xiong X, Chen Q. Immune checkpoint targeted therapy in glioma: status and hopes. Front Immunol. 2020;11: 578877.', 'ArticleIdList': [StringElement('33329549', attributes={'IdType': 'pubmed'}), StringElement('7729019', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2020.578877', attributes={'IdType': 'doi'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '22'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '22'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '5', 'Day': '1'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '12', 'Day': '2'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '8', 'Hour': '23', 'Minute': '59'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780198', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s40001-024-02192-w', attributes={'IdType': 'doi'}), StringElement('10.1186/s40001-024-02192-w', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('Ferroptosis', attributes={'MajorTopicYN': 'N'}), StringElement('Lung adenocarcinoma', attributes={'MajorTopicYN': 'N'}), StringElement('SETDB1', attributes={'MajorTopicYN': 'N'}), StringElement('SNX30', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780196', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '08'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '09'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s13019-024-03298-2', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1749-8090', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '20', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '09'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Journal of cardiothoracic surgery', 'ISOAbbreviation': 'J Cardiothorac Surg'}, 'ArticleTitle': 'SNX30 inhibits lung adenocarcinoma cell proliferation and induces cell ferroptosis through regulating SETDB1.', 'Pagination': {'StartPage': '51', 'MedlinePgn': '51'}, 'Abstract': {'AbstractText': [StringElement('Lung adenocarcinoma is the most common form of lung cancer and one of the most life-threatening malignant tumors. Ferroptosis is an iron-dependent regulatory cell death pathway that is crucial for tumor growth. SNX30 is a key regulatory factor in cardiac development; however, its regulatory mechanism and role in inducing ferroptosis in lung adenocarcinoma remain unclear.', attributes={'Label': 'BACKGROUND', 'NlmCategory': 'BACKGROUND'}), StringElement('This study aimed to elucidate the functions and specific mechanisms of action of SNX30 in lung adenocarcinomas.', attributes={'Label': 'OBJECTIVE', 'NlmCategory': 'OBJECTIVE'}), StringElement('SNX30 levels in lung adenocarcinoma cell lines (A549 and HCC827) were determined using reverse transcription quantitative real-time PCR (RT-qPCR) or western blotting. Cell proliferation and apoptosis were assessed by CCK8 and flow cytometry, respectively. The intracellular levels of total iron and Fe<sup>2+</sup> were detected using Iron Assay Kits. Reactive oxygen species (ROS) levels were evaluated using a DCFH-DA probe and flow cytometry. Cysteine (Cys), glutathione (GSH), and glutathione peroxidase 4 (GPX4) levels were measured using detection assay kits. Other related markers, including Ptgs2, Chac1, SETDB1 cleaved-Caspase3, and Caspase3 were analyzed by RT-qPCR or western blotting.', attributes={'Label': 'METHODS', 'NlmCategory': 'METHODS'}), StringElement('SNX30 is downregulated in lung adenocarcinoma cell lines. SNX30-plasmid depressed lung adenocarcinoma cell proliferation, accelerated apoptosis, enhanced cleaved-Caspase3 expression and cleaved-Caspase3/Caspase3 ratio. Ferrostatin-1 significantly reversed the effects of the SNX30-plasmid on cell ferroptosis in lung adenocarcinoma, as confirmed by the reduced ROS levels, inhibited intracellular total iron and Fe<sup>2+</sup> levels, decreased Ptgs2 and Chac1 expression, and increased Cys, GSH, and GPX4 release. We observed that the level of SETDB1 was lower in the SNX30-plasmid group than in the control-plasmid group, whereas the opposite results in ferrostatin-1 treated cells. SNX30 negatively regulates SETDB1 expression in lung adenocarcinoma cells. The upregulation of SETDB1 reversed the effects of the SNX30-plasmid on ferroptosis in lung adenocarcinoma cells.', attributes={'Label': 'RESULTS', 'NlmCategory': 'RESULTS'}), StringElement('SNX30 inhibits lung adenocarcinoma cell proliferation and induces ferroptosis by regulating SETDB1 expression.', attributes={'Label': 'CONCLUSION', 'NlmCategory': 'CONCLUSIONS'})], 'CopyrightInformation': '© 2024. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Respiratory and Critical Care Medicine, Datian County General Hospital, 180 Xueshan North Road, Datian County, 366100, China. fxj14391228@163.com.'}], 'Identifier': [], 'LastName': 'Fan', 'ForeName': 'Xinjie', 'Initials': 'X'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Respiratory and Critical Care Medicine, Datian County General Hospital, 180 Xueshan North Road, Datian County, 366100, China.'}], 'Identifier': [], 'LastName': 'Zhu', 'ForeName': 'Qichu', 'Initials': 'Q'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Respiratory and Critical Care Medicine, Datian County General Hospital, 180 Xueshan North Road, Datian County, 366100, China.'}], 'Identifier': [], 'LastName': 'Du', 'ForeName': 'Chengzhuo', 'Initials': 'C'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Respiratory and Critical Care Medicine, Datian County General Hospital, 180 Xueshan North Road, Datian County, 366100, China.'}], 'Identifier': [], 'LastName': 'Chen', 'ForeName': 'Jinlai', 'Initials': 'J'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Department of Respiratory and Critical Care Medicine, Datian County General Hospital, 180 Xueshan North Road, Datian County, 366100, China.'}], 'Identifier': [], 'LastName': 'Su', 'ForeName': 'Yingming', 'Initials': 'Y'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'J Cardiothorac Surg', 'NlmUniqueID': '101265113', 'ISSNLinking': '1749-8090'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: Not Applicable. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Abu RF, Singhi EK, Sridhar A, Faisal MS, Desai A. Lung Cancer treatment advances in 2022. Cancer Invest. 2023;41(1):12–24. https://doi.org/10.1080/07357907.2022.2119479 .', 'ArticleIdList': [StringElement('10.1080/07357907.2022.2119479', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim J, Lee H, Huang BW. Lung Cancer: diagnosis, Treatment principles, and screening. Am Fam Physician. 2022;105(5):487–94.', 'ArticleIdList': [StringElement('35559635', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Liu Y, Chen Q, Guo LW, Xu HF, Wang XY, Kang RH, Zhang LY, Wang H, Han BB, Zhang SK. Incidence and mortality of lung cancer in 2018 and the temporal trends from 2010 to 2018 in Henan Province, China: a population-based registry study. Ann Transl Med. 2022;10(18):1005. https://doi.org/10.21037/atm-22-4029 .', 'ArticleIdList': [StringElement('10.21037/atm-22-4029', attributes={'IdType': 'doi'}), StringElement('36267711', attributes={'IdType': 'pubmed'}), StringElement('9577782', attributes={'IdType': 'pmc'})]}, {'Citation': 'Kim EJ, Kim JS, Lee S, Cheon I, Kim SR, Ko YH, Kang K, Tan X, Kurie JM, Ahn YH. ZEB1-regulated lnc-Nr2f1 promotes the migration and invasion of lung adenocarcinoma cells. Cancer Lett. 2022;533:215601. https://doi.org/10.1016/j.canlet.2022.215601 .', 'ArticleIdList': [StringElement('10.1016/j.canlet.2022.215601', attributes={'IdType': 'doi'}), StringElement('35176421', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Xu S, Fang H, Shen T, Zhou Y, Zhang D, Ke Y, Chen Z, Lu Z. Causal association between immune cells and lung cancer risk: a two-sample bidirectional mendelian randomization analysis. Front Immunol. 2024;15:1433299. https://doi.org/10.3389/fimmu.2024.1433299 .', 'ArticleIdList': [StringElement('10.3389/fimmu.2024.1433299', attributes={'IdType': 'doi'}), StringElement('38962009', attributes={'IdType': 'pubmed'}), StringElement('11219561', attributes={'IdType': 'pmc'})]}, {'Citation': 'Xu S, Zheng Y, Ye M, Shen T, Zhang D, Li Z, Lu Z. Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response. BMC Cancer. 2024;24(1):1064. https://doi.org/10.1186/s12885-024-12843-0 .', 'ArticleIdList': [StringElement('10.1186/s12885-024-12843-0', attributes={'IdType': 'doi'}), StringElement('39198775', attributes={'IdType': 'pubmed'}), StringElement('11351591', attributes={'IdType': 'pmc'})]}, {'Citation': 'Xu S, Chen X, Fang J, Chu H, Fang S, Zeng L, Ma H, Zhang T, Chen Y, Wang T, Zhang X, Shen T, Zheng Y, Xu D, Lu Z, Pan Y, Liu Y. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2. Front Immunol. 2023;14:1155182. https://doi.org/10.3389/fimmu.2023.1155182 .', 'ArticleIdList': [StringElement('10.3389/fimmu.2023.1155182', attributes={'IdType': 'doi'}), StringElement('37275857', attributes={'IdType': 'pubmed'}), StringElement('10232969', attributes={'IdType': 'pmc'})]}, {'Citation': 'Xie X, Cai X, Zhou F, Li Y, Liu Q, Cai L, Zhu W, Wei J, Jin C, Liu Z, Jiang C, Zhao H, Yang L, Zhao C, Huang X. GPR37 promotes cancer growth by binding to CDK6 and represents a new theranostic target in lung adenocarcinoma. Pharmacol Res. 2022;183:106389. https://doi.org/10.1016/j.phrs.2022.106389 .', 'ArticleIdList': [StringElement('10.1016/j.phrs.2022.106389', attributes={'IdType': 'doi'}), StringElement('35934193', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang J, Liu J, Hou Q, Xu M. LINC02126 is a potential diagnostic, prognostic and immunotherapeutic target for lung adenocarcinoma. BMC Pulm Med. 2022;22(1):412. https://doi.org/10.1186/s12890-022-02215-4 .', 'ArticleIdList': [StringElement('10.1186/s12890-022-02215-4', attributes={'IdType': 'doi'}), StringElement('36357869', attributes={'IdType': 'pubmed'}), StringElement('9650865', attributes={'IdType': 'pmc'})]}, {'Citation': 'Li D, Wang Y, Dong C, Chen T, Dong A, Ren J, Li W, Shu G, Yang J, Shen W, Qin L, Hu L, Zhou J. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 2023;42(2):83–98. https://doi.org/10.1038/s41388-022-02537-x .', 'ArticleIdList': [StringElement('10.1038/s41388-022-02537-x', attributes={'IdType': 'doi'}), StringElement('36369321', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599–620. https://doi.org/10.1007/s13238-020-00789-5 .', 'ArticleIdList': [StringElement('10.1007/s13238-020-00789-5', attributes={'IdType': 'doi'}), StringElement('33000412', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang X, Xu Y, Ma L, Yu K, Niu Y, Xu X, Shi Y, Guo S, Xue X, Wang Y, Qiu S, Cui J, Wang H, Tian X, Miao Y, Meng F, Qiao Y, Yu Y, Wang J. Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma. Cancer Commun (Lond). 2022;42(4):287–313. https://doi.org/10.1002/cac2.12275 .', 'ArticleIdList': [StringElement('10.1002/cac2.12275', attributes={'IdType': 'doi'}), StringElement('35184419', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Zhang H, Shan G, Jin X, Yu X, Bi G, Feng M, Wang H, Lin M, Zhan C, Wang Q, Li M. ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma. Transl Oncol. 2022;26:101562. https://doi.org/10.1016/j.tranon.2022.101562 .', 'ArticleIdList': [StringElement('10.1016/j.tranon.2022.101562', attributes={'IdType': 'doi'}), StringElement('36228410', attributes={'IdType': 'pubmed'}), StringElement('9563212', attributes={'IdType': 'pmc'})]}, {'Citation': 'Meng X, Xiao W, Sun J, Li W, Yuan H, Yu T, Zhang X, Dong W. CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer. Cancer Lett. 2023;554:216023. https://doi.org/10.1016/j.canlet.2022.216023 .', 'ArticleIdList': [StringElement('10.1016/j.canlet.2022.216023', attributes={'IdType': 'doi'}), StringElement('36436682', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li W, Yang X, Liu X, Deng H, Li W, He X, Zhang W, Shen Y, Li X, Peng Q, Liu D. SETDB1 confers colorectal cancer metastasis by regulation of WNT/beta-catenin signaling. Biochim Biophys Acta Gen Subj. 2023;1867(7):130377. https://doi.org/10.1016/j.bbagen.2023.130377 .', 'ArticleIdList': [StringElement('10.1016/j.bbagen.2023.130377', attributes={'IdType': 'doi'}), StringElement('37169209', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Cui G, Fu X, Wang W, Chen X, Liu S, Cao P, Zhao S. LINC00476 suppresses the progression of Non-small Cell Lung Cancer by inducing the ubiquitination of SETDB1. Radiat Res. 2021;195(3):275–83. https://doi.org/10.1667/RADE-20-00105.1 .', 'ArticleIdList': [StringElement('10.1667/RADE-20-00105.1', attributes={'IdType': 'doi'}), StringElement('33370431', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Liu S, Li B, Xu J, Hu S, Zhan N, Wang H, Gao C, Li J, Xu X. SOD1 promotes cell proliferation and metastasis in non-small cell Lung Cancer via an miR-409-3p/SOD1/SETDB1. Epigenetic Regulatory Feedforward Loop. Front Cell Dev Biol. 2020;8:213. https://doi.org/10.3389/fcell.2020.00213 .', 'ArticleIdList': [StringElement('10.3389/fcell.2020.00213', attributes={'IdType': 'doi'}), StringElement('32391354', attributes={'IdType': 'pubmed'}), StringElement('7190798', attributes={'IdType': 'pmc'})]}, {'Citation': 'Wang K, Jiang L, Zhong Y, Zhang Y, Yin Q, Li S, Zhang X, Han H, Yao K. Ferrostatin-1-loaded liposome for treatment of corneal alkali burn via targeting ferroptosis. Bioeng Transl Med. 2022;7(2):e10276. https://doi.org/10.1002/btm2.10276 .', 'ArticleIdList': [StringElement('10.1002/btm2.10276', attributes={'IdType': 'doi'}), StringElement('35600640', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Na HH, Kim KC. SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells. Biochem Biophys Res Commun. 2018;495(1):512–8. https://doi.org/10.1016/j.bbrc.2017.10.176 .', 'ArticleIdList': [StringElement('10.1016/j.bbrc.2017.10.176', attributes={'IdType': 'doi'}), StringElement('29108991', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Jacobson FL, Dezube AR, Bravo-Iniguez C, Kucukak S, Bay CP, Wee JO, Coppolino AR, Jaklitsch MT, Ducko CT. Preserving NLST mortality benefits and acceptable morbidity for lung cancer surgery in a community hospital. J Surg Oncol. 2021;124(1):124–34. https://doi.org/10.1002/jso.26483 .', 'ArticleIdList': [StringElement('10.1002/jso.26483', attributes={'IdType': 'doi'}), StringElement('33844848', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Li W, Li X, Li X, Li M, Yang P, Wang X, Li L, Yang B. Lamin B1 overexpresses in lung adenocarcinoma and promotes proliferation in Lung Cancer cells via AKT Pathway. Onco Targets Ther. 2020;13:3129–39. https://doi.org/10.2147/OTT.S229997 .', 'ArticleIdList': [StringElement('10.2147/OTT.S229997', attributes={'IdType': 'doi'}), StringElement('32346296', attributes={'IdType': 'pubmed'}), StringElement('7167283', attributes={'IdType': 'pmc'})]}, {'Citation': 'Chan MV, Huo YR, Cao C, Ridley L. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Eur Radiol. 2021;31(7):5421–33. https://doi.org/10.1007/s00330-020-07634-7 .', 'ArticleIdList': [StringElement('10.1007/s00330-020-07634-7', attributes={'IdType': 'doi'}), StringElement('33449192', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Shang S, Liu J, Verma V, Wu M, Welsh J, Yu J, Chen D. Combined treatment of non-small cell lung cancer using radiotherapy and immunotherapy: challenges and updates. Cancer Commun (Lond). 2021;41(11):1086–99. https://doi.org/10.1002/cac2.12226 .', 'ArticleIdList': [StringElement('10.1002/cac2.12226', attributes={'IdType': 'doi'}), StringElement('34658186', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Wang P, Sun S, Lam S, Lockwood WW. New insights into the biology and development of lung cancer in never smokers-implications for early detection and treatment. J Transl Med. 2023;21(1):585. https://doi.org/10.1186/s12967-023-04430-x .', 'ArticleIdList': [StringElement('10.1186/s12967-023-04430-x', attributes={'IdType': 'doi'}), StringElement('37653450', attributes={'IdType': 'pubmed'}), StringElement('10472682', attributes={'IdType': 'pmc'})]}, {'Citation': 'Xu S, Liu Y, Ma H, Fang S, Wei S, Li X, Lu Z, Zheng Y, Liu T, Zhu X, Xu D, Pan Y. A Novel Signature Integrated of Immunoglobulin, glycosylation and anti-viral genes to predict prognosis for breast Cancer. Front Genet. 2022;13:834731. https://doi.org/10.3389/fgene.2022.834731 .', 'ArticleIdList': [StringElement('10.3389/fgene.2022.834731', attributes={'IdType': 'doi'}), StringElement('35432482', attributes={'IdType': 'pubmed'}), StringElement('9011196', attributes={'IdType': 'pmc'})]}, {'Citation': 'Shi X, Kou M, Dong X, Zhai J, Liu X, Lu D, Ni Z, Jiang J, Cai K. Integrative pan cancer analysis reveals the importance of CFTR in lung adenocarcinoma prognosis. Genomics. 2022;114(2):110279. https://doi.org/10.1016/j.ygeno.2022.110279 .', 'ArticleIdList': [StringElement('10.1016/j.ygeno.2022.110279', attributes={'IdType': 'doi'}), StringElement('35134493', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Qu Z, Jiang C, Wu J, Ding Y. Lenalidomide induces apoptosis and inhibits angiogenesis via caspase–3 and VEGF in hepatocellular carcinoma cells. Mol Med Rep. 2016;14(5):4781–6. https://doi.org/10.3892/mmr.2016.5797 .', 'ArticleIdList': [StringElement('10.3892/mmr.2016.5797', attributes={'IdType': 'doi'}), StringElement('27748917', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Yang Q, Li S, Fu Z, Lin B, Zhou Z, Wang Z, Hua Y, Cai Z. Shikonin promotes adriamycin–induced apoptosis by upregulating caspase–3 and caspase–8 in osteosarcoma. Mol Med Rep. 2017;16(2):1347–52. https://doi.org/10.3892/mmr.2017.6729 .', 'ArticleIdList': [StringElement('10.3892/mmr.2017.6729', attributes={'IdType': 'doi'}), StringElement('28627658', attributes={'IdType': 'pubmed'}), StringElement('5562087', attributes={'IdType': 'pmc'})]}, {'Citation': 'Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q, Chen C, Qi Y, Gao W, He W, Wang L, Chen D, Fan S, Chen H, Piao HL, Qiao Q, Xu Z, Zhang J, Zhao J, Zhang S, Yin Y, Peng C, Li X, Liu Q, Liu H, Wang Y. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021;131(22). https://doi.org/10.1172/JCI152067 .'}, {'Citation': 'Xu Y, Lv D, Yan C, Su H, Zhang X, Shi Y, Ying K. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)a modification. Cancer Cell Int. 2022;22(1):11. https://doi.org/10.1186/s12935-021-02433-6 .', 'ArticleIdList': [StringElement('10.1186/s12935-021-02433-6', attributes={'IdType': 'doi'}), StringElement('34996469', attributes={'IdType': 'pubmed'}), StringElement('8742440', attributes={'IdType': 'pmc'})]}, {'Citation': 'Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. 2023;20(1):7–23. https://doi.org/10.1038/s41569-022-00735-4 .', 'ArticleIdList': [StringElement('10.1038/s41569-022-00735-4', attributes={'IdType': 'doi'}), StringElement('35788564', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Liu J, Yang G, Zhang H. Glyphosate-triggered hepatocyte ferroptosis via suppressing Nrf2/GSH/GPX4 axis exacerbates hepatotoxicity. Sci Total Environ. 2023;862:160839. https://doi.org/10.1016/j.scitotenv.2022.160839 .', 'ArticleIdList': [StringElement('10.1016/j.scitotenv.2022.160839', attributes={'IdType': 'doi'}), StringElement('36521597', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Chu J, Liu CX, Song R, Li QL. Ferrostatin-1 protects HT-22 cells from oxidative toxicity. Neural Regen Res. 2020;15(3):528–36. https://doi.org/10.4103/1673-5374.266060 .', 'ArticleIdList': [StringElement('10.4103/1673-5374.266060', attributes={'IdType': 'doi'}), StringElement('31571665', attributes={'IdType': 'pubmed'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '23'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '1', 'Day': '8'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '12', 'Day': '25'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '8', 'Hour': '23', 'Minute': '59'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780196', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s13019-024-03298-2', attributes={'IdType': 'doi'}), StringElement('10.1186/s13019-024-03298-2', attributes={'IdType': 'pii'})]}}, {'MedlineCitation': DictElement({'KeywordList': [ListElement([StringElement('Cancer-associated fibroblasts', attributes={'MajorTopicYN': 'N'}), StringElement('Clinical trials', attributes={'MajorTopicYN': 'N'}), StringElement('Targeted therapy', attributes={'MajorTopicYN': 'N'}), StringElement('Tumour microenvironment', attributes={'MajorTopicYN': 'N'}), StringElement('Tumour stroma', attributes={'MajorTopicYN': 'N'})], attributes={'Owner': 'NOTNLM'})], 'OtherID': [], 'CitationSubset': ['IM'], 'InvestigatorList': [], 'SpaceFlightMission': [], 'OtherAbstract': [], 'GeneralNote': [], 'PMID': StringElement('39780187', attributes={'Version': '1'}), 'DateRevised': {'Year': '2025', 'Month': '01', 'Day': '08'}, 'Article': DictElement({'ArticleDate': [DictElement({'Year': '2025', 'Month': '01', 'Day': '09'}, attributes={'DateType': 'Electronic'})], 'ELocationID': [StringElement('10.1186/s12929-024-01099-2', attributes={'EIdType': 'doi', 'ValidYN': 'Y'})], 'Language': ['eng'], 'Journal': {'ISSN': StringElement('1423-0127', attributes={'IssnType': 'Electronic'}), 'JournalIssue': DictElement({'Volume': '32', 'Issue': '1', 'PubDate': {'Year': '2025', 'Month': 'Jan', 'Day': '09'}}, attributes={'CitedMedium': 'Internet'}), 'Title': 'Journal of biomedical science', 'ISOAbbreviation': 'J Biomed Sci'}, 'ArticleTitle': 'Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.', 'Pagination': {'StartPage': '7', 'MedlinePgn': '7'}, 'Abstract': {'AbstractText': ['Research into cancer treatment has been mainly focused on developing therapies to directly target cancer cells. Over the past decade, extensive studies have revealed critical roles of the tumour microenvironment (TME) in cancer initiation, progression, and drug resistance. Notably, cancer-associated fibroblasts (CAFs) have emerged as one of the primary contributors in shaping TME, creating a favourable environment for cancer development. Many preclinical studies have identified promising targets on CAFs, demonstrating remarkable efficacy of some CAF-targeted treatments in preclinical models. Encouraged by these compelling findings, therapeutic strategies have now advanced into clinical evaluation. We aim to provide a comprehensive review of relevant subjects on CAFs, including CAF-related markers and targets, their multifaceted roles, and current landscape of ongoing clinical trials. This knowledge can guide future research on CAFs and advocate for clinical investigations targeting CAFs.'], 'CopyrightInformation': '© 2025. The Author(s).'}, 'AuthorList': ListElement([DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia. Zhipeng.Cao@onjcri.org.au.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia. Zhipeng.Cao@onjcri.org.au.'}, {'Identifier': [], 'Affiliation': 'Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3084, Australia. Zhipeng.Cao@onjcri.org.au.'}], 'Identifier': [StringElement('0000-0003-4142-6190', attributes={'Source': 'ORCID'})], 'LastName': 'Cao', 'ForeName': 'Zhipeng', 'Initials': 'Z'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.'}], 'Identifier': [], 'LastName': 'Quazi', 'ForeName': 'Sadia', 'Initials': 'S'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.'}], 'Identifier': [], 'LastName': 'Arora', 'ForeName': 'Sakshi', 'Initials': 'S'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.'}], 'Identifier': [], 'LastName': 'Osellame', 'ForeName': 'Laura D', 'Initials': 'LD'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.'}], 'Identifier': [], 'LastName': 'Burvenich', 'ForeName': 'Ingrid J', 'Initials': 'IJ'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia.'}, {'Identifier': [], 'Affiliation': 'Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.'}], 'Identifier': [], 'LastName': 'Janes', 'ForeName': 'Peter W', 'Initials': 'PW'}, attributes={'ValidYN': 'Y'}), DictElement({'AffiliationInfo': [{'Identifier': [], 'Affiliation': 'Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, 3084, Australia. Andrew.Scott@onjcri.org.au.'}, {'Identifier': [], 'Affiliation': 'School of Cancer Medicine, La Trobe University, Melbourne, VIC, 3086, Australia. Andrew.Scott@onjcri.org.au.'}, {'Identifier': [], 'Affiliation': 'Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, 3084, Australia. Andrew.Scott@onjcri.org.au.'}, {'Identifier': [], 'Affiliation': 'Department of Medicine, University of Melbourne, Melbourne, VIC, 3010, Australia. Andrew.Scott@onjcri.org.au.'}], 'Identifier': [], 'LastName': 'Scott', 'ForeName': 'Andrew M', 'Initials': 'AM'}, attributes={'ValidYN': 'Y'})], attributes={'CompleteYN': 'Y'}), 'GrantList': ListElement([{'GrantID': '1177837', 'Agency': 'National Health and Medical Research Council', 'Country': ''}], attributes={'CompleteYN': 'Y'}), 'PublicationTypeList': [StringElement('Journal Article', attributes={'UI': 'D016428'}), StringElement('Review', attributes={'UI': 'D016454'})]}, attributes={'PubModel': 'Electronic'}), 'MedlineJournalInfo': {'Country': 'England', 'MedlineTA': 'J Biomed Sci', 'NlmUniqueID': '9421567', 'ISSNLinking': '1021-7770'}, 'CoiStatement': 'Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no conflict of interest.'}, attributes={'Status': 'Publisher', 'Owner': 'NLM'}), 'PubmedData': {'ReferenceList': [{'ReferenceList': [], 'Reference': [{'Citation': 'Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989;8(2):98–101.', 'ArticleIdList': [StringElement('2673568', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Lei X, Lei Y, Li J-K, Du W-X, Li R-G, Yang J, et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126–33.', 'ArticleIdList': [StringElement('31730903', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.canlet.2019.11.009', attributes={'IdType': 'doi'})]}, {'Citation': 'Lu C, Liu Y, Ali NM, Zhang B, Cui X. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. Front Immunol. 2023;13:1039260.', 'ArticleIdList': [StringElement('36741415', attributes={'IdType': 'pubmed'}), StringElement('9893925', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2022.1039260', attributes={'IdType': 'doi'})]}, {'Citation': 'Galli F, Aguilera JV, Palermo B, Markovic SN, Nisticò P, Signore A. Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy. J Exp Clin Cancer Res. 2020;39(1):89.', 'ArticleIdList': [StringElement('32423420', attributes={'IdType': 'pubmed'}), StringElement('7236372', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-020-01586-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Anjali B, Nishka B, Sneha M, Gurbind S, Sandeep Kumar Y, Aloukick KS. Role of various immune cells in the tumor microenvironment. Dis Res. 2023;3(1):30–40.', 'ArticleIdList': [StringElement('10.54457/DR.202301006', attributes={'IdType': 'doi'})]}, {'Citation': 'de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403.', 'ArticleIdList': [StringElement('36917948', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ccell.2023.02.016', attributes={'IdType': 'doi'})]}, {'Citation': 'Sullivan L, Pacheco RR, Kmeid M, Chen A, Lee H. Tumor stroma ratio and its significance in locally advanced colorectal cancer. Curr Oncol. 2022;29(5):3232–41.', 'ArticleIdList': [StringElement('35621653', attributes={'IdType': 'pubmed'}), StringElement('9139914', attributes={'IdType': 'pmc'}), StringElement('10.3390/curroncol29050263', attributes={'IdType': 'doi'})]}, {'Citation': 'Almangush A, Alabi RO, Troiano G, Coletta RD, Salo T, Pirinen M, et al. Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21(1):480.', 'ArticleIdList': [StringElement('33931044', attributes={'IdType': 'pubmed'}), StringElement('8086072', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12885-021-08222-8', attributes={'IdType': 'doi'})]}, {'Citation': 'van Pelt GW, Sandberg TP, Morreau H, Gelderblom H, van Krieken J, Tollenaar R, et al. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology. 2018;73(2):197–206.', 'ArticleIdList': [StringElement('29457843', attributes={'IdType': 'pubmed'}), StringElement('10.1111/his.13489', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang K, Ma W, Wang J, Yu L, Zhang X, Wang Z, et al. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol. 2012;7(9):1457–61.', 'ArticleIdList': [StringElement('22843085', attributes={'IdType': 'pubmed'}), StringElement('10.1097/JTO.0b013e318260dfe8', attributes={'IdType': 'doi'})]}, {'Citation': 'Kemi N, Eskuri M, Herva A, Leppänen J, Huhta H, Helminen O, et al. Tumour-stroma ratio and prognosis in gastric adenocarcinoma. Br J Cancer. 2018;119(4):435–9.', 'ArticleIdList': [StringElement('30057407', attributes={'IdType': 'pubmed'}), StringElement('6133938', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41416-018-0202-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Hosaka K, Yang Y, Seki T, Fischer C, Dubey O, Fredlund E, et al. Pericyte-fibroblast transition promotes tumor growth and metastasis. Proc Natl Acad Sci USA. 2016;113(38):E5618-5627.', 'ArticleIdList': [StringElement('27608497', attributes={'IdType': 'pubmed'}), StringElement('5035870', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.1608384113', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14(9):587.', 'ArticleIdList': [StringElement('37666813', attributes={'IdType': 'pubmed'}), StringElement('10477351', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-023-06110-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Xu M, Zhang T, Xia R, Wei Y, Wei X. Targeting the tumor stroma for cancer therapy. Mol Cancer. 2022;21(1):208.', 'ArticleIdList': [StringElement('36324128', attributes={'IdType': 'pubmed'}), StringElement('9628074', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-022-01670-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Czekay RP, Cheon DJ, Samarakoon R, Kutz SM, Higgins PJ. Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets. Cancers. 2022;14(5):1231.', 'ArticleIdList': [StringElement('35267539', attributes={'IdType': 'pubmed'}), StringElement('8909913', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers14051231', attributes={'IdType': 'doi'})]}, {'Citation': 'Belhabib I, Zaghdoudi S, Lac C, Bousquet C, Jean C. Extracellular matrices and cancer-associated fibroblasts: targets for cancer diagnosis and therapy? Cancers. 2021;13(14):3466.', 'ArticleIdList': [StringElement('34298680', attributes={'IdType': 'pubmed'}), StringElement('8303391', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers13143466', attributes={'IdType': 'doi'})]}, {'Citation': 'Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174–86.', 'ArticleIdList': [StringElement('31980749', attributes={'IdType': 'pubmed'}), StringElement('7046529', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41568-019-0238-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 2017;45(1):229–36.', 'ArticleIdList': [StringElement('28202677', attributes={'IdType': 'pubmed'}), StringElement('5371349', attributes={'IdType': 'pmc'}), StringElement('10.1042/BST20160387', attributes={'IdType': 'doi'})]}, {'Citation': 'Yuan Z, Li Y, Zhang S, Wang X, Dou H, Yu X, et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol Cancer. 2023;22(1):48.', 'ArticleIdList': [StringElement('36906534', attributes={'IdType': 'pubmed'}), StringElement('10007858', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-023-01744-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Papanicolaou M, Parker AL, Yam M, Filipe EC, Wu SZ, Chitty JL, et al. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun. 2022;13(1):4587.', 'ArticleIdList': [StringElement('35933466', attributes={'IdType': 'pubmed'}), StringElement('9357007', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-022-32255-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Stouten I, van Montfoort N, Hawinkels LJAC. The tango between cancer-associated fibroblasts (CAFs) and immune cells in affecting immunotherapy efficacy in pancreatic cancer. Int J Mol Sci. 2023;24(10):8707.', 'ArticleIdList': [StringElement('37240052', attributes={'IdType': 'pubmed'}), StringElement('10218125', attributes={'IdType': 'pmc'}), StringElement('10.3390/ijms24108707', attributes={'IdType': 'doi'})]}, {'Citation': 'Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.', 'ArticleIdList': [StringElement('34635121', attributes={'IdType': 'pubmed'}), StringElement('8504100', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12943-021-01428-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33(3):463-479.e410.', 'ArticleIdList': [StringElement('29455927', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ccell.2018.01.011', attributes={'IdType': 'doi'})]}, {'Citation': 'Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392–401.', 'ArticleIdList': [StringElement('16572188', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nrc1877', attributes={'IdType': 'doi'})]}, {'Citation': 'Yang D, Liu J, Qian H, Zhuang Q. Cancer-associated fibroblasts: from basic science to anticancer therapy. Exp Mol Med. 2023;55(7):1322–32.', 'ArticleIdList': [StringElement('37394578', attributes={'IdType': 'pubmed'}), StringElement('10394065', attributes={'IdType': 'pmc'}), StringElement('10.1038/s12276-023-01013-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Rettig WJ, Garin-Chesa P, Beresford HR, Oettgen HF, Melamed MR, Old LJ. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci USA. 1988;85(9):3110–4.', 'ArticleIdList': [StringElement('2896356', attributes={'IdType': 'pubmed'}), StringElement('280153', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.85.9.3110', attributes={'IdType': 'doi'})]}, {'Citation': 'Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999;274(51):36505–12.', 'ArticleIdList': [StringElement('10593948', attributes={'IdType': 'pubmed'}), StringElement('10.1074/jbc.274.51.36505', attributes={'IdType': 'doi'})]}, {'Citation': 'Crane JN, Graham DS, Mona CE, Nelson SD, Samiei A, Dawson DW, et al. Fibroblast activation protein expression in sarcomas. Sarcoma. 2023;2023:2480493.', 'ArticleIdList': [StringElement('37333052', attributes={'IdType': 'pubmed'}), StringElement('10275689', attributes={'IdType': 'pmc'}), StringElement('10.1155/2023/2480493', attributes={'IdType': 'doi'})]}, {'Citation': 'Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783–803.', 'ArticleIdList': [StringElement('32601975', attributes={'IdType': 'pubmed'}), StringElement('7487063', attributes={'IdType': 'pmc'}), StringElement('10.1007/s10555-020-09909-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Jacob M, Chang L, Puré E. Fibroblast activation protein in remodeling tissues. Curr Mol Med. 2012;12(10):1220–43.', 'ArticleIdList': [StringElement('22834826', attributes={'IdType': 'pubmed'}), StringElement('10.2174/156652412803833607', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang Z, Wang J, Lan T, Zhang L, Yan Z, Zhang N, et al. Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis. Front Immunol. 2023;14:1135384.', 'ArticleIdList': [StringElement('37006278', attributes={'IdType': 'pubmed'}), StringElement('10064071', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2023.1135384', attributes={'IdType': 'doi'})]}, {'Citation': 'Lay AJ, Zhang HE, McCaughan GW, Gorrell MD. Fibroblast activation protein in liver fibrosis. Front Biosci (Landmark Ed). 2019;24(1):1–17.', 'ArticleIdList': [StringElement('30468644', attributes={'IdType': 'pubmed'}), StringElement('10.2741/4706', attributes={'IdType': 'doi'})]}, {'Citation': 'Ebert LM, Yu W, Gargett T, Toubia J, Kollis PM, Tea MN, et al. Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy. Clin Transl Immunol. 2020;9(10): e1191.', 'ArticleIdList': [StringElement('10.1002/cti2.1191', attributes={'IdType': 'doi'})]}, {'Citation': 'Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E. In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer. 2020;146(4):895–905.', 'ArticleIdList': [StringElement('30734283', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ijc.32193', attributes={'IdType': 'doi'})]}, {'Citation': 'Lyu Z, Li Y, Zhu D, Wu S, Hu F, Zhang Y, et al. Fibroblast activation protein-alpha is a prognostic biomarker associated with ferroptosis in stomach adenocarcinoma. Fronti Cell Dev Biol. 2022;10: 859999.', 'ArticleIdList': [StringElement('10.3389/fcell.2022.859999', attributes={'IdType': 'doi'})]}, {'Citation': 'Muilwijk T, Akand M, Daelemans S, Marien K, Waumans Y, Kockx M, et al. Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer. PLoS ONE. 2021;16(9): e0257195.', 'ArticleIdList': [StringElement('34525114', attributes={'IdType': 'pubmed'}), StringElement('8443055', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0257195', attributes={'IdType': 'doi'})]}, {'Citation': 'Kalaei Z, Manafi-Farid R, Rashidi B, Kiani FK, Zarei A, Fathi M, et al. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer. Cell Commun Signal. 2023;21(1):139.', 'ArticleIdList': [StringElement('37316886', attributes={'IdType': 'pubmed'}), StringElement('10265921', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12964-023-01151-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Yanagawa N, Sugai M, Shikanai S, Sugimoto R, Osakabe M, Uesugi N, et al. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma. Thoracic Cancer. 2022;13(16):2377–84.', 'ArticleIdList': [StringElement('35818720', attributes={'IdType': 'pubmed'}), StringElement('9376177', attributes={'IdType': 'pmc'}), StringElement('10.1111/1759-7714.14579', attributes={'IdType': 'doi'})]}, {'Citation': 'Park H, Lee Y, Lee H, Kim JW, Hwang JH, Kim J, et al. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Tumour Biol. 2017;39(10):1010428317718403.', 'ArticleIdList': [StringElement('29025374', attributes={'IdType': 'pubmed'}), StringElement('10.1177/1010428317718403', attributes={'IdType': 'doi'})]}, {'Citation': 'Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer. 2001;95(1):67–72.', 'ArticleIdList': [StringElement('11241314', attributes={'IdType': 'pubmed'}), StringElement('10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U', attributes={'IdType': 'doi'})]}, {'Citation': 'Cheng JD, Dunbrack RL Jr, Valianou M, Rogatko A, Alpaugh RK, Weiner LM. Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002;62(16):4767–72.', 'ArticleIdList': [StringElement('12183436', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS ONE. 2009;4(11): e7965.', 'ArticleIdList': [StringElement('19956757', attributes={'IdType': 'pubmed'}), StringElement('2775953', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0007965', attributes={'IdType': 'doi'})]}, {'Citation': 'Lo A, Li CP, Buza EL, Blomberg R, Govindaraju P, Avery D, et al. Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma. JCI Insight. 2017;2(19): e92232.', 'ArticleIdList': [StringElement('28978805', attributes={'IdType': 'pubmed'}), StringElement('5841864', attributes={'IdType': 'pmc'}), StringElement('10.1172/jci.insight.92232', attributes={'IdType': 'doi'})]}, {'Citation': 'Ji D, Jia J, Cui X, Li Z, Wu A. FAP promotes metastasis and chemoresistance via regulating YAP1 and macrophages in mucinous colorectal adenocarcinoma. iScience. 2023;26(6): 106600.', 'ArticleIdList': [StringElement('37213233', attributes={'IdType': 'pubmed'}), StringElement('10196996', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.isci.2023.106600', attributes={'IdType': 'doi'})]}, {'Citation': 'Lee H-O, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer. 2011;11(1):245.', 'ArticleIdList': [StringElement('21668992', attributes={'IdType': 'pubmed'}), StringElement('3141768', attributes={'IdType': 'pmc'}), StringElement('10.1186/1471-2407-11-245', attributes={'IdType': 'doi'})]}, {'Citation': 'Barrett RL, Puré E. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife. 2020;9: e57243.', 'ArticleIdList': [StringElement('33370234', attributes={'IdType': 'pubmed'}), StringElement('7769568', attributes={'IdType': 'pmc'}), StringElement('10.7554/eLife.57243', attributes={'IdType': 'doi'})]}, {'Citation': 'Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science. 2010;330(6005):827–30.', 'ArticleIdList': [StringElement('21051638', attributes={'IdType': 'pubmed'}), StringElement('10.1126/science.1195300', attributes={'IdType': 'doi'})]}, {'Citation': 'Fearon DT. The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance. Cancer Immunol Res. 2014;2(3):187–93.', 'ArticleIdList': [StringElement('24778314', attributes={'IdType': 'pubmed'}), StringElement('10.1158/2326-6066.CIR-14-0002', attributes={'IdType': 'doi'})]}, {'Citation': 'Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3–CCL2 signaling. Can Res. 2016;76(14):4124–35.', 'ArticleIdList': [StringElement('10.1158/0008-5472.CAN-15-2973', attributes={'IdType': 'doi'})]}, {'Citation': 'Santos AM, Jung J, Aziz N, Kissil JL, Puré E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009;119(12):3613–25.', 'ArticleIdList': [StringElement('19920354', attributes={'IdType': 'pubmed'}), StringElement('2786791', attributes={'IdType': 'pmc'}), StringElement('10.1172/JCI38988', attributes={'IdType': 'doi'})]}, {'Citation': 'Teichgräber V, Monasterio C, Chaitanya K, Boger R, Gordon K, Dieterle T, et al. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro. Adv Med Sci. 2015;60(2):264–72.', 'ArticleIdList': [StringElement('26057860', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.advms.2015.04.006', attributes={'IdType': 'doi'})]}, {'Citation': 'Lin Y, Li B, Yang X, Cai Q, Liu W, Tian M, et al. Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment. Neoplasia. 2019;21(12):1133–42.', 'ArticleIdList': [StringElement('31759251', attributes={'IdType': 'pubmed'}), StringElement('6880109', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.neo.2019.10.005', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang M, Fu M, Wang J, Xia C, Zhang H, Xiong Y, et al. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α. Biochem Pharmacol. 2021;188: 114527.', 'ArticleIdList': [StringElement('33741330', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.bcp.2021.114527', attributes={'IdType': 'doi'})]}, {'Citation': 'Wen X, He X, Jiao F, Wang C, Sun Y, Ren X, et al. Fibroblast activation protein-α-positive fibroblasts promote gastric cancer progression and resistance to immune checkpoint blockade. Oncol Res. 2017;25(4):629–40.', 'ArticleIdList': [StringElement('27983931', attributes={'IdType': 'pubmed'}), StringElement('7841289', attributes={'IdType': 'pmc'}), StringElement('10.3727/096504016X14768383625385', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang H, Wu Q, Liu Z, Luo X, Fan Y, Liu Y, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014;5(4): e1155.', 'ArticleIdList': [StringElement('24722280', attributes={'IdType': 'pubmed'}), StringElement('5424105', attributes={'IdType': 'pmc'}), StringElement('10.1038/cddis.2014.122', attributes={'IdType': 'doi'})]}, {'Citation': 'An J, Hou D, Wang L, Wang L, Yang Y, Wang H. Fibroblast activation protein-alpha knockdown suppresses prostate cancer cell invasion and proliferation. Histol Histopathol. 2022;37(6):597–607.', 'ArticleIdList': [StringElement('35129203', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Muchlińska A, Nagel A, Popęda M, Szade J, Niemira M, Zieliński J, et al. Alpha-smooth muscle actin-positive cancer-associated fibroblasts secreting osteopontin promote growth of luminal breast cancer. Cell Mol Biol Lett. 2022;27(1):45.', 'ArticleIdList': [StringElement('35690734', attributes={'IdType': 'pubmed'}), StringElement('9188043', attributes={'IdType': 'pmc'}), StringElement('10.1186/s11658-022-00351-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Chen J, Yang P, Xiao Y, Zhang Y, Liu J, Xie D, et al. Overexpression of α-sma-positive fibroblasts (CAFs) in nasopharyngeal carcinoma predicts poor prognosis. J Cancer. 2017;8(18):3897–902.', 'ArticleIdList': [StringElement('29151978', attributes={'IdType': 'pubmed'}), StringElement('5688944', attributes={'IdType': 'pmc'}), StringElement('10.7150/jca.20324', attributes={'IdType': 'doi'})]}, {'Citation': 'Chuaysri C, Thuwajit P, Paupairoj A, Chau-In S, Suthiphongchai T, Thuwajit C. Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. Oncol Rep. 2009;21(4):957–69.', 'ArticleIdList': [StringElement('19287994', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Patel AK, Vipparthi K, Thatikonda V, Arun I, Bhattacharjee S, Sharan R, et al. A subtype of cancer-associated fibroblasts with lower expression of alpha-smooth muscle actin suppresses stemness through BMP4 in oral carcinoma. Oncogenesis. 2018;7(10):78.', 'ArticleIdList': [StringElement('30287850', attributes={'IdType': 'pubmed'}), StringElement('6172238', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41389-018-0087-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang M, Li Y, Zhang H, Nan F. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction. J Exp Clin Cancer Res. 2010;29(1):80.', 'ArticleIdList': [StringElement('20569497', attributes={'IdType': 'pubmed'}), StringElement('2911413', attributes={'IdType': 'pmc'}), StringElement('10.1186/1756-9966-29-80', attributes={'IdType': 'doi'})]}, {'Citation': 'Lau EY, Lo J, Cheng BY, Ma MK, Lee JM, Ng JK, et al. Cancer-associated fibroblasts regulate tumor-initiating cell plasticity in hepatocellular carcinoma through c-Met/FRA1/HEY1 signaling. Cell Rep. 2016;15(6):1175–89.', 'ArticleIdList': [StringElement('27134167', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.celrep.2016.04.019', attributes={'IdType': 'doi'})]}, {'Citation': 'Mace TA, Ameen Z, Collins A, Wojcik S, Mair M, Young GS, et al. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Cancer Res. 2013;73(10):3007–18.', 'ArticleIdList': [StringElement('23514705', attributes={'IdType': 'pubmed'}), StringElement('3785672', attributes={'IdType': 'pmc'}), StringElement('10.1158/0008-5472.CAN-12-4601', attributes={'IdType': 'doi'})]}, {'Citation': 'Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17(9):559–72.', 'ArticleIdList': [StringElement('28555670', attributes={'IdType': 'pubmed'}), StringElement('5731833', attributes={'IdType': 'pmc'}), StringElement('10.1038/nri.2017.49', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang R, Qi F, Zhao F, Li G, Shao S, Zhang X, et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Cell Death Dis. 2019;10(4):273.', 'ArticleIdList': [StringElement('30894509', attributes={'IdType': 'pubmed'}), StringElement('6426970', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-019-1435-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Cheng Y, Li H, Deng Y, Tai Y, Zeng K, Zhang Y, et al. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis. 2018;9(4):422.', 'ArticleIdList': [StringElement('29556041', attributes={'IdType': 'pubmed'}), StringElement('5859264', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-018-0458-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Özdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719–34.', 'ArticleIdList': [StringElement('24856586', attributes={'IdType': 'pubmed'}), StringElement('4180632', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ccr.2014.04.005', attributes={'IdType': 'doi'})]}, {'Citation': 'Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735–47.', 'ArticleIdList': [StringElement('24856585', attributes={'IdType': 'pubmed'}), StringElement('4096698', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ccr.2014.04.021', attributes={'IdType': 'doi'})]}, {'Citation': 'Heldin C-H. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal. 2013;11(1):97.', 'ArticleIdList': [StringElement('24359404', attributes={'IdType': 'pubmed'}), StringElement('3878225', attributes={'IdType': 'pmc'}), StringElement('10.1186/1478-811X-11-97', attributes={'IdType': 'doi'})]}, {'Citation': 'Guérit E, Arts F, Dachy G, Boulouadnine B, Demoulin J-B. PDGF receptor mutations in human diseases. Cell Mol Life Sci. 2021;78(8):3867–81.', 'ArticleIdList': [StringElement('33449152', attributes={'IdType': 'pubmed'}), StringElement('11072557', attributes={'IdType': 'pmc'}), StringElement('10.1007/s00018-020-03753-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Ying HZ, Chen Q, Zhang WY, Zhang HH, Ma Y, Zhang SZ, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (review). Mol Med Rep. 2017;16(6):7879–89.', 'ArticleIdList': [StringElement('28983598', attributes={'IdType': 'pubmed'}), StringElement('5779870', attributes={'IdType': 'pmc'}), StringElement('10.3892/mmr.2017.7641', attributes={'IdType': 'doi'})]}, {'Citation': 'Gouveia L, Kraut S, Hadzic S, Vazquéz-Liébanas E, Kojonazarov B, Wu C-Y, et al. Lung developmental arrest caused by PDGF-A deletion: consequences for the adult mouse lung. Am J Physiol Lung Cell Mol Physiol. 2020;318(4):L831–43.', 'ArticleIdList': [StringElement('32186397', attributes={'IdType': 'pubmed'}), StringElement('7191480', attributes={'IdType': 'pmc'}), StringElement('10.1152/ajplung.00295.2019', attributes={'IdType': 'doi'})]}, {'Citation': 'Boström H, Gritli-Linde A, Betsholtz C. PDGF-A/PDGF alpha-receptor signaling is required for lung growth and the formation of alveoli but not for early lung branching morphogenesis. Dev Dyn. 2002;223(1):155–62.', 'ArticleIdList': [StringElement('11803579', attributes={'IdType': 'pubmed'}), StringElement('10.1002/dvdy.1225', attributes={'IdType': 'doi'})]}, {'Citation': 'Tian Y, Zhan Y, Jiang Q, Lu W, Li X. Expression and function of PDGF-C in development and stem cells. Open Biol. 2021;11(12): 210268.', 'ArticleIdList': [StringElement('34847773', attributes={'IdType': 'pubmed'}), StringElement('8633783', attributes={'IdType': 'pmc'}), StringElement('10.1098/rsob.210268', attributes={'IdType': 'doi'})]}, {'Citation': 'Nordby Y, Richardsen E, Rakaee M, Ness N, Donnem T, Patel HRH, et al. High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Sci Rep. 2017;7(1):43378.', 'ArticleIdList': [StringElement('28233816', attributes={'IdType': 'pubmed'}), StringElement('5324133', attributes={'IdType': 'pmc'}), StringElement('10.1038/srep43378', attributes={'IdType': 'doi'})]}, {'Citation': 'Winkler EA, Bell RD, Zlokovic BV. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener. 2010;5:32.', 'ArticleIdList': [StringElement('20738866', attributes={'IdType': 'pubmed'}), StringElement('2936891', attributes={'IdType': 'pmc'}), StringElement('10.1186/1750-1326-5-32', attributes={'IdType': 'doi'})]}, {'Citation': 'Hägglöf C, Hammarsten P, Josefsson A, Stattin P, Paulsson J, Bergh A, et al. Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival. PLoS ONE. 2010;5(5): e10747.', 'ArticleIdList': [StringElement('20505768', attributes={'IdType': 'pubmed'}), StringElement('2873980', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0010747', attributes={'IdType': 'doi'})]}, {'Citation': 'Strell C, Stenmark Tullberg A, Jetne Edelmann R, Akslen LA, Malmström P, Fernö M, et al. Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial. Breast Cancer Res Treat. 2021;187(1):45–55.', 'ArticleIdList': [StringElement('33661437', attributes={'IdType': 'pubmed'}), StringElement('8062362', attributes={'IdType': 'pmc'}), StringElement('10.1007/s10549-021-06136-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Fujino S, Miyoshi N, Ohue M, Takahashi Y, Yasui M, Hata T, et al. Platelet-derived growth factor receptor-β gene expression relates to recurrence in colorectal cancer. Oncol Rep. 2018;39(5):2178–84.', 'ArticleIdList': [StringElement('29498405', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Madsen CV, Dahl Steffensen K, Waldstrøm M, Jakobsen A. Immunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up. Patholog Res Int. 2012;2012: 851432.', 'ArticleIdList': [StringElement('23094199', attributes={'IdType': 'pubmed'}), StringElement('3461633', attributes={'IdType': 'pmc'})]}, {'Citation': 'Chang KK, Yoon C, Yi BC, Tap WD, Simon MC, Yoon SS. Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas. Oncogenesis. 2018;7(6):47.', 'ArticleIdList': [StringElement('29915281', attributes={'IdType': 'pubmed'}), StringElement('6006341', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41389-018-0059-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Erdogan B, Ao M, White LM, Means AL, Brewer BM, Yang L, et al. Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin. J Cell Biol. 2017;216(11):3799–816.', 'ArticleIdList': [StringElement('29021221', attributes={'IdType': 'pubmed'}), StringElement('5674895', attributes={'IdType': 'pmc'}), StringElement('10.1083/jcb.201704053', attributes={'IdType': 'doi'})]}, {'Citation': 'Primac I, Maquoi E, Blacher S, Heljasvaara R, Van Deun J, Smeland HYH, et al. Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression. J Clin Investig. 2019;129(11):4609–28.', 'ArticleIdList': [StringElement('31287804', attributes={'IdType': 'pubmed'}), StringElement('6819106', attributes={'IdType': 'pmc'}), StringElement('10.1172/JCI125890', attributes={'IdType': 'doi'})]}, {'Citation': 'Peña C, Céspedes MV, Lindh MB, Kiflemariam S, Mezheyeuski A, Edqvist PH, et al. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res. 2013;73(4):1287–97.', 'ArticleIdList': [StringElement('23243022', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-12-1875', attributes={'IdType': 'doi'})]}, {'Citation': 'Aoto K, Ito K, Aoki S. Complex formation between platelet-derived growth factor receptor β and transforming growth factor β receptor regulates the differentiation of mesenchymal stem cells into cancer-associated fibroblasts. Oncotarget. 2018;9(75):34090–102.', 'ArticleIdList': [StringElement('30344924', attributes={'IdType': 'pubmed'}), StringElement('6183337', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.26124', attributes={'IdType': 'doi'})]}, {'Citation': 'Djurec M, Graña O, Lee A, Troulé K, Espinet E, Cabras L, et al. Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors. Proc Natl Acad Sci USA. 2018;115(6):E1147-e1156.', 'ArticleIdList': [StringElement('29351990', attributes={'IdType': 'pubmed'}), StringElement('5819438', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.1717802115', attributes={'IdType': 'doi'})]}, {'Citation': 'Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L, et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017;36(31):4457–68.', 'ArticleIdList': [StringElement('28368410', attributes={'IdType': 'pubmed'}), StringElement('5507301', attributes={'IdType': 'pmc'}), StringElement('10.1038/onc.2017.65', attributes={'IdType': 'doi'})]}, {'Citation': 'Lakins MA, Ghorani E, Munir H, Martins CP, Shields JD. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T cells to protect tumour cells. Nat Commun. 2018;9(1):948.', 'ArticleIdList': [StringElement('29507342', attributes={'IdType': 'pubmed'}), StringElement('5838096', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-018-03347-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Wu Z, Xu J, Tang R, Wang W, Zhang B, Yu X, et al. The role of PDGFRA in predicting oncological and immune characteristics in pancreatic ductal adenocarcinoma. J Oncol. 2022;2022:4148805.', 'ArticleIdList': [StringElement('35378770', attributes={'IdType': 'pubmed'}), StringElement('8976608', attributes={'IdType': 'pmc'})]}, {'Citation': 'Yoon H, Tang C-M, Banerjee S, Yebra M, Noh S, Burgoyne AM, et al. Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis. Oncogene. 2021;40(11):1957–73.', 'ArticleIdList': [StringElement('33603171', attributes={'IdType': 'pubmed'}), StringElement('7979540', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41388-021-01685-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Hayashi Y, Bardsley MR, Toyomasu Y, Milosavljevic S, Gajdos GB, Choi KM, et al. Platelet-derived growth factor receptor-α regulates proliferation of gastrointestinal stromal tumor cells with mutations in KIT by stabilizing ETV1. Gastroenterology. 2015;149(2):420-432.e416.', 'ArticleIdList': [StringElement('25865047', attributes={'IdType': 'pubmed'}), StringElement('10.1053/j.gastro.2015.04.006', attributes={'IdType': 'doi'})]}, {'Citation': 'Peng G, Wang Y, Ge P, Bailey C, Zhang P, Zhang D, et al. The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin. J Exp Clin Cancer Res. 2021;40(1):278.', 'ArticleIdList': [StringElement('34470658', attributes={'IdType': 'pubmed'}), StringElement('8411541', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-021-02082-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Bai F, Liu S, Liu X, Hollern DP, Scott A, Wang C, et al. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors. Breast Cancer Res. 2021;23(1):10.', 'ArticleIdList': [StringElement('33478572', attributes={'IdType': 'pubmed'}), StringElement('7819225', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13058-021-01387-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Li Y, Tao Y, Gao S, Li P, Zheng J, Zhang S, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 2018;36:209–20.', 'ArticleIdList': [StringElement('30243489', attributes={'IdType': 'pubmed'}), StringElement('6197737', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ebiom.2018.09.006', attributes={'IdType': 'doi'})]}, {'Citation': 'Maehira H, Miyake T, Iida H, Tokuda A, Mori H, Yasukawa D, et al. Vimentin expression in tumor microenvironment predicts survival in pancreatic ductal adenocarcinoma: heterogeneity in fibroblast population. Ann Surg Oncol. 2019;26(13):4791–804.', 'ArticleIdList': [StringElement('31583548', attributes={'IdType': 'pubmed'}), StringElement('10.1245/s10434-019-07891-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Ngan CY, Yamamoto H, Seshimo I, Tsujino T, Man-i M, Ikeda JI, et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer. 2007;96(6):986–92.', 'ArticleIdList': [StringElement('17325702', attributes={'IdType': 'pubmed'}), StringElement('2360104', attributes={'IdType': 'pmc'}), StringElement('10.1038/sj.bjc.6603651', attributes={'IdType': 'doi'})]}, {'Citation': 'Szubert S, Koper K, Dutsch-Wicherek MM, Jozwicki W. High tumor cell vimentin expression indicates prolonged survival in patients with ovarian malignant tumors. Ginekol Pol. 2019;90(1):11–9.', 'ArticleIdList': [StringElement('30756366', attributes={'IdType': 'pubmed'}), StringElement('10.5603/GP.2019.0003', attributes={'IdType': 'doi'})]}, {'Citation': 'Strouhalova K, Přechová M, Gandalovičová A, Brábek J, Gregor M, Rosel D. Vimentin intermediate filaments as potential target for cancer treatment. Cancers. 2020;12(1):184.', 'ArticleIdList': [StringElement('31940801', attributes={'IdType': 'pubmed'}), StringElement('7017239', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers12010184', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu CY, Lin HH, Tang MJ, Wang YK. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget. 2015;6(18):15966–83.', 'ArticleIdList': [StringElement('25965826', attributes={'IdType': 'pubmed'}), StringElement('4599250', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.3862', attributes={'IdType': 'doi'})]}, {'Citation': 'Richardson AM, Havel LS, Koyen AE, Konen JM, Shupe J, Wiles WG IV, et al. Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell–cancer-associated fibroblast interactions during collective invasion. Clin Cancer Res. 2018;24(2):420–32.', 'ArticleIdList': [StringElement('29208669', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-17-1776', attributes={'IdType': 'doi'})]}, {'Citation': 'Berr AL, Wiese K, dos Santos G, Koch CM, Anekalla KR, Kidd M, et al. Vimentin is required for tumor progression and metastasis in a mouse model of non–small cell lung cancer. Oncogene. 2023;42(25):2074–87.', 'ArticleIdList': [StringElement('37161053', attributes={'IdType': 'pubmed'}), StringElement('10275760', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41388-023-02703-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Dmello C, Sawant S, Alam H, Gangadaran P, Tiwari R, Dongre H, et al. Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells. Int J Biochem Cell Biol. 2016;70:161–72.', 'ArticleIdList': [StringElement('26646105', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.biocel.2015.11.015', attributes={'IdType': 'doi'})]}, {'Citation': 'Xuan B, Ghosh D, Jiang J, Shao R, Dawson MR. Vimentin filaments drive migratory persistence in polyploidal cancer cells. Proc Natl Acad Sci. 2020;117(43):26756–65.', 'ArticleIdList': [StringElement('33046658', attributes={'IdType': 'pubmed'}), StringElement('7604438', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.2011912117', attributes={'IdType': 'doi'})]}, {'Citation': 'Schacht V, Ramirez MI, Hong Y-K, Hirakawa S, Feng D, Harvey N, et al. T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003;22(14):3546–56.', 'ArticleIdList': [StringElement('12853470', attributes={'IdType': 'pubmed'}), StringElement('165612', attributes={'IdType': 'pmc'}), StringElement('10.1093/emboj/cdg342', attributes={'IdType': 'doi'})]}, {'Citation': 'Fu J, Gerhardt H, McDaniel JM, Xia B, Liu X, Ivanciu L, et al. Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Investig. 2008;118(11):3725–37.', 'ArticleIdList': [StringElement('18924607', attributes={'IdType': 'pubmed'}), StringElement('2567837', attributes={'IdType': 'pmc'}), StringElement('10.1172/JCI36077', attributes={'IdType': 'doi'})]}, {'Citation': 'Kong LL, Yang NZ, Shi LH, Zhao GH, Zhou W, Ding Q, et al. The optimum marker for the detection of lymphatic vessels. Mol Clin Oncol. 2017;7(4):515–20.', 'ArticleIdList': [StringElement('28855985', attributes={'IdType': 'pubmed'}), StringElement('5574200', attributes={'IdType': 'pmc'}), StringElement('10.3892/mco.2017.1356', attributes={'IdType': 'doi'})]}, {'Citation': 'Suzuki J, Aokage K, Neri S, Sakai T, Hashimoto H, Su Y, et al. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma. Lung Cancer. 2021;153:1–10.', 'ArticleIdList': [StringElement('33429158', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.lungcan.2020.12.020', attributes={'IdType': 'doi'})]}, {'Citation': 'Pula B, Jethon A, Piotrowska A, Gomulkiewicz A, Owczarek T, Calik J, et al. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Histopathology. 2011;59(6):1249–60.', 'ArticleIdList': [StringElement('22175904', attributes={'IdType': 'pubmed'}), StringElement('10.1111/j.1365-2559.2011.04060.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Shindo K, Aishima S, Ohuchida K, Fujiwara K, Fujino M, Mizuuchi Y, et al. Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Mol Cancer. 2013;12:1–16.', 'ArticleIdList': [StringElement('10.1186/1476-4598-12-168', attributes={'IdType': 'doi'})]}, {'Citation': 'Neri S, Ishii G, Hashimoto H, Kuwata T, Nagai K, Date H, et al. Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma. Int J Cancer. 2015;137(4):784–96.', 'ArticleIdList': [StringElement('25648219', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ijc.29464', attributes={'IdType': 'doi'})]}, {'Citation': 'Suchanski J, Tejchman A, Zacharski M, Piotrowska A, Grzegrzolka J, Chodaczek G, et al. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression. PLoS ONE. 2017;12(9): e0184970.', 'ArticleIdList': [StringElement('28938000', attributes={'IdType': 'pubmed'}), StringElement('5609749', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0184970', attributes={'IdType': 'doi'})]}, {'Citation': 'Takahashi A, Ishii G, Neri S, Yoshida T, Hashimoto H, Suzuki S, et al. Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth. Oncotarget. 2015;6(11):9531–41.', 'ArticleIdList': [StringElement('25909164', attributes={'IdType': 'pubmed'}), StringElement('4496236', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.3371', attributes={'IdType': 'doi'})]}, {'Citation': 'Choi SY, Sung R, Lee SJ, Lee TG, Kim N, Yoon SM, et al. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers. J Korean Med Sci. 2013;28(9):1293–301.', 'ArticleIdList': [StringElement('24015033', attributes={'IdType': 'pubmed'}), StringElement('3763102', attributes={'IdType': 'pmc'}), StringElement('10.3346/jkms.2013.28.9.1293', attributes={'IdType': 'doi'})]}, {'Citation': 'Chihara N, Madi A, Kondo T, Zhang H, Acharya N, Singer M, et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature. 2018;558(7710):454–9.', 'ArticleIdList': [StringElement('29899446', attributes={'IdType': 'pubmed'}), StringElement('6130914', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41586-018-0206-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Bieniasz-Krzywiec P, Martín-Pérez R, Ehling M, García-Caballero M, Pinioti S, Pretto S, et al. Podoplanin-expressing macrophages promote lymphangiogenesis and lymphoinvasion in breast cancer. Cell Metab. 2019;30(5):917-936.e910.', 'ArticleIdList': [StringElement('31447322', attributes={'IdType': 'pubmed'}), StringElement('7616630', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.cmet.2019.07.015', attributes={'IdType': 'doi'})]}, {'Citation': 'Hsu YB, Huang CF, Lin KT, Kuo YL, Lan MC, Lan MY. Podoplanin, a potential therapeutic target for nasopharyngeal carcinoma. Biomed Res Int. 2019;2019:7457013.', 'ArticleIdList': [StringElement('31321241', attributes={'IdType': 'pubmed'}), StringElement('6610758', attributes={'IdType': 'pmc'}), StringElement('10.1155/2019/7457013', attributes={'IdType': 'doi'})]}, {'Citation': 'Sasano T, Gonzalez-Delgado R, Muñoz NM, Carlos-Alcade W, Cho MS, Sheth RA, et al. Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer. J Thromb Haemost. 2022;20(1):104–14.', 'ArticleIdList': [StringElement('34608736', attributes={'IdType': 'pubmed'}), StringElement('10.1111/jth.15544', attributes={'IdType': 'doi'})]}, {'Citation': 'Sikorska J, Gaweł D, Domek H, Rudzińska M, Czarnocka B. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases. BMC Cancer. 2019;19(1):85.', 'ArticleIdList': [StringElement('30654768', attributes={'IdType': 'pubmed'}), StringElement('6337816', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12885-018-5239-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Lawson WE, Polosukhin VV, Zoia O, Stathopoulos GT, Han W, Plieth D, et al. Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171(8):899–907.', 'ArticleIdList': [StringElement('15618458', attributes={'IdType': 'pubmed'}), StringElement('10.1164/rccm.200311-1535OC', attributes={'IdType': 'doi'})]}, {'Citation': 'Schneider M, Kostin S, Strøm CC, Aplin M, Lyngbaek S, Theilade J, et al. S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc Res. 2007;75(1):40–50.', 'ArticleIdList': [StringElement('17466960', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.cardiores.2007.03.027', attributes={'IdType': 'doi'})]}, {'Citation': 'Ye F, Liang Y, Wang Y, Le Yang R, Luo D, Li Y, et al. Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication. Cell Death Dis. 2023;14(7):471.', 'ArticleIdList': [StringElement('37495592', attributes={'IdType': 'pubmed'}), StringElement('10372047', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-023-05986-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007;67(21):10123–8.', 'ArticleIdList': [StringElement('17974953', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-07-3127', attributes={'IdType': 'doi'})]}, {'Citation': 'Österreicher CH, Penz-Österreicher M, Grivennikov SI, Guma M, Koltsova EK, Datz C, et al. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc Natl Acad Sci. 2011;108(1):308–13.', 'ArticleIdList': [StringElement('21173249', attributes={'IdType': 'pubmed'}), StringElement('10.1073/pnas.1017547108', attributes={'IdType': 'doi'})]}, {'Citation': 'Im SB, Cho JM, Kim HB, Shin DH, Kwon MS, Lee IY, et al. FSP-1 expression in cancer cells is relevant to long-term oncological outcomes in nonmetastatic colorectal cancer. Korean J Clin Oncol. 2022;18(2):66–77.', 'ArticleIdList': [StringElement('36945241', attributes={'IdType': 'pubmed'}), StringElement('9942758', attributes={'IdType': 'pmc'}), StringElement('10.14216/kjco.22009', attributes={'IdType': 'doi'})]}, {'Citation': 'Park CK, Jung WH, Koo JS. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. Breast Cancer Res Treat. 2016;159(1):55–69.', 'ArticleIdList': [StringElement('27469595', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s10549-016-3929-2', attributes={'IdType': 'doi'})]}, {'Citation': 'O’Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A. 2011;108(38):16002–7.', 'ArticleIdList': [StringElement('21911392', attributes={'IdType': 'pubmed'}), StringElement('3179047', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.1109493108', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang J, Chen L, Xiao M, Wang C, Qin Z. FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation. Am J Pathol. 2011;178(1):382–90.', 'ArticleIdList': [StringElement('21224075', attributes={'IdType': 'pubmed'}), StringElement('3070559', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ajpath.2010.11.017', attributes={'IdType': 'doi'})]}, {'Citation': 'Grum-Schwensen B, Klingelhofer J, Berg CH, El-Naaman C, Grigorian M, Lukanidin E, et al. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. Cancer Res. 2005;65(9):3772–80.', 'ArticleIdList': [StringElement('15867373', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-04-4510', attributes={'IdType': 'doi'})]}, {'Citation': 'Jiao J, González Á, Stevenson HL, Gagea M, Sugimoto H, Kalluri R, et al. Depletion of S100A4+ stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. Exp Mol Med. 2018;50(1):e422–e422.', 'ArticleIdList': [StringElement('29303514', attributes={'IdType': 'pubmed'}), StringElement('5992984', attributes={'IdType': 'pmc'}), StringElement('10.1038/emm.2017.175', attributes={'IdType': 'doi'})]}, {'Citation': 'Rasanen K, Sriswasdi S, Valiga A, Tang HY, Zhang G, Perego M, et al. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target. Mol Cell Proteomics. 2013;12(12):3778–92.', 'ArticleIdList': [StringElement('24037664', attributes={'IdType': 'pubmed'}), StringElement('3861723', attributes={'IdType': 'pmc'}), StringElement('10.1074/mcp.M113.029587', attributes={'IdType': 'doi'})]}, {'Citation': 'Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693–8.', 'ArticleIdList': [StringElement('31634899', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41586-019-1707-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3(3–4):287–310.', 'ArticleIdList': [StringElement('19838819', attributes={'IdType': 'pubmed'}), StringElement('2778592', attributes={'IdType': 'pmc'}), StringElement('10.1007/s12079-009-0075-1', attributes={'IdType': 'doi'})]}, {'Citation': 'De Wever O, Nguyen QD, Van Hoorde L, Bracke M, Bruyneel E, Gespach C, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. Faseb j. 2004;18(9):1016–8.', 'ArticleIdList': [StringElement('15059978', attributes={'IdType': 'pubmed'}), StringElement('10.1096/fj.03-1110fje', attributes={'IdType': 'doi'})]}, {'Citation': 'Jang I, Beningo KA. Integrins, CAFs and mechanical forces in the progression of cancer. Cancers. 2019;11(5):721.', 'ArticleIdList': [StringElement('31137693', attributes={'IdType': 'pubmed'}), StringElement('6562616', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers11050721', attributes={'IdType': 'doi'})]}, {'Citation': 'Ni WD, Yang ZT, Cui CA, Cui Y, Fang LY, Xuan YH. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer. Biochem Biophys Res Commun. 2017;486(3):607–12.', 'ArticleIdList': [StringElement('28341124', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.bbrc.2017.03.021', attributes={'IdType': 'doi'})]}, {'Citation': 'Furuhashi S, Morita Y, Matsumoto A, Ida S, Muraki R, Kitajima R, et al. Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor. Am J Cancer Res. 2023;13(11):5641–55.', 'ArticleIdList': [StringElement('38058842', attributes={'IdType': 'pubmed'}), StringElement('10695794', attributes={'IdType': 'pmc'})]}, {'Citation': 'Shen C, Wang C, Yin Y, Chen H, Yin X, Cai Z, et al. Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs. Medicine. 2019;98(2): e14045.', 'ArticleIdList': [StringElement('30633201', attributes={'IdType': 'pubmed'}), StringElement('6336641', attributes={'IdType': 'pmc'}), StringElement('10.1097/MD.0000000000014045', attributes={'IdType': 'doi'})]}, {'Citation': 'Ming X, Qiu S, Liu X, Li S, Wang Y, Zhu M, et al. Prognostic role of tenascin-c for cancer outcome: a meta-analysis. Technol Cancer Res Treat. 2019;18:1533033818821106.', 'ArticleIdList': [StringElement('30803361', attributes={'IdType': 'pubmed'}), StringElement('6373989', attributes={'IdType': 'pmc'}), StringElement('10.1177/1533033818821106', attributes={'IdType': 'doi'})]}, {'Citation': 'Yang Z-T, Yeo S-Y, Yin Y-X, Lin Z-H, Lee H-M, Xuan Y-H, et al. Tenascin-C, a prognostic determinant of esophageal squamous cell carcinoma. PLoS ONE. 2016;11(1): e0145807.', 'ArticleIdList': [StringElement('26731558', attributes={'IdType': 'pubmed'}), StringElement('4701415', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0145807', attributes={'IdType': 'doi'})]}, {'Citation': 'Yang Z, Zhang C, Feng Y, Quan M, Cui Y, Xuan Y. Tenascin-C predicts poor outcomes for patients with colorectal cancer and drives cancer stemness via Hedgehog signaling pathway. Cancer Cell Int. 2020;20(1):122.', 'ArticleIdList': [StringElement('32322169', attributes={'IdType': 'pubmed'}), StringElement('7161260', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12935-020-01188-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Sun Z, Schwenzer A, Rupp T, Murdamoothoo D, Vegliante R, Lefebvre O, et al. Tenascin-C promotes tumor cell migration and metastasis through integrin α9β1–mediated YAP inhibition. Can Res. 2018;78(4):950–61.', 'ArticleIdList': [StringElement('10.1158/0008-5472.CAN-17-1597', attributes={'IdType': 'doi'})]}, {'Citation': 'Murdamoothoo D, Sun Z, Yilmaz A, Riegel G, Abou-Faycal C, Deligne C, et al. Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Mol Med. 2021;13(6): e13270.', 'ArticleIdList': [StringElement('33988305', attributes={'IdType': 'pubmed'}), StringElement('8185552', attributes={'IdType': 'pmc'}), StringElement('10.15252/emmm.202013270', attributes={'IdType': 'doi'})]}, {'Citation': 'Spenlé C, Loustau T, Murdamoothoo D, Erne W, Beghelli-de la Forest Divonne S, Veber R, et al. Tenascin-C orchestrates an immune-suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunol Res. 2020;8(9):1122–38.', 'ArticleIdList': [StringElement('32665262', attributes={'IdType': 'pubmed'}), StringElement('10.1158/2326-6066.CIR-20-0074', attributes={'IdType': 'doi'})]}, {'Citation': 'Sun Z, Velázquez-Quesada I, Murdamoothoo D, Ahowesso C, Yilmaz A, Spenlé C, et al. Tenascin-C increases lung metastasis by impacting blood vessel invasions. Matrix Biol. 2019;83:26–47.', 'ArticleIdList': [StringElement('31288084', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.matbio.2019.07.001', attributes={'IdType': 'doi'})]}, {'Citation': 'Rupp T, Langlois B, Koczorowska MM, Radwanska A, Sun Z, Hussenet T, et al. Tenascin-C orchestrates glioblastoma angiogenesis by modulation of pro- and anti-angiogenic signaling. Cell Rep. 2016;17(10):2607–19.', 'ArticleIdList': [StringElement('27926865', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.celrep.2016.11.012', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu Y, Yang L-Y, Chen D-X, Chang C, Yuan Q, Zhang Y, et al. Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma. Transl Oncol. 2024;42: 101888.', 'ArticleIdList': [StringElement('38354632', attributes={'IdType': 'pubmed'}), StringElement('10877408', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.tranon.2024.101888', attributes={'IdType': 'doi'})]}, {'Citation': 'Yilmaz A, Loustau T, Salomé N, Poilil Surendran S, Li C, Tucker RP, et al. Advances on the roles of tenascin-C in cancer. J Cell Sci. 2022;135(18): jcs260244.', 'ArticleIdList': [StringElement('36102918', attributes={'IdType': 'pubmed'}), StringElement('9584351', attributes={'IdType': 'pmc'}), StringElement('10.1242/jcs.260244', attributes={'IdType': 'doi'})]}, {'Citation': 'Dhaouadi S, Bouhaouala-Zahar B, Orend G. Tenascin-C targeting strategies in cancer. Matrix Biol. 2024;130:1–19.', 'ArticleIdList': [StringElement('38642843', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.matbio.2024.04.002', attributes={'IdType': 'doi'})]}, {'Citation': 'Ratajczak-Wielgomas K, Grzegrzolka J, Piotrowska A, Gomulkiewicz A, Witkiewicz W, Dziegiel P. Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma. Oncol Rep. 2016;36(5):2745–54.', 'ArticleIdList': [StringElement('27633896', attributes={'IdType': 'pubmed'}), StringElement('10.3892/or.2016.5095', attributes={'IdType': 'doi'})]}, {'Citation': 'Wei W-F, Chen X-J, Liang L-J, Yu L, Wu X-G, Zhou C-F, et al. Periostin+cancer-associated fibroblasts promote lymph node metastasis by impairing the lymphatic endothelial barriers in cervical squamous cell carcinoma. Mol Oncol. 2021;15(1):210–27.', 'ArticleIdList': [StringElement('33124726', attributes={'IdType': 'pubmed'}), StringElement('10.1002/1878-0261.12837', attributes={'IdType': 'doi'})]}, {'Citation': 'Kikuchi Y, Kashima TG, Nishiyama T, Shimazu K, Morishita Y, Shimazaki M, et al. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J Histochem Cytochem. 2008;56(8):753–64.', 'ArticleIdList': [StringElement('18443362', attributes={'IdType': 'pubmed'}), StringElement('2443605', attributes={'IdType': 'pmc'}), StringElement('10.1369/jhc.2008.951061', attributes={'IdType': 'doi'})]}, {'Citation': 'Deng X, Ao S, Hou J, Li Z, Lei Y, Lyu G. Prognostic significance of periostin in colorectal cancer. Chin J Cancer Res. 2019;31(3):547–56.', 'ArticleIdList': [StringElement('31354223', attributes={'IdType': 'pubmed'}), StringElement('6613499', attributes={'IdType': 'pmc'}), StringElement('10.21147/j.issn.1000-9604.2019.03.16', attributes={'IdType': 'doi'})]}, {'Citation': 'Underwood TJ, Hayden AL, Derouet M, Garcia E, Noble F, White MJ, et al. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol. 2015;235(3):466–77.', 'ArticleIdList': [StringElement('25345775', attributes={'IdType': 'pubmed'}), StringElement('4312957', attributes={'IdType': 'pmc'}), StringElement('10.1002/path.4467', attributes={'IdType': 'doi'})]}, {'Citation': 'Neuzillet C, Nicolle R, Raffenne J, Tijeras-Raballand A, Brunel A, Astorgues-Xerri L, et al. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma. J Pathol. 2022;258(4):408–25.', 'ArticleIdList': [StringElement('36102377', attributes={'IdType': 'pubmed'}), StringElement('9828775', attributes={'IdType': 'pmc'}), StringElement('10.1002/path.6011', attributes={'IdType': 'doi'})]}, {'Citation': 'Akinjiyan FA, Dave RM, Alpert E, Longmore GD, Fuh KC. DDR2 expression in cancer-associated fibroblasts promotes ovarian cancer tumor invasion and metastasis through periostin-ITGB1. Cancers. 2022;14(14):3482.', 'ArticleIdList': [StringElement('35884543', attributes={'IdType': 'pubmed'}), StringElement('9319689', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers14143482', attributes={'IdType': 'doi'})]}, {'Citation': 'Yue H, Li W, Chen R, Wang J, Lu X, Li J. Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer. Gynecol Oncol. 2021;160(2):530–8.', 'ArticleIdList': [StringElement('33317907', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ygyno.2020.11.026', attributes={'IdType': 'doi'})]}, {'Citation': 'Yoshikawa M, Takatsu F, Suzawa K, Habu T, Masayoshi O, Iwata K, et al. Abstract 5845: Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer. Cancer Res. 2023;83(7_Supplement):5845–5845.', 'ArticleIdList': [StringElement('10.1158/1538-7445.AM2023-5845', attributes={'IdType': 'doi'})]}, {'Citation': 'Kikuchi Y, Kunita A, Iwata C, Komura D, Nishiyama T, Shimazu K, et al. The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation. Am J Pathol. 2014;184(3):859–70.', 'ArticleIdList': [StringElement('24418260', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ajpath.2013.11.012', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu Y, Li F, Gao F, Xing L, Qin P, Liang X, et al. Role of microenvironmental periostin in pancreatic cancer progression. Oncotarget. 2016;8(52):89552.', 'ArticleIdList': [StringElement('29163770', attributes={'IdType': 'pubmed'}), StringElement('5685691', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.11533', attributes={'IdType': 'doi'})]}, {'Citation': 'Yu B, Wu K, Wang X, Zhang J, Wang L, Jiang Y, et al. Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7. Cell Death Dis. 2018;9(11):1082.', 'ArticleIdList': [StringElement('30348980', attributes={'IdType': 'pubmed'}), StringElement('6197282', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-018-1116-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Lin S-C, Liao Y-C, Chen P-M, Yang Y-Y, Wang Y-H, Tung S-L, et al. Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-κB and TGF-β2 signaling. J Biomed Sci. 2022;29(1):109.', 'ArticleIdList': [StringElement('36550569', attributes={'IdType': 'pubmed'}), StringElement('9784270', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12929-022-00888-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Wei T, Wang K, Liu S, Fang Y, Hong Z, Liu Y, et al. Periostin deficiency reduces PD-1(+) tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer. Cell Rep. 2023;42(2): 112090.', 'ArticleIdList': [StringElement('36773295', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.celrep.2023.112090', attributes={'IdType': 'doi'})]}, {'Citation': 'Ma H, Wang J, Zhao X, Wu T, Huang Z, Chen D, et al. Periostin promotes colorectal tumorigenesis through integrin-FAK-Src pathway-mediated YAP/TAZ activation. Cell Rep. 2020;30(3):793-806.e796.', 'ArticleIdList': [StringElement('31968254', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.celrep.2019.12.075', attributes={'IdType': 'doi'})]}, {'Citation': 'Okazaki T, Tamai K, Shibuya R, Nakamura M, Mochizuki M, Yamaguchi K, et al. Periostin is a negative prognostic factor and promotes cancer cell proliferation in non-small cell lung cancer. Oncotarget. 2018;9(58):31187–99.', 'ArticleIdList': [StringElement('30131847', attributes={'IdType': 'pubmed'}), StringElement('6101292', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.25435', attributes={'IdType': 'doi'})]}, {'Citation': 'Shimazaki M, Kudo A. Impaired capsule formation of tumors in periostin-null mice. Biochem Biophys Res Commun. 2008;367(4):736–42.', 'ArticleIdList': [StringElement('18190787', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.bbrc.2008.01.009', attributes={'IdType': 'doi'})]}, {'Citation': 'Hu W-W, Chen P-C, Chen J-M, Wu Y-M, Liu P-Y, Lu C-H, et al. Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer. Oncotarget. 2017;8(37):62248.', 'ArticleIdList': [StringElement('28977942', attributes={'IdType': 'pubmed'}), StringElement('5617502', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.19273', attributes={'IdType': 'doi'})]}, {'Citation': 'Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology. 2006;16(11):137R-157R.', 'ArticleIdList': [StringElement('16840800', attributes={'IdType': 'pubmed'}), StringElement('10.1093/glycob/cwl025', attributes={'IdType': 'doi'})]}, {'Citation': 'Chong Y, Tang D, Xiong Q, Jiang X, Xu C, Huang Y, et al. Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer. J Exp Clin Cancer Res. 2016;35(1):175.', 'ArticleIdList': [StringElement('27836001', attributes={'IdType': 'pubmed'}), StringElement('5106768', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-016-0449-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Tang D, Gao J, Wang S, Ye N, Chong Y, Huang Y, et al. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression. Tumor Biol. 2016;37(2):1889–99.', 'ArticleIdList': [StringElement('10.1007/s13277-015-3942-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Zheng L, Xu C, Guan Z, Su X, Xu Z, Cao J, et al. Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer. Am J Transl Res. 2016;8(4):1641–58.', 'ArticleIdList': [StringElement('27186290', attributes={'IdType': 'pubmed'}), StringElement('4859895', attributes={'IdType': 'pmc'})]}, {'Citation': 'Rizzolio S, Orrù C, Volante M, Bellomo SE, Migliore C, Giordano S, et al. CAF-released galectin 1 mediates non-cell-autonomous resistance to ceritinib in NSCLC. Research Square, 2023.'}, {'Citation': 'Wu M-H, Hong H-C, Hong T-M, Chiang W-F, Jin Y-T, Chen Y-L. Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression. Clin Cancer Res. 2011;17(6):1306–16.', 'ArticleIdList': [StringElement('21385934', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-10-1824', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhu X, Wang K, Zhang K, Xu F, Yin Y, Zhu L, et al. Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression. Acta Biochim Biophys Sin. 2016;48(5):462–7.', 'ArticleIdList': [StringElement('27025601', attributes={'IdType': 'pubmed'}), StringElement('4888361', attributes={'IdType': 'pmc'}), StringElement('10.1093/abbs/gmw019', attributes={'IdType': 'doi'})]}, {'Citation': 'Dalotto-Moreno T, Croci DO, Cerliani JP, Martinez-Allo VC, Dergan-Dylon S, Méndez-Huergo SP, et al. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease. Cancer Res. 2013;73(3):1107–17.', 'ArticleIdList': [StringElement('23204230', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-12-2418', attributes={'IdType': 'doi'})]}, {'Citation': 'Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res. 2012;18(15):4037–47.', 'ArticleIdList': [StringElement('22696230', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-11-3348', attributes={'IdType': 'doi'})]}, {'Citation': 'Miao J-H, Wang S-Q, Zhang M-H, Yu FB, Zhang L, Yu Z-X, et al. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway. Oncol Rep. 2014;32(4):1497–504.', 'ArticleIdList': [StringElement('25069486', attributes={'IdType': 'pubmed'}), StringElement('10.3892/or.2014.3358', attributes={'IdType': 'doi'})]}, {'Citation': 'Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A. 2006;103(43):15975–80.', 'ArticleIdList': [StringElement('17043243', attributes={'IdType': 'pubmed'}), StringElement('1635112', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.0603883103', attributes={'IdType': 'doi'})]}, {'Citation': 'Cagnoni AJ, Giribaldi ML, Blidner AG, Cutine AM, Gatto SG, Morales RM, et al. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8(+) regulatory T cells. Proc Natl Acad Sci USA. 2021;118(21): e2102950118.', 'ArticleIdList': [StringElement('34006646', attributes={'IdType': 'pubmed'}), StringElement('8166155', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.2102950118', attributes={'IdType': 'doi'})]}, {'Citation': 'Parton RG. Caveolae: structure, function, and relationship to disease. Annu Rev Cell Dev Biol. 2018;34:111–36.', 'ArticleIdList': [StringElement('30296391', attributes={'IdType': 'pubmed'}), StringElement('10.1146/annurev-cellbio-100617-062737', attributes={'IdType': 'doi'})]}, {'Citation': 'Simón L, Campos A, Leyton L, Quest AFG. Caveolin-1 function at the plasma membrane and in intracellular compartments in cancer. Cancer Metastasis Rev. 2020;39(2):435–53.', 'ArticleIdList': [StringElement('32458269', attributes={'IdType': 'pubmed'}), StringElement('7311495', attributes={'IdType': 'pmc'}), StringElement('10.1007/s10555-020-09890-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: implications for the response to hormonal therapy. Cancer Biol Ther. 2008;7(8):1212–25.', 'ArticleIdList': [StringElement('18458534', attributes={'IdType': 'pubmed'}), StringElement('10.4161/cbt.7.8.6220', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhao X, He Y, Gao J, Fan L, Li Z, Yang G, et al. Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer. PLoS ONE. 2013;8(3): e59102.', 'ArticleIdList': [StringElement('23527097', attributes={'IdType': 'pubmed'}), StringElement('3602462', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0059102', attributes={'IdType': 'doi'})]}, {'Citation': 'Meng Q, Fang Z, Mao X, Tang R, Liang C, Hua J, et al. Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT. Comput Struct Biotechnol J. 2023;21:2631–9.', 'ArticleIdList': [StringElement('37153537', attributes={'IdType': 'pubmed'}), StringElement('10160596', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.csbj.2023.04.003', attributes={'IdType': 'doi'})]}, {'Citation': 'Kamposioras K, Tsimplouli C, Verbeke C, Anthoney A, Daoukopoulou A, Papandreou CN, et al. Silencing of caveolin-1 in fibroblasts as opposed to epithelial tumor cells results in increased tumor growth rate and chemoresistance in a human pancreatic cancer model. Int J Oncol. 2019;54(2):537–49.', 'ArticleIdList': [StringElement('30483772', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Guan H, Liu Y, Li M. Loss of caveolin-1 in cancer associated fibroblasts promotes hepatocellular carcinoma development. Int J Clin Exp Med. 2018;11(6):5648–56.'}, {'Citation': 'Shen X-J, Zhang H, Tang G-S, Wang X-D, Zheng R, Wang Y, et al. Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer. Int J Biol Sci. 2015;11(4):370–9.', 'ArticleIdList': [StringElement('25798057', attributes={'IdType': 'pubmed'}), StringElement('4366636', attributes={'IdType': 'pmc'}), StringElement('10.7150/ijbs.10666', attributes={'IdType': 'doi'})]}, {'Citation': 'Lin MI, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 2007;67(6):2849–56.', 'ArticleIdList': [StringElement('17363608', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-06-4082', attributes={'IdType': 'doi'})]}, {'Citation': 'Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, et al. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol. 2012;181(1):278–93.', 'ArticleIdList': [StringElement('22698676', attributes={'IdType': 'pubmed'}), StringElement('3388151', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ajpath.2012.03.017', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang R, Li Z, Guo H, Shi W, Xin Y, Chang W, et al. Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer BT474 cells. Mol Med Rep. 2014;9(5):1723–8.', 'ArticleIdList': [StringElement('24604116', attributes={'IdType': 'pubmed'}), StringElement('10.3892/mmr.2014.2018', attributes={'IdType': 'doi'})]}, {'Citation': 'Díaz MI, Díaz P, Bennett JC, Urra H, Ortiz R, Orellana PC, et al. Caveolin-1 suppresses tumor formation through the inhibition of the unfolded protein response. Cell Death Dis. 2020;11(8):648.', 'ArticleIdList': [StringElement('32811828', attributes={'IdType': 'pubmed'}), StringElement('7434918', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-020-02792-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Pasquale EB. Eph receptors and ephrins in cancer progression. Nat Rev Cancer. 2024;24(1):5–27.', 'ArticleIdList': [StringElement('37996538', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41568-023-00634-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Janes PW, Vail ME, Ernst M, Scott AM. Eph receptors in the immunosuppressive tumor microenvironment. Cancer Res. 2021;81(4):801–5.', 'ArticleIdList': [StringElement('33177063', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-20-3047', attributes={'IdType': 'doi'})]}, {'Citation': 'Kikuchi S, Kaibe N, Morimoto K, Fukui H, Niwa H, Maeyama Y, et al. Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer. Gastric Cancer. 2015;18(3):485–94.', 'ArticleIdList': [StringElement('24908114', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s10120-014-0390-y', attributes={'IdType': 'doi'})]}, {'Citation': 'Wu X, Zahari MS, Renuse S, Sahasrabuddhe NA, Chaerkady R, Kim MS, et al. Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts. Clin Proteomics. 2018;15:21.', 'ArticleIdList': [StringElement('29946230', attributes={'IdType': 'pubmed'}), StringElement('6003199', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12014-018-9197-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y, et al. Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis. Cell Metab. 2019;29(1):141-155.e149.', 'ArticleIdList': [StringElement('30174305', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.cmet.2018.08.007', attributes={'IdType': 'doi'})]}, {'Citation': 'Astin JW, Batson J, Kadir S, Charlet J, Persad RA, Gillatt D, et al. Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells. Nat Cell Biol. 2010;12(12):1194–204.', 'ArticleIdList': [StringElement('21076414', attributes={'IdType': 'pubmed'}), StringElement('10.1038/ncb2122', attributes={'IdType': 'doi'})]}, {'Citation': 'Vail ME, Murone C, Tan A, Hii L, Abebe D, Janes PW, et al. Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment. Cancer Res. 2014;74(16):4470–81.', 'ArticleIdList': [StringElement('25125683', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-14-0218', attributes={'IdType': 'doi'})]}, {'Citation': 'Vail ME, Farnsworth RH, Hii L, Allen S, Arora S, Anderson RL, et al. Inhibition of EphA3 expression in tumour stromal cells suppresses tumour growth and progression. Cancers. 2023;15(18):4646.', 'ArticleIdList': [StringElement('37760615', attributes={'IdType': 'pubmed'}), StringElement('10527215', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers15184646', attributes={'IdType': 'doi'})]}, {'Citation': 'Talia M, Cirillo F, Spinelli A, Zicarelli A, Scordamaglia D, Muglia L, et al. The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells. J Exp Clin Cancer Res. 2023;42(1):164.', 'ArticleIdList': [StringElement('37434266', attributes={'IdType': 'pubmed'}), StringElement('10337103', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-023-02747-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Nakajima K, Ino Y, Naito C, Nara S, Shimasaki M, Ishimoto U, et al. Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5. Br J Cancer. 2022;126(4):628–39.', 'ArticleIdList': [StringElement('34824448', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41416-021-01639-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Lagares D, Ghassemi-Kakroodi P, Tremblay C, Santos A, Probst CK, Franklin A, et al. ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis. Nat Med. 2017;23(12):1405–15.', 'ArticleIdList': [StringElement('29058717', attributes={'IdType': 'pubmed'}), StringElement('5720906', attributes={'IdType': 'pmc'}), StringElement('10.1038/nm.4419', attributes={'IdType': 'doi'})]}, {'Citation': 'Mueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, et al. Induction of ADAM10 by radiation therapy drives fibrosis, resistance, and epithelial-to-mesenchyal transition in pancreatic cancer. Cancer Res. 2021;81(12):3255–69.', 'ArticleIdList': [StringElement('33526513', attributes={'IdType': 'pubmed'}), StringElement('8260469', attributes={'IdType': 'pmc'}), StringElement('10.1158/0008-5472.CAN-20-3892', attributes={'IdType': 'doi'})]}, {'Citation': 'Kakarla M, ChallaSivaKanaka S, Dufficy MF, Gil V, Filipovich Y, Vickman R, et al. Ephrin B activate Src family kinases in fibroblasts inducing stromal remodeling in prostate cancer. Cancers. 2022;14(9):2336.', 'ArticleIdList': [StringElement('35565468', attributes={'IdType': 'pubmed'}), StringElement('9102363', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers14092336', attributes={'IdType': 'doi'})]}, {'Citation': 'Cremasco V, Astarita JL, Grauel AL, Keerthivasan S, MacIsaac K, Woodruff MC, et al. FAP delineates heterogeneous and functionally divergent stromal cells in immune-excluded breast tumors. Cancer Immunol Res. 2018;6(12):1472–85.', 'ArticleIdList': [StringElement('30266714', attributes={'IdType': 'pubmed'}), StringElement('6597261', attributes={'IdType': 'pmc'}), StringElement('10.1158/2326-6066.CIR-18-0098', attributes={'IdType': 'doi'})]}, {'Citation': 'Higashino N, Koma YI, Hosono M, Takase N, Okamoto M, Kodaira H, et al. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma. Lab Invest. 2019;99(6):777–92.', 'ArticleIdList': [StringElement('30683902', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41374-018-0185-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Ziani L, Chouaib S, Thiery J. Alteration of the antitumor immune response by cancer-associated fibroblasts. Front Immunol. 2018;9:414.', 'ArticleIdList': [StringElement('29545811', attributes={'IdType': 'pubmed'}), StringElement('5837994', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2018.00414', attributes={'IdType': 'doi'})]}, {'Citation': 'Li T, Yi S, Liu W, Jia C, Wang G, Hua X, et al. Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity. Med Oncol. 2013;30(3):663.', 'ArticleIdList': [StringElement('23873014', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s12032-013-0663-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Lee HW, Park YM, Lee SJ, Cho HJ, Kim D-H, Lee J-I, et al. Alpha-Smooth Muscle Actin (ACTA2) is required for metastatic potential of human lung adenocarcinoma. Clin Cancer Res. 2013;19(21):5879–89.', 'ArticleIdList': [StringElement('23995859', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-13-1181', attributes={'IdType': 'doi'})]}, {'Citation': 'Ding Y, Lv C, Zhou Y, Zhang H, Zhao L, Xu Y, et al. Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway. Exp Cell Res. 2021;405(1): 112666.', 'ArticleIdList': [StringElement('34052237', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.yexcr.2021.112666', attributes={'IdType': 'doi'})]}, {'Citation': 'Kondo R, Sakamoto N, Harada K, Hashimoto H, Morisue R, Yanagihara K, et al. Cancer-associated fibroblast-dependent and -independent invasion of gastric cancer cells. J Cancer Res Clin Oncol. 2023;149(8):5309–19.', 'ArticleIdList': [StringElement('36416958', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00432-022-04484-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang J, Chen L, Liu X, Kammertoens T, Blankenstein T, Qin Z. Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens. Can Res. 2013;73(9):2770–81.', 'ArticleIdList': [StringElement('10.1158/0008-5472.CAN-12-3022', attributes={'IdType': 'doi'})]}, {'Citation': 'Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther. 2006;5(12):1640–6.', 'ArticleIdList': [StringElement('17106243', attributes={'IdType': 'pubmed'}), StringElement('10.4161/cbt.5.12.3354', attributes={'IdType': 'doi'})]}, {'Citation': 'Öhlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579–96.', 'ArticleIdList': [StringElement('28232471', attributes={'IdType': 'pubmed'}), StringElement('5339682', attributes={'IdType': 'pmc'}), StringElement('10.1084/jem.20162024', attributes={'IdType': 'doi'})]}, {'Citation': 'Biffi G, Oni TE, Spielman B, Hao Y, Elyada E, Park Y, et al. IL1-induced JAK/STAT signaling is antagonized by TGFβ to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 2019;9(2):282–301.', 'ArticleIdList': [StringElement('30366930', attributes={'IdType': 'pubmed'}), StringElement('10.1158/2159-8290.CD-18-0710', attributes={'IdType': 'doi'})]}, {'Citation': 'Peiffer R, Boumahd Y, Gullo C, Crake R, Letellier E, Bellahcène A, et al. Cancer-associated fibroblast diversity shapes tumor metabolism in pancreatic cancer. Cancers. 2022;15(1):61.', 'ArticleIdList': [StringElement('36612058', attributes={'IdType': 'pubmed'}), StringElement('9817728', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers15010061', attributes={'IdType': 'doi'})]}, {'Citation': 'Krishnamurty AT, Shyer JA, Thai M, Gandham V, Buechler MB, Yang YA, et al. LRRC15<sup>+</sup> myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature. 2022;611(7934):148–54.', 'ArticleIdList': [StringElement('36171287', attributes={'IdType': 'pubmed'}), StringElement('9630141', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41586-022-05272-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Wu SZ, Roden DL, Wang C, Holliday H, Harvey K, Cazet AS, et al. Stromal cell diversity associated with immune evasion in human triple-negative breast cancer. EMBO J. 2020;39(19): e104063.', 'ArticleIdList': [StringElement('32790115', attributes={'IdType': 'pubmed'}), StringElement('7527929', attributes={'IdType': 'pmc'}), StringElement('10.15252/embj.2019104063', attributes={'IdType': 'doi'})]}, {'Citation': 'Sebastian A, Hum NR, Martin KA, Gilmore SF, Peran I, Byers SW, et al. Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer. Cancers. 2020;12(5):1307.', 'ArticleIdList': [StringElement('32455670', attributes={'IdType': 'pubmed'}), StringElement('7281266', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers12051307', attributes={'IdType': 'doi'})]}, {'Citation': 'Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10(9):1330–51.', 'ArticleIdList': [StringElement('32434947', attributes={'IdType': 'pubmed'}), StringElement('10.1158/2159-8290.CD-19-1384', attributes={'IdType': 'doi'})]}, {'Citation': 'Houthuijzen JM, de Bruijn R, van der Burg E, Drenth AP, Wientjens E, Filipovic T, et al. CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer. Nat Commun. 2023;14(1):183.', 'ArticleIdList': [StringElement('36635273', attributes={'IdType': 'pubmed'}), StringElement('9837080', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-023-35793-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Chung HC, Cho EJ, Lee H, Kim WK, Oh JH, Kim SH, et al. Integrated single-cell RNA sequencing analyses suggest developmental paths of cancer-associated fibroblasts with gene expression dynamics. Clin Transl Med. 2021;11(7): e487.', 'ArticleIdList': [StringElement('34323427', attributes={'IdType': 'pubmed'}), StringElement('8287981', attributes={'IdType': 'pmc'}), StringElement('10.1002/ctm2.487', attributes={'IdType': 'doi'})]}, {'Citation': 'Lippert AL, Johnson KA, Pasch CA, Kraus SG, Emmerich PB, Clipson L, et al. Abstract 3198: validation and analysis of cancer associated fibroblast subtype markers in metastatic colorectal cancer. Cancer Res. 2022;82(12_Supplement):3198–3198.', 'ArticleIdList': [StringElement('10.1158/1538-7445.AM2022-3198', attributes={'IdType': 'doi'})]}, {'Citation': 'Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, et al. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biol. 2022;23(1):113.', 'ArticleIdList': [StringElement('35538548', attributes={'IdType': 'pubmed'}), StringElement('9092724', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13059-022-02677-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu W, Wang M, Wang M, Liu M. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer. Medicine. 2023;102(32): e34611.', 'ArticleIdList': [StringElement('37565899', attributes={'IdType': 'pubmed'}), StringElement('10419654', attributes={'IdType': 'pmc'}), StringElement('10.1097/MD.0000000000034611', attributes={'IdType': 'doi'})]}, {'Citation': 'Grout JA, Sirven P, Leader AM, Maskey S, Hector E, Puisieux I, et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors. Cancer Discov. 2022;12(11):2606–25.', 'ArticleIdList': [StringElement('36027053', attributes={'IdType': 'pubmed'}), StringElement('9633420', attributes={'IdType': 'pmc'}), StringElement('10.1158/2159-8290.CD-21-1714', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang H, Li N, Liu Q, Guo J, Pan Q, Cheng B, et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell. 2023;41(7):1345-1362.e1349.', 'ArticleIdList': [StringElement('37352863', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.ccell.2023.05.016', attributes={'IdType': 'doi'})]}, {'Citation': 'Hong Z, Xie W, Zhuo H, Wei X, Wang K, Cheng J, et al. Crosstalk between cancer cells and cancer-associated fibroblasts mediated by TGF-&beta;1&ndash;IGFBP7 signaling promotes the progression of infiltrative gastric cancer. Cancers. 2023;15(15):3965.', 'ArticleIdList': [StringElement('37568781', attributes={'IdType': 'pubmed'}), StringElement('10417438', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers15153965', attributes={'IdType': 'doi'})]}, {'Citation': 'Schütz S, Solé-Boldo L, Lucena-Porcel C, Hoffmann J, Brobeil A, Lonsdorf AS, et al. Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma. Nat Commun. 2023;14(1):5413.', 'ArticleIdList': [StringElement('37669956', attributes={'IdType': 'pubmed'}), StringElement('10480447', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-023-41141-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M, et al. Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear cell renal cell carcinoma. Can Res. 2023;83(17):2952–69.', 'ArticleIdList': [StringElement('10.1158/0008-5472.CAN-22-3034', attributes={'IdType': 'doi'})]}, {'Citation': 'Affo S, Nair A, Brundu F, Ravichandra A, Bhattacharjee S, Matsuda M, et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021;39(6):866-882.e811.', 'ArticleIdList': [StringElement('33930309', attributes={'IdType': 'pubmed'}), StringElement('8241235', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ccell.2021.03.012', attributes={'IdType': 'doi'})]}, {'Citation': 'Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, et al. Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. J Clin Investig. 2021;131(11): e146987.', 'ArticleIdList': [StringElement('33905375', attributes={'IdType': 'pubmed'}), StringElement('8159701', attributes={'IdType': 'pmc'}), StringElement('10.1172/JCI146987', attributes={'IdType': 'doi'})]}, {'Citation': 'Schwörer S, Cimino FV, Ros M, Tsanov KM, Ng C, Lowe SW, et al. Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines. Cancer Res. 2023;83(10):1596–610.', 'ArticleIdList': [StringElement('36912618', attributes={'IdType': 'pubmed'}), StringElement('10658995', attributes={'IdType': 'pmc'}), StringElement('10.1158/0008-5472.CAN-22-2316', attributes={'IdType': 'doi'})]}, {'Citation': 'Mello AM, Ngodup T, Lee Y, Donahue KL, Li J, Rao A, et al. Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer. Oncogenesis. 2022;11(1):56.', 'ArticleIdList': [StringElement('36109493', attributes={'IdType': 'pubmed'}), StringElement('9478137', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41389-022-00434-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Picard FSR, Lutz V, Brichkina A, Neuhaus F, Ruckenbrod T, Hupfer A, et al. IL-17A-producing CD8(+) T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Gut. 2023;72(8):1510–22.', 'ArticleIdList': [StringElement('36759154', attributes={'IdType': 'pubmed'}), StringElement('10.1136/gutjnl-2022-327855', attributes={'IdType': 'doi'})]}, {'Citation': 'Cui Zhou D, Jayasinghe RG, Chen S, Herndon JM, Iglesia MD, Navale P, et al. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nat Genet. 2022;54(9):1390–405.', 'ArticleIdList': [StringElement('35995947', attributes={'IdType': 'pubmed'}), StringElement('9470535', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41588-022-01157-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang X, Zheng S, Hu C, Li G, Lin H, Xia R, et al. Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair. Oncogene. 2022;41(16):2372–89.', 'ArticleIdList': [StringElement('35264742', attributes={'IdType': 'pubmed'}), StringElement('9010302', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41388-022-02253-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Dings MPG, Manoukian P, Waasdorp C, Quik JSE, Strijker M, Lodestijn SC, et al. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer. Int J Cancer. 2023;152(3):511–23.', 'ArticleIdList': [StringElement('36069222', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ijc.34276', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim J, Park C, Kim KH, Kim EH, Kim H, Woo JK, et al. Single-cell analysis of gastric pre-cancerous and cancer lesions reveals cell lineage diversity and intratumoral heterogeneity. NPJ Precis Oncol. 2022;6(1):9.', 'ArticleIdList': [StringElement('35087207', attributes={'IdType': 'pubmed'}), StringElement('8795238', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41698-022-00251-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12(2):620–38.', 'ArticleIdList': [StringElement('34976204', attributes={'IdType': 'pubmed'}), StringElement('8692898', attributes={'IdType': 'pmc'}), StringElement('10.7150/thno.60540', attributes={'IdType': 'doi'})]}, {'Citation': 'Li C, Chen T, Liu J, Wang Y, Zhang C, Guo L, et al. FGF19-induced inflammatory CAF promoted neutrophil extracellular trap formation in the liver metastasis of colorectal cancer. Adv Sci. 2023;10(24):2302613.', 'ArticleIdList': [StringElement('10.1002/advs.202302613', attributes={'IdType': 'doi'})]}, {'Citation': 'Koncina E, Nurmik M, Pozdeev VI, Gilson C, Tsenkova M, Begaj R, et al. IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nat Commun. 2023;14(1):4251.', 'ArticleIdList': [StringElement('37460545', attributes={'IdType': 'pubmed'}), StringElement('10352362', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-023-39953-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11(1):5077.', 'ArticleIdList': [StringElement('33033240', attributes={'IdType': 'pubmed'}), StringElement('7545162', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-020-18916-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Lo A, Wang LS, Scholler J, Monslow J, Avery D, Newick K, et al. Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells. Cancer Res. 2015;75(14):2800–10.', 'ArticleIdList': [StringElement('25979873', attributes={'IdType': 'pubmed'}), StringElement('4506263', attributes={'IdType': 'pmc'}), StringElement('10.1158/0008-5472.CAN-14-3041', attributes={'IdType': 'doi'})]}, {'Citation': 'Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102–23.', 'ArticleIdList': [StringElement('31197017', attributes={'IdType': 'pubmed'}), StringElement('6727976', attributes={'IdType': 'pmc'}), StringElement('10.1158/2159-8290.CD-19-0094', attributes={'IdType': 'doi'})]}, {'Citation': 'Huang H, Wang Z, Zhang Y, Pradhan RN, Ganguly D, Chandra R, et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell. 2022;40(6):656-673.e657.', 'ArticleIdList': [StringElement('35523176', attributes={'IdType': 'pubmed'}), StringElement('9197998', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.ccell.2022.04.011', attributes={'IdType': 'doi'})]}, {'Citation': 'Kerdidani D, Aerakis E, Verrou K-M, Angelidis I, Douka K, Maniou M-A, et al. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J Exp Med. 2022;219(2): e20210815.', 'ArticleIdList': [StringElement('35029648', attributes={'IdType': 'pubmed'}), StringElement('8764966', attributes={'IdType': 'pmc'}), StringElement('10.1084/jem.20210815', attributes={'IdType': 'doi'})]}, {'Citation': 'Iida T, Mizutani Y, Esaki N, Ponik SM, Burkel BM, Weng L, et al. Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics. Oncogene. 2022;41(19):2764–77.', 'ArticleIdList': [StringElement('35414659', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41388-022-02288-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14(1):4294.', 'ArticleIdList': [StringElement('37463917', attributes={'IdType': 'pubmed'}), StringElement('10354071', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-023-39762-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Wong HY, Sheng Q, Hesterberg AB, Croessmann S, Rios BL, Giri K, et al. Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease. Nat Commun. 2022;13(1):6036.', 'ArticleIdList': [StringElement('36229464', attributes={'IdType': 'pubmed'}), StringElement('9562361', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-022-33780-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Ni C, Lou X, Yao X, Wang L, Wan J, Duan X, et al. ZIP1+ fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn2+ transfer. Nat Commun. 2022;13(1):5919.', 'ArticleIdList': [StringElement('36207295', attributes={'IdType': 'pubmed'}), StringElement('9547061', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-022-33521-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Brichkina A, Polo P, Sharma SD, Visestamkul N, Lauth M. A quick guide to CAF subtypes in pancreatic cancer. Cancers. 2023;15(9):2614.', 'ArticleIdList': [StringElement('37174079', attributes={'IdType': 'pubmed'}), StringElement('10177377', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers15092614', attributes={'IdType': 'doi'})]}, {'Citation': 'Han C, Liu T, Yin R. Biomarkers for cancer-associated fibroblasts. Biomarker Res. 2020;8(1):64.', 'ArticleIdList': [StringElement('10.1186/s40364-020-00245-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Menezes S, Okail MH, Jalil SMA, Kocher HM, Cameron AJM. Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets. J Pathol. 2022;257(4):526–44.', 'ArticleIdList': [StringElement('35533046', attributes={'IdType': 'pubmed'}), StringElement('9327514', attributes={'IdType': 'pmc'}), StringElement('10.1002/path.5926', attributes={'IdType': 'doi'})]}, {'Citation': 'DeLeon-Pennell KY, Barker TH, Lindsey ML. Fibroblasts: the arbiters of extracellular matrix remodeling. Matrix Biol. 2020;91–92:1–7.', 'ArticleIdList': [StringElement('32504772', attributes={'IdType': 'pubmed'}), StringElement('7434687', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.matbio.2020.05.006', attributes={'IdType': 'doi'})]}, {'Citation': 'Smolgovsky S, Theall B, Wagner N, Alcaide P. Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis. Am J Physiol Heart Circ Physiol. 2024;326(2):H303-h316.', 'ArticleIdList': [StringElement('38038714', attributes={'IdType': 'pubmed'}), StringElement('10.1152/ajpheart.00545.2023', attributes={'IdType': 'doi'})]}, {'Citation': 'Younesi FS, Miller AE, Barker TH, Rossi FMV, Hinz B. Fibroblast and myofibroblast activation in normal tissue repair and fibrosis. Nat Rev Mol Cell Biol. 2024;25(8):617–38.', 'ArticleIdList': [StringElement('38589640', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41580-024-00716-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Gauthier V, Kyriazi M, Nefla M, Pucino V, Raza K, Buckley CD, et al. Fibroblast heterogeneity: keystone of tissue homeostasis and pathology in inflammation and ageing. Front Immunol. 2023;14:1137659.', 'ArticleIdList': [StringElement('36926329', attributes={'IdType': 'pubmed'}), StringElement('10011104', attributes={'IdType': 'pmc'}), StringElement('10.3389/fimmu.2023.1137659', attributes={'IdType': 'doi'})]}, {'Citation': 'Gomes RN, Manuel F, Nascimento DS. The bright side of fibroblasts: molecular signature and regenerative cues in major organs. NPJ Regen Med. 2021;6(1):43.', 'ArticleIdList': [StringElement('34376677', attributes={'IdType': 'pubmed'}), StringElement('8355260', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41536-021-00153-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Łuszczyński K, Soszyńska M, Komorowski M, Lewandowska P, Zdanowski R, Sobiepanek A, et al. Markers of dermal fibroblast subpopulations for viable cell isolation via cell sorting: a comprehensive review. Cells. 2024;13(14):1206.', 'ArticleIdList': [StringElement('39056788', attributes={'IdType': 'pubmed'}), StringElement('11274970', attributes={'IdType': 'pmc'}), StringElement('10.3390/cells13141206', attributes={'IdType': 'doi'})]}, {'Citation': 'Plikus MV, Wang X, Sinha S, Forte E, Thompson SM, Herzog EL, et al. Fibroblasts: origins, definitions, and functions in health and disease. Cell. 2021;184(15):3852–72.', 'ArticleIdList': [StringElement('34297930', attributes={'IdType': 'pubmed'}), StringElement('8566693', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.cell.2021.06.024', attributes={'IdType': 'doi'})]}, {'Citation': 'Lendahl U, Muhl L, Betsholtz C. Identification, discrimination and heterogeneity of fibroblasts. Nat Commun. 2022;13(1):3409.', 'ArticleIdList': [StringElement('35701396', attributes={'IdType': 'pubmed'}), StringElement('9192344', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-022-30633-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Smyth LCD, Highet B, Jansson D, Wu J, Rustenhoven J, Aalderink M, et al. Characterisation of PDGF-BB:PDGFRβ signalling pathways in human brain pericytes: evidence of disruption in Alzheimer’s disease. Commun Biol. 2022;5(1):235.', 'ArticleIdList': [StringElement('35301433', attributes={'IdType': 'pubmed'}), StringElement('8931009', attributes={'IdType': 'pmc'}), StringElement('10.1038/s42003-022-03180-8', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang Y, Ertl HC. Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors. Oncotarget. 2016;7(17):23282–99.', 'ArticleIdList': [StringElement('26943036', attributes={'IdType': 'pubmed'}), StringElement('5029626', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.7818', attributes={'IdType': 'doi'})]}, {'Citation': 'Adams S, Miller GT, Jesson MI, Watanabe T, Jones B, Wallner BP. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 2004;64(15):5471–80.', 'ArticleIdList': [StringElement('15289357', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-04-0447', attributes={'IdType': 'doi'})]}, {'Citation': 'Kakarla S, Chow KK, Mata M, Shaffer DR, Song XT, Wu MF, et al. Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma. Mol Ther. 2013;21(8):1611–20.', 'ArticleIdList': [StringElement('23732988', attributes={'IdType': 'pubmed'}), StringElement('3734659', attributes={'IdType': 'pmc'}), StringElement('10.1038/mt.2013.110', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang LC, Lo A, Scholler J, Sun J, Majumdar RS, Kapoor V, et al. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity. Cancer Immunol Res. 2014;2(2):154–66.', 'ArticleIdList': [StringElement('24778279', attributes={'IdType': 'pubmed'}), StringElement('10.1158/2326-6066.CIR-13-0027', attributes={'IdType': 'doi'})]}, {'Citation': 'Schuberth PC, Hagedorn C, Jensen SM, Gulati P, van den Broek M, Mischo A, et al. Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells. J Transl Med. 2013;11:187.', 'ArticleIdList': [StringElement('23937772', attributes={'IdType': 'pubmed'}), StringElement('3751305', attributes={'IdType': 'pmc'}), StringElement('10.1186/1479-5876-11-187', attributes={'IdType': 'doi'})]}, {'Citation': 'Fischer E, Chaitanya K, Wüest T, Wadle A, Scott AM, van den Broek M, et al. Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies. Clin Cancer Res. 2012;18(22):6208–18.', 'ArticleIdList': [StringElement('22992515', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-12-0644', attributes={'IdType': 'doi'})]}, {'Citation': 'Ostermann E, Garin-Chesa P, Heider KH, Kalat M, Lamche H, Puri C, et al. Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts. Clin Cancer Res. 2008;14(14):4584–92.', 'ArticleIdList': [StringElement('18628473', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-07-5211', attributes={'IdType': 'doi'})]}, {'Citation': 'Fabre M, Ferrer C, Domínguez-Hormaetxe S, Bockorny B, Murias L, Seifert O, et al. OMTX705, a novel FAP-targeting ADC demonstrates activity in chemotherapy and pembrolizumab-resistant solid tumor models. Clin Cancer Res. 2020;26(13):3420–30.', 'ArticleIdList': [StringElement('32161121', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-19-2238', attributes={'IdType': 'doi'})]}, {'Citation': 'Tanswell P, Garin-Chesa P, Rettig WJ, Welt S, Divgi CR, Casper ES, et al. Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients. Br J Clin Pharmacol. 2001;51(2):177–80.', 'ArticleIdList': [StringElement('11259992', attributes={'IdType': 'pubmed'}), StringElement('2014433', attributes={'IdType': 'pmc'}), StringElement('10.1111/j.1365-2125.2001.01335.x', attributes={'IdType': 'doi'})]}, {'Citation': 'Scott AM, Wiseman G, Welt S, Adjei A, Lee FT, Hopkins W, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003;9(5):1639–47.', 'ArticleIdList': [StringElement('12738716', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Hofheinz RD, Al-Batran SE, Hartmann F, Hartung G, Jäger D, Renner C, et al. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 2003;26(1):44–8.', 'ArticleIdList': [StringElement('12624517', attributes={'IdType': 'pubmed'})]}, {'Citation': 'Narra K, Mullins SR, Lee HO, Strzemkowski-Brun B, Magalong K, Christiansen VJ, et al. Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer. Cancer Biol Ther. 2007;6(11):1691–9.', 'ArticleIdList': [StringElement('18032930', attributes={'IdType': 'pubmed'}), StringElement('10.4161/cbt.6.11.4874', attributes={'IdType': 'doi'})]}, {'Citation': 'Eager RM, Cunningham CC, Senzer NN, Stephenson J, Anthony SP, O’Day SJ, et al. Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. BMC Cancer. 2009;9(1):263.', 'ArticleIdList': [StringElement('19643020', attributes={'IdType': 'pubmed'}), StringElement('2731782', attributes={'IdType': 'pmc'}), StringElement('10.1186/1471-2407-9-263', attributes={'IdType': 'doi'})]}, {'Citation': 'Aggarwal RR, Costin D, O’Neill VJ, Corsi-Travali S, Adurthi S, Adedoyin A, et al. Phase 1b study of BXCL701, a novel small molecule inhibitor of dipeptidyl peptidases (DPP), combined with pembrolizumab (pembro), in men with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol. 2020;38(15):e17581–e17581.', 'ArticleIdList': [StringElement('10.1200/JCO.2020.38.15_suppl.e17581', attributes={'IdType': 'doi'})]}, {'Citation': 'Weinberg BA, Gutierrez M, Tesfaye AA, Tan MT, Noel MS, He AR, et al. Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC). J Clin Oncol. 2023;41(16):TPS4194.', 'ArticleIdList': [StringElement('10.1200/JCO.2023.41.16_suppl.TPS4194', attributes={'IdType': 'doi'})]}, {'Citation': 'Soerensen MM, Ros W, Rodriguez-Ruiz ME, Robbrecht D, Rohrberg KS, Martin-Liberal J, et al. Safety, PK/PD, and anti-tumor activity of RO6874281, an engineered variant of interleukin-2 (IL-2v) targeted to tumor-associated fibroblasts via binding to fibroblast activation protein (FAP). J Clin Oncol. 2018;36(15):e15155–e15155.', 'ArticleIdList': [StringElement('10.1200/JCO.2018.36.15_suppl.e15155', attributes={'IdType': 'doi'})]}, {'Citation': 'Brünker P, Wartha K, Friess T, Grau-Richards S, Waldhauer I, Koller CF, et al. RG7386, a novel tetravalent FAP-DR5 antibody, effectively triggers FAP-dependent, avidity-driven DR5 hyperclustering and tumor cell apoptosis. Mol Cancer Ther. 2016;15(5):946–57.', 'ArticleIdList': [StringElement('27037412', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1535-7163.MCT-15-0647', attributes={'IdType': 'doi'})]}, {'Citation': 'Bendell J, Blay J-Y, Cassier P, Bauer T, Terret C, Mueller C, et al. Abstract A092: phase 1 trial of RO6874813, a novel bispecific FAP-DR5 antibody, in patients with solid tumors. Mol Cancer Ther. 2018;17(1_Supplement):A092–A092.', 'ArticleIdList': [StringElement('10.1158/1535-7163.TARG-17-A092', attributes={'IdType': 'doi'})]}, {'Citation': 'Melero I, Tanos T, Bustamante M, Sanmamed MF, Calvo E, Moreno I, et al. A first-in-human study of the fibroblast activation protein-targeted, 4–1BB agonist RO7122290 in patients with advanced solid tumors. Sci Transl Med. 2023;15(695): eabp9229.', 'ArticleIdList': [StringElement('37163618', attributes={'IdType': 'pubmed'}), StringElement('10.1126/scitranslmed.abp9229', attributes={'IdType': 'doi'})]}, {'Citation': 'Hiltbrunner S, Britschgi C, Schuberth P, Bankel L, Nguyen-Kim TDL, Gulati P, et al. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial. Ann Oncol. 2021;32(1):120–1.', 'ArticleIdList': [StringElement('33098996', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.annonc.2020.10.474', attributes={'IdType': 'doi'})]}, {'Citation': 'Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. (68)Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60(6):801–5.', 'ArticleIdList': [StringElement('30954939', attributes={'IdType': 'pubmed'}), StringElement('6581228', attributes={'IdType': 'pmc'}), StringElement('10.2967/jnumed.119.227967', attributes={'IdType': 'doi'})]}, {'Citation': 'Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, et al. Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using (177)Lu-FAP-2286: first-in-humans results. J Nucl Med. 2022;63(3):415–23.', 'ArticleIdList': [StringElement('34168013', attributes={'IdType': 'pubmed'}), StringElement('8978187', attributes={'IdType': 'pmc'}), StringElement('10.2967/jnumed.120.259192', attributes={'IdType': 'doi'})]}, {'Citation': 'Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, Ooe K, et al. Fibroblast activation protein targeted therapy using [(177)Lu]FAPI-46 compared with [(225)Ac]FAPI-46 in a pancreatic cancer model. Eur J Nucl Med Mol Imaging. 2022;49(3):871–80.', 'ArticleIdList': [StringElement('34537893', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00259-021-05554-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E, et al. Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. Eur J Nucl Med Mol Imaging. 2022;49(11):3651–67.', 'ArticleIdList': [StringElement('35608703', attributes={'IdType': 'pubmed'}), StringElement('9399058', attributes={'IdType': 'pmc'}), StringElement('10.1007/s00259-022-05842-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Capaccione KM, Doubrovin M, Braumuller B, Leibowitz D, Bhatt N, Momen-Heravi F, et al. Evaluating the combined anticancer response of checkpoint inhibitor immunotherapy and FAP-targeted molecular radiotherapy in murine models of melanoma and lung cancer. Cancers. 2022;14(19):4575.', 'ArticleIdList': [StringElement('36230500', attributes={'IdType': 'pubmed'}), StringElement('9559475', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers14194575', attributes={'IdType': 'doi'})]}, {'Citation': 'Fu H, Huang J, Sun L, Wu H, Chen H. FAP-targeted radionuclide therapy of advanced radioiodine-refractory differentiated thyroid cancer with multiple cycles of 177Lu-FAPI-46. Clin Nucl Med. 2022;47(10):906–7.', 'ArticleIdList': [StringElement('35485857', attributes={'IdType': 'pubmed'}), StringElement('10.1097/RLU.0000000000004260', attributes={'IdType': 'doi'})]}, {'Citation': 'Fu H, Huang J, Zhao T, Wang H, Chen Y, Xu W, et al. Fibroblast activation protein-targeted radioligand therapy with 177Lu-EB-FAPI for metastatic radioiodine refractory thyroid cancer: first-in-human, dose-escalation study. Clin Cancer Res. 2023;29:4740–50.', 'ArticleIdList': [StringElement('37801296', attributes={'IdType': 'pubmed'}), StringElement('10690094', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-23-1983', attributes={'IdType': 'doi'})]}, {'Citation': 'Pandey P, Khan F, Upadhyay TK, Seungjoon M, Park MN, Kim B. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies. Biomed Pharmacother. 2023;161: 114491.', 'ArticleIdList': [StringElement('37002577', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.biopha.2023.114491', attributes={'IdType': 'doi'})]}, {'Citation': 'Doleschel D, Hoff S, Koletnik S, Rix A, Zopf D, Kiessling F, et al. Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth. J Exp Clin Cancer Res. 2021;40(1):288.', 'ArticleIdList': [StringElement('34517894', attributes={'IdType': 'pubmed'}), StringElement('8436536', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-021-02043-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Balachandran VP, Cavnar MJ, Zeng S, Bamboat ZM, Ocuin LM, Obaid H, et al. Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat Med. 2011;17(9):1094–100.', 'ArticleIdList': [StringElement('21873989', attributes={'IdType': 'pubmed'}), StringElement('3278279', attributes={'IdType': 'pmc'}), StringElement('10.1038/nm.2438', attributes={'IdType': 'doi'})]}, {'Citation': 'Reilley MJ, Bailey A, Subbiah V, Janku F, Naing A, Falchook G, et al. Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. J Immunother Cancer. 2017;5(1):35.', 'ArticleIdList': [StringElement('28428884', attributes={'IdType': 'pubmed'}), StringElement('5394629', attributes={'IdType': 'pmc'}), StringElement('10.1186/s40425-017-0238-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Hirai I, Tanese K, Fukuda K, Fusumae T, Nakamura Y, Sato Y, et al. Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: a phase I/II trial and study protocol. Medicine. 2021;100(49): e27832.', 'ArticleIdList': [StringElement('34889232', attributes={'IdType': 'pubmed'}), StringElement('8663894', attributes={'IdType': 'pmc'}), StringElement('10.1097/MD.0000000000027832', attributes={'IdType': 'doi'})]}, {'Citation': 'Bauer S, George S, von Mehren M, Heinrich MC. Early and NEXT-GENERATION KIT/PDGFRA kinase inhibitors and the future of treatment for advanced gastrointestinal stromal tumor. Front Oncol. 2021;11: 672500.', 'ArticleIdList': [StringElement('34322383', attributes={'IdType': 'pubmed'}), StringElement('8313277', attributes={'IdType': 'pmc'}), StringElement('10.3389/fonc.2021.672500', attributes={'IdType': 'doi'})]}, {'Citation': 'Tap WD, Wagner AJ, Schöffski P, Martin-Broto J, Krarup-Hansen A, Ganjoo KN, et al. Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial. JAMA. 2020;323(13):1266–76.', 'ArticleIdList': [StringElement('32259228', attributes={'IdType': 'pubmed'}), StringElement('7139275', attributes={'IdType': 'pmc'}), StringElement('10.1001/jama.2020.1707', attributes={'IdType': 'doi'})]}, {'Citation': 'Schöffski P, Bahleda R, Wagner AJ, Burgess MA, Junker N, Chisamore M, et al. Results of an open-label, phase Ia/b study of pembrolizumab plus olaratumab in patients with unresectable, locally advanced, or metastatic soft-tissue sarcoma. Clin Cancer Res. 2023;29(17):3320–8.', 'ArticleIdList': [StringElement('37382656', attributes={'IdType': 'pubmed'}), StringElement('10472093', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-23-0742', attributes={'IdType': 'doi'})]}, {'Citation': 'Mega A, Mebrahtu A, Aniander G, Ryer E, Sköld A, Sandegren A, et al. A PDGFRB- and CD40-targeting bispecific AffiMab induces stroma-targeted immune cell activation. MAbs. 2023;15(1):2223750.', 'ArticleIdList': [StringElement('37332119', attributes={'IdType': 'pubmed'}), StringElement('10332328', attributes={'IdType': 'pmc'}), StringElement('10.1080/19420862.2023.2223750', attributes={'IdType': 'doi'})]}, {'Citation': 'Mabry R, Gilbertson DG, Frank A, Vu T, Ardourel D, Ostrander C, et al. A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo. MAbs. 2010;2(1):20–34.', 'ArticleIdList': [StringElement('20065654', attributes={'IdType': 'pubmed'}), StringElement('2828575', attributes={'IdType': 'pmc'}), StringElement('10.4161/mabs.2.1.10498', attributes={'IdType': 'doi'})]}, {'Citation': 'Bailey JM, Mohr AM, Hollingsworth MA. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene. 2009;28(40):3513–25.', 'ArticleIdList': [StringElement('19633682', attributes={'IdType': 'pubmed'}), StringElement('2910592', attributes={'IdType': 'pmc'}), StringElement('10.1038/onc.2009.220', attributes={'IdType': 'doi'})]}, {'Citation': 'Fendrich V, Oh E, Bang S, Karikari C, Ottenhof N, Bisht S, et al. Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas. Neoplasia. 2011;13(10):923–30.', 'ArticleIdList': [StringElement('22028618', attributes={'IdType': 'pubmed'}), StringElement('3201569', attributes={'IdType': 'pmc'}), StringElement('10.1593/neo.11088', attributes={'IdType': 'doi'})]}, {'Citation': 'Steele NG, Biffi G, Kemp SB, Zhang Y, Drouillard D, Syu L, et al. Inhibition of hedgehog signaling alters fibroblast composition in pancreatic cancer. Clin Cancer Res. 2021;27(7):2023–37.', 'ArticleIdList': [StringElement('33495315', attributes={'IdType': 'pubmed'}), StringElement('8026631', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-20-3715', attributes={'IdType': 'doi'})]}, {'Citation': 'Wong H, Alicke B, West KA, Pacheco P, La H, Januario T, et al. Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent hedgehog pathway activation. Clin Cancer Res. 2011;17(14):4682–92.', 'ArticleIdList': [StringElement('21610148', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-11-0975', attributes={'IdType': 'doi'})]}, {'Citation': 'Lewis K, Dummer R, Farberg AS, Guminski A, Squittieri N, Migden M. Effects of sonidegib following dose reduction and treatment interruption in patients with advanced basal cell carcinoma during 42-month BOLT trial. Dermatol Ther. 2021;11(6):2225–34.', 'ArticleIdList': [StringElement('10.1007/s13555-021-00619-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Ruiz-Borrego M, Jimenez B, Antolín S, García-Saenz JA, Corral J, Jerez Y, et al. A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study. Invest New Drugs. 2019;37(1):98–108.', 'ArticleIdList': [StringElement('29948356', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s10637-018-0614-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Shanshal M, Foster NR, Lou Y, Zhao Y, Seetharam M, Mansfield AS, et al. A phase I trial of sequential dosing of sonidegib and pembrolizumab in advanced solid tumors (aST) and non–small-cell lung cancer (NSCLC). J Clin Oncol. 2023;41(16_suppl):9093–9093.', 'ArticleIdList': [StringElement('10.1200/JCO.2023.41.16_suppl.9093', attributes={'IdType': 'doi'})]}, {'Citation': 'Bertrand N, Guerreschi P, Basset-Seguin N, Saiag P, Dupuy A, Dalac-Rat S, et al. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: first results of a multicenter, open-label, phase 2 trial (VISMONEO study): neoadjuvant vismodegib in locally advanced basal cell carcinoma. EClinicalMedicine. 2021;35: 100844.', 'ArticleIdList': [StringElement('33997740', attributes={'IdType': 'pubmed'}), StringElement('8093898', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.eclinm.2021.100844', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim R, Ji JH, Kim JH, Hong JY, Lim HY, Kang WK, et al. Safety and anti-tumor effects of vismodegib in patients with refractory advanced gastric cancer: a single-arm, phase-II trial. J Cancer. 2022;13(4):1097–102.', 'ArticleIdList': [StringElement('35281856', attributes={'IdType': 'pubmed'}), StringElement('8899372', attributes={'IdType': 'pmc'}), StringElement('10.7150/jca.67050', attributes={'IdType': 'doi'})]}, {'Citation': 'De Jesus-Acosta A, Sugar EA, O’Dwyer PJ, Ramanathan RK, Von Hoff DD, Rasheed Z, et al. Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma. Br J Cancer. 2020;122(4):498–505.', 'ArticleIdList': [StringElement('31857726', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41416-019-0683-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, et al. Novel effect of antihelminthic niclosamide on S100A4-mediated metastatic progression in colon cancer. J Natl Cancer Inst. 2011;103(13):1018–36.', 'ArticleIdList': [StringElement('21685359', attributes={'IdType': 'pubmed'}), StringElement('10.1093/jnci/djr190', attributes={'IdType': 'doi'})]}, {'Citation': 'Luo F, Luo M, Rong Q-X, Zhang H, Chen Z, Wang F, et al. Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer. J Immunother Cancer. 2019;7(1):245.', 'ArticleIdList': [StringElement('31511071', attributes={'IdType': 'pubmed'}), StringElement('6739982', attributes={'IdType': 'pmc'}), StringElement('10.1186/s40425-019-0733-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Burock S, Daum S, Tröger H, Kim TD, Krüger S, Rieke DT, et al. Niclosamide a new chemotherapy agent? Pharmacokinetics of the potential anticancer drug in a patient cohort of the NIKOLO trial. J Clin Oncol. 2018;36(15_suppl):e14536–e14536.', 'ArticleIdList': [StringElement('10.1200/JCO.2018.36.15_suppl.e14536', attributes={'IdType': 'doi'})]}, {'Citation': 'Takemoto A, Takagi S, Ukaji T, Gyobu N, Kakino M, Takami M, et al. Targeting podoplanin for the treatment of osteosarcoma. Clin Cancer Res. 2022;28(12):2633–45.', 'ArticleIdList': [StringElement('35381070', attributes={'IdType': 'pubmed'}), StringElement('9359727', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-21-4509', attributes={'IdType': 'doi'})]}, {'Citation': 'Kaneko MK, Nakamura T, Kunita A, Fukayama M, Abe S, Nishioka Y, et al. ChLpMab-23: cancer-specific human-mouse chimeric anti-podoplanin antibody exhibits antitumor activity via antibody-dependent cellular cytotoxicity. Monoclon Antib Immunodiagn Immunother. 2017;36(3):104–12.', 'ArticleIdList': [StringElement('28504613', attributes={'IdType': 'pubmed'}), StringElement('10.1089/mab.2017.0014', attributes={'IdType': 'doi'})]}, {'Citation': 'Abe S, Kaneko MK, Tsuchihashi Y, Izumi T, Ogasawara S, Okada N, et al. Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model. Cancer Sci. 2016;107(9):1198–205.', 'ArticleIdList': [StringElement('27294401', attributes={'IdType': 'pubmed'}), StringElement('5021042', attributes={'IdType': 'pmc'}), StringElement('10.1111/cas.12985', attributes={'IdType': 'doi'})]}, {'Citation': 'Slemmons KK, Mukherjee S, Meltzer P, Purcell JW, Helman LJ. LRRC15 antibody-drug conjugates show promise as osteosarcoma therapeutics in preclinical studies. Pediatr Blood Cancer. 2021;68(2): e28771.', 'ArticleIdList': [StringElement('33063919', attributes={'IdType': 'pubmed'}), StringElement('10.1002/pbc.28771', attributes={'IdType': 'doi'})]}, {'Citation': 'Demetri GD, Luke JJ, Hollebecque A, Powderly JD 2nd, Spira AI, Subbiah V, et al. First-in-human phase I Study of ABBV-085, an antibody-drug conjugate targeting LRRC15, in sarcomas and other advanced solid tumors. Clin Cancer Res. 2021;27(13):3556–66.', 'ArticleIdList': [StringElement('33820780', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-20-4513', attributes={'IdType': 'doi'})]}, {'Citation': 'Brunetto E, De Monte L, Balzano G, Camisa B, Laino V, Riba M, et al. The IL-1/IL-1 receptor axis and tumor cell released inflammasome adaptor ASC are key regulators of TSLP secretion by cancer associated fibroblasts in pancreatic cancer. J Immunother Cancer. 2019;7(1):45.', 'ArticleIdList': [StringElement('30760333', attributes={'IdType': 'pubmed'}), StringElement('6373075', attributes={'IdType': 'pmc'}), StringElement('10.1186/s40425-019-0521-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Isambert N, Hervieu A, Hennequin A, Borg C, Rebe C, Derangere V, et al. 5-fluorouracil plus bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): an investigator-initiated, open-label, single-arm, multicentre, phase 2 study. J Clin Oncol. 2018;36(15_suppl):e15540–e15540.', 'ArticleIdList': [StringElement('10.1200/JCO.2018.36.15_suppl.e15540', attributes={'IdType': 'doi'})]}, {'Citation': 'Costa LJ, Mailankody S, Shaughnessy P, Hari P, Kaufman JL, Larson SM, et al. Anakinra (AKR) prophylaxis (ppx) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) receiving orvacabtagene autoleucel (orva-cel). J Clin Oncol. 2021;39(15_suppl):2537–2537.', 'ArticleIdList': [StringElement('10.1200/JCO.2021.39.15_suppl.2537', attributes={'IdType': 'doi'})]}, {'Citation': 'Yang K, Han L, Wu S, Qu X, Li Q, Zhao C, et al. Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: a multicenter study. Cancer Immunol Immunother. 2022;71(6):1443–51.', 'ArticleIdList': [StringElement('34689233', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00262-021-03083-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Martin-Broto J, Hindi N, Grignani G, Martinez-Trufero J, Redondo A, Valverde C, et al. Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. J Immunother Cancer. 2020;8(2): e001561.', 'ArticleIdList': [StringElement('33203665', attributes={'IdType': 'pubmed'}), StringElement('7674086', attributes={'IdType': 'pmc'}), StringElement('10.1136/jitc-2020-001561', attributes={'IdType': 'doi'})]}, {'Citation': 'Martin CJ, Datta A, Littlefield C, Kalra A, Chapron C, Wawersik S, et al. Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape. Sci Transl Med. 2020;12(536): eaay8456.', 'ArticleIdList': [StringElement('32213632', attributes={'IdType': 'pubmed'}), StringElement('10.1126/scitranslmed.aay8456', attributes={'IdType': 'doi'})]}, {'Citation': 'Welsh BT, Faucette R, Bilic S, Martin CJ, Schürpf T, Chen D, et al. Nonclinical development of SRK-181: an anti-latent TGFβ1 monoclonal antibody for the treatment of locally advanced or metastatic solid tumors. Int J Toxicol. 2021;40(3):226–41.', 'ArticleIdList': [StringElement('33739172', attributes={'IdType': 'pubmed'}), StringElement('8135237', attributes={'IdType': 'pmc'}), StringElement('10.1177/1091581821998945', attributes={'IdType': 'doi'})]}, {'Citation': 'Yap T, Barve M, Gainor J, Bockorny B, Ju Y, Cote S, et al. 532 First-in-human phase 1 trial of SRK-181: a latent TGFβ1 inhibitor, alone or in combination with anti-PD-(L)1 treatment in patients with advanced solid tumors (DRAGON trial). J Immunother Cancer. 2021;9(Suppl 2):A563–A563.'}, {'Citation': 'Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M, et al. Phase I Study of GC1008 (Fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS ONE. 2014;9(3): e90353.', 'ArticleIdList': [StringElement('24618589', attributes={'IdType': 'pubmed'}), StringElement('3949712', attributes={'IdType': 'pmc'}), StringElement('10.1371/journal.pone.0090353', attributes={'IdType': 'doi'})]}, {'Citation': 'Stevenson JP, Kindler HL, Papasavvas E, Sun J, Jacobs-Small M, Hull J, et al. Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients. Oncoimmunology. 2013;2(8): e26218.', 'ArticleIdList': [StringElement('24179709', attributes={'IdType': 'pubmed'}), StringElement('3812201', attributes={'IdType': 'pmc'}), StringElement('10.4161/onci.26218', attributes={'IdType': 'doi'})]}, {'Citation': 'den Hollander MW, Bensch F, Glaudemans AW, Oude Munnink TH, Enting RH, den Dunnen WF, et al. TGF-β antibody uptake in recurrent high-grade glioma imaged with 89Zr-fresolimumab PET. J Nucl Med. 2015;56(9):1310–4.', 'ArticleIdList': [StringElement('10.2967/jnumed.115.154401', attributes={'IdType': 'doi'})]}, {'Citation': 'Greco R, Qu H, Qu H, Theilhaber J, Shapiro G, Gregory R, et al. Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade. Oncoimmunology. 2020;9(1):1811605.', 'ArticleIdList': [StringElement('33224628', attributes={'IdType': 'pubmed'}), StringElement('7657645', attributes={'IdType': 'pmc'}), StringElement('10.1080/2162402X.2020.1811605', attributes={'IdType': 'doi'})]}, {'Citation': 'Robbrecht D, Doger B, Grob J-J, Bechter OE, Miguel MJ, Vieito M, et al. Safety and efficacy results from the expansion phase of the first-in-human study evaluating TGFβ inhibitor SAR439459 alone and combined with cemiplimab in adults with advanced solid tumors. J Clin Oncol. 2022;40(16_suppl):2524–2524.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.16_suppl.2524', attributes={'IdType': 'doi'})]}, {'Citation': 'Tremblay G, Gruosso T, Denis J-F, Figueredo R, Koropatnick J, O’Connor-McCourt M. Abstract 6710: AVID200, a first-in-class selective TGF-beta 1 and -beta 3 inhibitor, sensitizes tumors to immune checkpoint blockade therapies. Cancer Res. 2020;80(16_Supplement):6710–6710.', 'ArticleIdList': [StringElement('10.1158/1538-7445.AM2020-6710', attributes={'IdType': 'doi'})]}, {'Citation': 'Yap TA, Lakhani NJ, Araujo DV, Ahnert JR, Chandana SR, Sharma M, et al. AVID200, first-in-class TGF-beta 1 and 3 selective and potent inhibitor: Safety and biomarker results of a phase I monotherapy dose-escalation study in patients with advanced solid tumors. J Clin Oncol. 2020;38(15_suppl):3587–3587.', 'ArticleIdList': [StringElement('10.1200/JCO.2020.38.15_suppl.3587', attributes={'IdType': 'doi'})]}, {'Citation': 'Lind H, Gameiro SR, Jochems C, Donahue RN, Strauss J, Gulley JM, et al. Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances. J Immunother Cancer. 2020;8(1): e000433.', 'ArticleIdList': [StringElement('32079617', attributes={'IdType': 'pubmed'}), StringElement('7057416', attributes={'IdType': 'pmc'}), StringElement('10.1136/jitc-2019-000433', attributes={'IdType': 'doi'})]}, {'Citation': 'Burvenich IJG, Goh YW, Guo N, Gan HK, Rigopoulos A, Cao D, et al. Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa. Eur J Nucl Med Mol Imaging. 2021;48(10):3075–88.', 'ArticleIdList': [StringElement('33608805', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s00259-021-05251-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Cheng B, Ding K, Chen P, Ji J, Luo T, Guo X, et al. Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer. Cancer Commun. 2022;42(1):17–36.', 'ArticleIdList': [StringElement('10.1002/cac2.12244', attributes={'IdType': 'doi'})]}, {'Citation': 'Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, et al. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nat Commun. 2018;9(1):741.', 'ArticleIdList': [StringElement('29467463', attributes={'IdType': 'pubmed'}), StringElement('5821872', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-017-02696-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Keedy VL, Bauer TM, Clarke JM, Hurwitz H, Baek I, Ha I, et al. Association of TGF-β responsive signature with anti-tumor effect of vactosertib, a potent, oral TGF-β receptor type I (TGFBRI) inhibitor in patients with advanced solid tumors. J Clin Oncol. 2018;36(15_suppl):3031–3031.', 'ArticleIdList': [StringElement('10.1200/JCO.2018.36.15_suppl.3031', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim HS, Ahn J-H, Kim JE, Hong JY, Lee J, Kim SH, et al. A phase I study of TGF-β inhibitor, vactosertib in combination with imatinib in patients with advanced desmoid tumor (aggressive fibromatosis). J Clin Oncol. 2020;38(15):11557–11557.', 'ArticleIdList': [StringElement('10.1200/JCO.2020.38.15_suppl.11557', attributes={'IdType': 'doi'})]}, {'Citation': 'Kelley RK, Gane E, Assenat E, Siebler J, Galle PR, Merle P, et al. A phase 2 study of galunisertib (TGF-β1 receptor type I inhibitor) and sorafenib in patients with advanced hepatocellular carcinoma. Clin Transl Gastroenterol. 2019;10(7): e00056.', 'ArticleIdList': [StringElement('31295152', attributes={'IdType': 'pubmed'}), StringElement('6708671', attributes={'IdType': 'pmc'}), StringElement('10.14309/ctg.0000000000000056', attributes={'IdType': 'doi'})]}, {'Citation': 'Melisi D, Garcia-Carbonero R, Macarulla T, Pezet D, Deplanque G, Fuchs M, et al. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. Br J Cancer. 2018;119(10):1208–14.', 'ArticleIdList': [StringElement('30318515', attributes={'IdType': 'pubmed'}), StringElement('6251034', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41416-018-0246-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Yap TA, Vieito M, Baldini C, Sepúlveda-Sánchez JM, Kondo S, Simonelli M, et al. First-in-human phase i study of a next-generation, oral, TGFβ receptor 1 inhibitor, LY3200882, in patients with advanced cancer. Clin Cancer Res. 2021;27(24):6666–76.', 'ArticleIdList': [StringElement('34548321', attributes={'IdType': 'pubmed'}), StringElement('9414273', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-21-1504', attributes={'IdType': 'doi'})]}, {'Citation': 'Malek E, Hwang S, Caimi PF, Metheny LL, Tomlinson BK, Cooper BW, et al. Phase Ib trial of vactosertib in combination with pomalidomide in relapsed multiple myeloma: a corticosteroid-free approach by targeting TGF-β signaling pathway. J Clin Oncol. 2021;39(15):8039–8039.', 'ArticleIdList': [StringElement('10.1200/JCO.2021.39.15_suppl.8039', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim B-G, Choi SH, Luo G, Sergeeva O, Lee Z, Driscoll J, et al. Vactosertib, a TGF-ß receptor I kinase/ALK5 inhibitor, diminishes tumor progression and bone disease in a mouse model of multiple myeloma and overcomes resistance to proteasome inhibitors. Blood. 2018;132:1918.', 'ArticleIdList': [StringElement('10.1182/blood-2018-99-117852', attributes={'IdType': 'doi'})]}, {'Citation': 'Malek E, Kim B-G, Valent J, Driscoll J, Caimi P, Kim S-J, et al. Preclinical studies and a phase I trial of the TGF-β receptor inhibitor, vactosertib (TEW-7197), in combination with pomalidomide in patients with multiple myeloma refractory to bortezomib or lenalidomide. Blood. 2018;132:1962.', 'ArticleIdList': [StringElement('10.1182/blood-2018-99-112449', attributes={'IdType': 'doi'})]}, {'Citation': 'Nada H, Sivaraman A, Lu Q, Min K, Kim S, Goo JI, et al. Perspective for discovery of small molecule IL-6 inhibitors through study of structure-activity relationships and molecular docking. J Med Chem. 2023;66(7):4417–33.', 'ArticleIdList': [StringElement('36971365', attributes={'IdType': 'pubmed'}), StringElement('10.1021/acs.jmedchem.2c01957', attributes={'IdType': 'doi'})]}, {'Citation': 'Song L, Smith MA, Doshi P, Sasser K, Fulp W, Altiok S, et al. Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer. J Thorac Oncol. 2014;9(7):974–82.', 'ArticleIdList': [StringElement('24922005', attributes={'IdType': 'pubmed'}), StringElement('4057975', attributes={'IdType': 'pmc'}), StringElement('10.1097/JTO.0000000000000193', attributes={'IdType': 'doi'})]}, {'Citation': 'Fulciniti M, Hideshima T, Vermot-Desroches C, Pozzi S, Nanjappa P, Shen Z, et al. A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma. Clin Cancer Res. 2009;15(23):7144–52.', 'ArticleIdList': [StringElement('19934301', attributes={'IdType': 'pubmed'}), StringElement('2787636', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-09-1483', attributes={'IdType': 'doi'})]}, {'Citation': 'Dorff TB, Goldman B, Pinski JK, Mack PC, Lara PN Jr, Van Veldhuizen PJ, et al. Clinical and correlative results of SWOG S0354: a phase II Trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer. Clin Cancer Res. 2010;16(11):3028–34.', 'ArticleIdList': [StringElement('20484019', attributes={'IdType': 'pubmed'}), StringElement('2898710', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-09-3122', attributes={'IdType': 'doi'})]}, {'Citation': 'Schuster M, Rigas JR, Orlov SV, Milovanovic B, Prabhash K, Smith JT, et al. ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): results of a phase II, randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2010;28(15):7631–7631.', 'ArticleIdList': [StringElement('10.1200/jco.2010.28.15_suppl.7631', attributes={'IdType': 'doi'})]}, {'Citation': 'Huseni MA, Wang L, Klementowicz JE, Yuen K, Breart B, Orr C, et al. CD8(+) T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. Cell Rep Med. 2023;4(1): 100878.', 'ArticleIdList': [StringElement('36599350', attributes={'IdType': 'pubmed'}), StringElement('9873827', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.xcrm.2022.100878', attributes={'IdType': 'doi'})]}, {'Citation': 'Li J, Xu J, Yan X, Jin K, Li W, Zhang R. Targeting interleukin-6 (IL-6) sensitizes Anti-PD-L1 treatment in a colorectal cancer preclinical model. Med Sci Monit. 2018;24:5501–8.', 'ArticleIdList': [StringElement('30087314', attributes={'IdType': 'pubmed'}), StringElement('6097097', attributes={'IdType': 'pmc'}), StringElement('10.12659/MSM.907439', attributes={'IdType': 'doi'})]}, {'Citation': 'Akce M, Shaib WL, Diab M, Alese OB, Wu C, Thomas S, et al. Phase Ib/II trial of siltuximab and spartalizumab in patients in metastatic pancreatic cancer. J Clin Oncol. 2022;40(4):TPS626.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.4_suppl.TPS626', attributes={'IdType': 'doi'})]}, {'Citation': 'Shah JJ, Feng L, Thomas SK, Berkova Z, Weber DM, Wang M, et al. Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. Blood Cancer J. 2016;6(2):e396–e396.', 'ArticleIdList': [StringElement('26871714', attributes={'IdType': 'pubmed'}), StringElement('4771967', attributes={'IdType': 'pmc'}), StringElement('10.1038/bcj.2016.4', attributes={'IdType': 'doi'})]}, {'Citation': 'Wang X, Che X, Liu C, Fan Y, Bai M, Hou K, et al. Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1. Exp Cell Res. 2018;368(2):184–93.', 'ArticleIdList': [StringElement('29709516', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.yexcr.2018.04.028', attributes={'IdType': 'doi'})]}, {'Citation': 'Li H, Zhang Q, Wu Q, Cui Y, Zhu H, Fang M, et al. Interleukin-22 secreted by cancer-associated fibroblasts regulates the proliferation and metastasis of lung cancer cells via the PI3K-Akt-mTOR signaling pathway. Am J Transl Res. 2019;11(7):4077–88.', 'ArticleIdList': [StringElement('31396319', attributes={'IdType': 'pubmed'}), StringElement('6684901', attributes={'IdType': 'pmc'})]}, {'Citation': 'Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, et al. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. Cancer Lett. 2019;442:320–32.', 'ArticleIdList': [StringElement('30391782', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.canlet.2018.10.015', attributes={'IdType': 'doi'})]}, {'Citation': 'Sullivan KM, Jiang X, Guha P, Lausted C, Carter JA, Hsu C, et al. Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut. 2023;72(2):325–37.', 'ArticleIdList': [StringElement('35705369', attributes={'IdType': 'pubmed'}), StringElement('10.1136/gutjnl-2021-325808', attributes={'IdType': 'doi'})]}, {'Citation': 'Oft M. IL-10: master switch from tumor-promoting inflammation to antitumor immunity. Cancer Immunol Res. 2014;2(3):194–9.', 'ArticleIdList': [StringElement('24778315', attributes={'IdType': 'pubmed'}), StringElement('10.1158/2326-6066.CIR-13-0214', attributes={'IdType': 'doi'})]}, {'Citation': 'Naing A, Wong DJ, Infante JR, Korn WM, Aljumaily R, Papadopoulos KP, et al. Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial. Lancet Oncol. 2019;20(11):1544–55.', 'ArticleIdList': [StringElement('31563517', attributes={'IdType': 'pubmed'}), StringElement('8436252', attributes={'IdType': 'pmc'}), StringElement('10.1016/S1470-2045(19)30514-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Hecht JR, Lonardi S, Bendell JC, Sim H-W, Macarulla T, Lopez CD, et al. Randomized Phase III study of FOLFOX alone and with pegilodecakin as second-line therapy in patients with metastatic pancreatic cancer (SEQUOIA). J Clin Oncol. 2020;38(4_suppl):637–637.', 'ArticleIdList': [StringElement('10.1200/JCO.2020.38.4_suppl.637', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang H, Yue J, Jiang Z, Zhou R, Xie R, Xu Y, et al. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma. Cell Death Dis. 2017;8(5):e2790–e2790.', 'ArticleIdList': [StringElement('28518141', attributes={'IdType': 'pubmed'}), StringElement('5520705', attributes={'IdType': 'pmc'}), StringElement('10.1038/cddis.2017.180', attributes={'IdType': 'doi'})]}, {'Citation': 'Miyake M, Hori S, Morizawa Y, Tatsumi Y, Nakai Y, Anai S, et al. CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer. Neoplasia. 2016;18(10):636–46.', 'ArticleIdList': [StringElement('27690238', attributes={'IdType': 'pubmed'}), StringElement('5043399', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.neo.2016.08.002', attributes={'IdType': 'doi'})]}, {'Citation': 'Murakami K, Sasaki Y, Furuya H, Rosser C. Abstract 2858: development of a first-in-class humanized antibody targeting CXCL1 in bladder cancer. Cancer Res. 2022;82(12_Supplement):2858–2858.', 'ArticleIdList': [StringElement('10.1158/1538-7445.AM2022-2858', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhai J, Shen J, Xie G, Wu J, He M, Gao L, et al. Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Lett. 2019;454:37–43.', 'ArticleIdList': [StringElement('30978440', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.canlet.2019.04.002', attributes={'IdType': 'doi'})]}, {'Citation': 'Davar D, Simonelli M, Gutierrez M, Calvo E, Melear J, Piha-Paul S, et al. 394 Interleukin-8–neutralizing monoclonal antibody BMS-986253 plus nivolumab (NIVO) in biomarker-enriched, primarily anti–PD-(L)1–experienced patients with advanced cancer: initial phase 1 results. J Immunother Cancer. 2020;8(Suppl 3):A239–40.'}, {'Citation': 'Liu G, Sun J, Yang ZF, Zhou C, Zhou PY, Guan RY, et al. Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death Dis. 2021;12(3):260.', 'ArticleIdList': [StringElement('33707417', attributes={'IdType': 'pubmed'}), StringElement('7952559', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-021-03545-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Gao Q, Wang S, Chen X, Cheng S, Zhang Z, Li F, et al. Cancer-cell-secreted CXCL11 promoted CD8<sup>+</sup> T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J Immunother Cancer. 2019;7(1):42.', 'ArticleIdList': [StringElement('30744691', attributes={'IdType': 'pubmed'}), StringElement('6371476', attributes={'IdType': 'pmc'}), StringElement('10.1186/s40425-019-0511-6', attributes={'IdType': 'doi'})]}, {'Citation': 'Cao Y, Jiao N, Sun T, Ma Y, Zhang X, Chen H, et al. CXCL11 correlates with antitumor immunity and an improved prognosis in colon cancer. Front Cell Dev Biol. 2021;9: 646252.', 'ArticleIdList': [StringElement('33777950', attributes={'IdType': 'pubmed'}), StringElement('7991085', attributes={'IdType': 'pmc'}), StringElement('10.3389/fcell.2021.646252', attributes={'IdType': 'doi'})]}, {'Citation': 'Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, et al. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. 2018;37(32):4428–42.', 'ArticleIdList': [StringElement('29720724', attributes={'IdType': 'pubmed'}), StringElement('7063845', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41388-018-0263-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Labernadie A, Kato T, Brugués A, Serra-Picamal X, Derzsi S, Arwert E, et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017;19(3):224–37.', 'ArticleIdList': [StringElement('28218910', attributes={'IdType': 'pubmed'}), StringElement('5831988', attributes={'IdType': 'pmc'}), StringElement('10.1038/ncb3478', attributes={'IdType': 'doi'})]}, {'Citation': 'Jiang H, Ge H, Shi Y, Yuan F, Yue H. CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages. Med Oncol. 2023;40(3):90.', 'ArticleIdList': [StringElement('36737590', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s12032-023-01953-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Holter JC, Chang CW, Avendano A, Garg AA, Verma AK, Charan M, et al. Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility. Front Bioeng Biotechnol. 2022;10: 888431.', 'ArticleIdList': [StringElement('36118583', attributes={'IdType': 'pubmed'}), StringElement('9478647', attributes={'IdType': 'pmc'}), StringElement('10.3389/fbioe.2022.888431', attributes={'IdType': 'doi'})]}, {'Citation': 'Halama N, Williams A, Prüfer U, Frömming A, Beyer D, Eulberg D, et al. Abstract CT117: Phase 1/2 study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer. Cancer Res. 2020;80(16_Supplement):CT117.', 'ArticleIdList': [StringElement('10.1158/1538-7445.AM2020-CT117', attributes={'IdType': 'doi'})]}, {'Citation': 'Giordano FA, Layer JP, Leonardelli S, Friker LL, Seidel C, Schaub C, et al. Radiotherapy and olaptesed pegol (NOX-A12) in partially resected or biopsy-only MGMT-unmethylated glioblastoma: interim data from the German multicenter phase 1/2 GLORIA trial. J Clin Oncol. 2022;40(16_suppl):2050–2050.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.16_suppl.2050', attributes={'IdType': 'doi'})]}, {'Citation': 'Sun X, He X, Zhang Y, Hosaka K, Andersson P, Wu J, et al. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut. 2022;71(1):129–47.', 'ArticleIdList': [StringElement('33568427', attributes={'IdType': 'pubmed'}), StringElement('10.1136/gutjnl-2020-322744', attributes={'IdType': 'doi'})]}, {'Citation': 'Li Z, Zhou J, Zhang J, Li S, Wang H, Du J. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5. Int J Cancer. 2019;145(7):1946–57.', 'ArticleIdList': [StringElement('30873585', attributes={'IdType': 'pubmed'}), StringElement('6767568', attributes={'IdType': 'pmc'}), StringElement('10.1002/ijc.32278', attributes={'IdType': 'doi'})]}, {'Citation': 'Xu H, Zhao J, Li J, Zhu Z, Cui Z, Liu R, et al. Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axis. Cell Death Dis. 2022;13(5):478.', 'ArticleIdList': [StringElement('35589690', attributes={'IdType': 'pubmed'}), StringElement('9119971', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-022-04935-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Christenson E, Lim SJ, Wang H, Ferguson A, Parkinson R, Cetasaan Y, et al. Nivolumab and a CCR2/CCR5 dual antagonist (BMS-813160) with or without GVAX for locally advanced pancreatic ductal adenocarcinomas: results of phase I study. J Clin Oncol. 2023;41(4_suppl):730–730.', 'ArticleIdList': [StringElement('10.1200/JCO.2023.41.4_suppl.730', attributes={'IdType': 'doi'})]}, {'Citation': 'Korbecki J, Kupnicka P, Chlubek M, Gorący J, Gutowska I, Baranowska-Bosiacka I. CXCR2 receptor: regulation of expression, signal transduction, and involvement in cancer. Int J Mol Sci. 2022;23(4):2168.', 'ArticleIdList': [StringElement('35216283', attributes={'IdType': 'pubmed'}), StringElement('8878198', attributes={'IdType': 'pmc'}), StringElement('10.3390/ijms23042168', attributes={'IdType': 'doi'})]}, {'Citation': 'Guo C, Sharp A, Vogl U, Colombo I, Stathis A, Jain S, et al. 454O A phase (Ph) I/II trial of the CXCR2 antagonist AZD5069 in combination with enzalutamide (ENZA) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC). Ann Oncol. 2022;33:S745.', 'ArticleIdList': [StringElement('10.1016/j.annonc.2022.07.583', attributes={'IdType': 'doi'})]}, {'Citation': 'Guo C, Sharp A, Gurel B, Crespo M, Figueiredo I, Jain S, et al. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance. Nature. 2023;623(7989):1053–61.', 'ArticleIdList': [StringElement('37844613', attributes={'IdType': 'pubmed'}), StringElement('10686834', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41586-023-06696-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Pawlick RL, Wink J, Pepper AR, Bruni A, Abualhassen N, Rafiei Y, et al. Reparixin, a CXCR1/2 inhibitor in islet allotransplantation. Islets. 2016;8(5):115–24.', 'ArticleIdList': [StringElement('27328412', attributes={'IdType': 'pubmed'}), StringElement('5029202', attributes={'IdType': 'pmc'}), StringElement('10.1080/19382014.2016.1199303', attributes={'IdType': 'doi'})]}, {'Citation': 'Liotti F, De Pizzol M, Allegretti M, Prevete N, Melillo RM. Multiple anti-tumor effects of Reparixin on thyroid cancer. Oncotarget. 2017;8(22):35946–61.', 'ArticleIdList': [StringElement('28415590', attributes={'IdType': 'pubmed'}), StringElement('5482629', attributes={'IdType': 'pmc'}), StringElement('10.18632/oncotarget.16412', attributes={'IdType': 'doi'})]}, {'Citation': 'Goldstein LJ, Mansutti M, Levy C, Chang JC, Henry S, Fernandez-Perez I, et al. A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida). Breast Cancer Res Treat. 2021;190(2):265–75.', 'ArticleIdList': [StringElement('34476645', attributes={'IdType': 'pubmed'}), StringElement('8558154', attributes={'IdType': 'pmc'}), StringElement('10.1007/s10549-021-06367-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Redman J, Spira A, Javle M, Kelly K, Pavlakis N, Jehl G, et al. P-133 Clinical responses in pancreaticobiliary cancer patients who received bintrafusp alfa (BA) or BA plus CXCR1/2 inhibitor (SX-682) plus CEA/MUC1-targted vaccine (CV301). Ann Oncol. 2022;33:S297.', 'ArticleIdList': [StringElement('10.1016/j.annonc.2022.04.223', attributes={'IdType': 'doi'})]}, {'Citation': 'Dunne RF, Ullman NA, Belt BA, Ruffolo LI, Burchard P, Hezel AF, et al. A phase I study to evaluate the safety and tolerability of SX-682 in combination with PD-1 inhibitor as maintenance therapy for unresectable pancreatic adenocarcinoma. J Clin Oncol. 2022;40(4_suppl):TPS631.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.4_suppl.TPS631', attributes={'IdType': 'doi'})]}, {'Citation': 'Johnson B, Haymaker C, Morris VK, Dasari A, Higbie VS, Shen JP, et al. Abstract CT118: A phase I/II trial of a CXCR1/2 inhibitor in combination with anti-PD-1 for circulating tumor DNA (ctDNA) positive & refractoryRAS-mutated microsatellite stable (MSS) colorectal cancer. Cancer Res. 2023;83(8_supplement):CT118.', 'ArticleIdList': [StringElement('10.1158/1538-7445.AM2023-CT118', attributes={'IdType': 'doi'})]}, {'Citation': 'De Clercq E. Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. Antivir Chem Chemother. 2019;27:2040206619829382.', 'ArticleIdList': [StringElement('30776910', attributes={'IdType': 'pubmed'}), StringElement('6379795', attributes={'IdType': 'pmc'}), StringElement('10.1177/2040206619829382', attributes={'IdType': 'doi'})]}, {'Citation': 'Ghobrial IM, Liu CJ, Zavidij O, Azab AK, Baz R, Laubach JP, et al. Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma. Am J Hematol. 2019;94(11):1244–53.', 'ArticleIdList': [StringElement('31456261', attributes={'IdType': 'pubmed'}), StringElement('10.1002/ajh.25627', attributes={'IdType': 'doi'})]}, {'Citation': 'Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin BM, Stemmer SM, et al. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat Med. 2020;26(6):878–85.', 'ArticleIdList': [StringElement('32451495', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41591-020-0880-x', attributes={'IdType': 'doi'})]}, {'Citation': 'Hainsworth JD, Reeves JA, Mace JR, Crane EJ, Hamid O, Stille JR, et al. A randomized, open-label phase 2 study of the CXCR4 inhibitor LY2510924 in combination with sunitinib versus sunitinib alone in patients with metastatic renal cell carcinoma (RCC). Target Oncol. 2016;11(5):643–53.', 'ArticleIdList': [StringElement('27154357', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11523-016-0434-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Salgia R, Stille JR, Weaver RW, McCleod M, Hamid O, Polzer J, et al. A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive-disease small cell lung cancer. Lung Cancer. 2017;105:7–13.', 'ArticleIdList': [StringElement('28236984', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.lungcan.2016.12.020', attributes={'IdType': 'doi'})]}, {'Citation': 'Ghobrial IM, Liu C-J, Redd RA, Perez RP, Baz R, Zavidij O, et al. A phase Ib/II trial of the first-in-class anti-CXCR4 antibody ulocuplumab in combination with lenalidomide or bortezomib plus dexamethasone in relapsed multiple myeloma. Clin Cancer Res. 2020;26(2):344–53.', 'ArticleIdList': [StringElement('31672767', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-19-0647', attributes={'IdType': 'doi'})]}, {'Citation': 'Seitz S, Dreyer TF, Stange C, Steiger K, Bräuer R, Scheutz L, et al. CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer. Br J Cancer. 2022;126(10):1470–80.', 'ArticleIdList': [StringElement('35314795', attributes={'IdType': 'pubmed'}), StringElement('9090786', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41416-022-01763-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Xiao W, Huang H, Zheng P, Liu Y, Chen Y, Chen J, et al. The CXCL10/CXCR3 pathway contributes to the synergy of thermal ablation and PD-1 blockade therapy against tumors. Cancers. 2023;15(5):1427.', 'ArticleIdList': [StringElement('36900218', attributes={'IdType': 'pubmed'}), StringElement('10000434', attributes={'IdType': 'pmc'}), StringElement('10.3390/cancers15051427', attributes={'IdType': 'doi'})]}, {'Citation': 'House IG, Savas P, Lai J, Chen AXY, Oliver AJ, Teo ZL, et al. Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade. Clin Cancer Res. 2020;26(2):487–504.', 'ArticleIdList': [StringElement('31636098', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-19-1868', attributes={'IdType': 'doi'})]}, {'Citation': 'Simon G, Subbiah V, Rosen L, Lenz H-J, Park H, Patel M, et al. 762 First-in-human phase 1a study of NG-641, a tumour-selective vector expressing a FAP-TAc bispecific antibody and immune enhancer module, in patients with metastatic/advanced epithelial tumours (STAR). J Immunother Cancer. 2022;10(Suppl 2):A794–A794.'}, {'Citation': 'Ding X, Ji J, Jiang J, Cai Q, Wang C, Shi M, et al. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis. Cell Death Dis. 2018;9(9):867.', 'ArticleIdList': [StringElement('30158543', attributes={'IdType': 'pubmed'}), StringElement('6115420', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41419-018-0922-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Bauman JE, Saba NF, Roe D, Bauman JR, Kaczmar J, Bhatia A, et al. Randomized Phase II trial of ficlatuzumab with or without cetuximab in pan-refractory, recurrent/metastatic head and neck cancer. J Clin Oncol. 2023;41(22):3851–62.', 'ArticleIdList': [StringElement('36977289', attributes={'IdType': 'pubmed'}), StringElement('10.1200/JCO.22.01994', attributes={'IdType': 'doi'})]}, {'Citation': 'Mok TSK, Geater SL, Su W-C, Tan E-H, Yang JC-H, Chang G-C, et al. A randomized Phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in asian patients with advanced stage pulmonary adenocarcinoma. J Thorac Oncol. 2016;11(10):1736–44.', 'ArticleIdList': [StringElement('27448761', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.jtho.2016.05.038', attributes={'IdType': 'doi'})]}, {'Citation': 'Camidge DR, Moran T, Demedts I, Grosch H, Mercurio J-PD, Mileham KF, et al. A randomized, open-label, phase 2 study of emibetuzumab plus erlotinib (LY+E) and emibetuzumab monotherapy (LY) in patients with acquired resistance to erlotinib and MET diagnostic positive (MET Dx+) metastatic NSCLC. J Clin Oncol. 2016;34(15):9070–9070.', 'ArticleIdList': [StringElement('10.1200/JCO.2016.34.15_suppl.9070', attributes={'IdType': 'doi'})]}, {'Citation': 'Harding JJ, Zhu AX, Bauer TM, Choueiri TK, Drilon A, Voss MH, et al. A phase Ib/II study of ramucirumab in combination with emibetuzumab in patients with advanced cancer. Clin Cancer Res. 2019;25(17):5202–11.', 'ArticleIdList': [StringElement('31142504', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-18-4010', attributes={'IdType': 'doi'})]}, {'Citation': 'Cunningham D, Tebbutt NC, Davidenko I, Murad AM, Al-Batran S-E, Ilson DH, et al. Phase III, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus epirubicin, cisplatin and capecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 study. J Clin Oncol. 2015;33(15):4000–4000.', 'ArticleIdList': [StringElement('10.1200/jco.2015.33.15_suppl.4000', attributes={'IdType': 'doi'})]}, {'Citation': 'Spigel DR, Ervin TJ, Ramlau RA, Daniel DB, Goldschmidt JH Jr, Blumenschein GR Jr, et al. Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2013;31(32):4105–14.', 'ArticleIdList': [StringElement('24101053', attributes={'IdType': 'pubmed'}), StringElement('4878106', attributes={'IdType': 'pmc'}), StringElement('10.1200/JCO.2012.47.4189', attributes={'IdType': 'doi'})]}, {'Citation': 'Mathieu LN, Larkins E, Akinboro O, Roy P, Amatya AK, Fiero MH, et al. FDA approval summary: capmatinib and tepotinib for the treatment of metastatic NSCLC harboring MET Exon 14 skipping mutations or alterations. Clin Cancer Res. 2022;28(2):249–54.', 'ArticleIdList': [StringElement('34344795', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-21-1566', attributes={'IdType': 'doi'})]}, {'Citation': 'Ryoo B-Y, Ren Z, Kim T-Y, Pan H, Rau K-M, Choi H, et al. Phase II trial of tepotinib vs sorafenib in Asian patients (pts) with advanced hepatocellular carcinoma (HCC). Ann Oncol. 2018;29:viii207.', 'ArticleIdList': [StringElement('10.1093/annonc/mdy282.005', attributes={'IdType': 'doi'})]}, {'Citation': 'Mok TSK, Cortinovis DL, Majem M, Johnson ML, Mardjuadi FI, Zhao X, et al. Efficacy and safety of capmatinib plus pembrolizumab in treatment (tx)-naïve patients with advanced non–small cell lung cancer (NSCLC) with high tumor PD-L1 expression: results of a randomized, open-label, multicenter, phase 2 study. J Clin Oncol. 2022;40(16_suppl):9118–9118.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.16_suppl.9118', attributes={'IdType': 'doi'})]}, {'Citation': 'Babina IS, Turner NC. Advances and challenges in targeting FGFR signalling in cancer. Nat Rev Cancer. 2017;17(5):318–32.', 'ArticleIdList': [StringElement('28303906', attributes={'IdType': 'pubmed'}), StringElement('10.1038/nrc.2017.8', attributes={'IdType': 'doi'})]}, {'Citation': 'Krook MA, Reeser JW, Ernst G, Barker H, Wilberding M, Li G, et al. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance. Br J Cancer. 2021;124(5):880–92.', 'ArticleIdList': [StringElement('33268819', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41416-020-01157-0', attributes={'IdType': 'doi'})]}, {'Citation': 'van Brummelen EMJ, Levchenko E, Dómine M, Fennell DA, Kindler HL, Viteri S, et al. A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma. Invest New Drugs. 2020;38(2):457–67.', 'ArticleIdList': [StringElement('31065954', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s10637-019-00783-7', attributes={'IdType': 'doi'})]}, {'Citation': 'Morgensztern D, Karaseva N, Felip E, Delgado I, Burdaeva O, Dómine M, et al. An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer. Lung Cancer. 2019;136:74–9.', 'ArticleIdList': [StringElement('31446228', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.lungcan.2019.08.011', attributes={'IdType': 'doi'})]}, {'Citation': 'Wekking D, Pretta A, Martella S, D’Agata AP, Joeun Choe J, Denaro N, et al. Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas. Heliyon. 2023;9(9): e19541.', 'ArticleIdList': [StringElement('37681152', attributes={'IdType': 'pubmed'}), StringElement('10481293', attributes={'IdType': 'pmc'}), StringElement('10.1016/j.heliyon.2023.e19541', attributes={'IdType': 'doi'})]}, {'Citation': 'Siefker-Radtke AO, Necchi A, Park SH, García-Donas J, Huddart RA, Burgess EF, et al. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Lancet Oncol. 2022;23(2):248–58.', 'ArticleIdList': [StringElement('35030333', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S1470-2045(21)00660-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Feng Y-H, Su W-C, Oh D-Y, Shen L, Kim K-P, Liu X, et al. Updated analysis with longer follow up of a phase 2a study evaluating erdafitinib in Asian patients (pts) with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor (FGFR) alterations. J Clin Oncol. 2022;40(4_suppl):430–430.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.4_suppl.430', attributes={'IdType': 'doi'})]}, {'Citation': 'Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21(5):671–84.', 'ArticleIdList': [StringElement('32203698', attributes={'IdType': 'pubmed'}), StringElement('8461541', attributes={'IdType': 'pmc'}), StringElement('10.1016/S1470-2045(20)30109-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Coombes RC, Badman PD, Lozano-Kuehne JP, Liu X, Macpherson IR, Zubairi I, et al. Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nat Commun. 2022;13(1):3246.', 'ArticleIdList': [StringElement('35688802', attributes={'IdType': 'pubmed'}), StringElement('9187670', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-022-30666-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Chae YK, Vaklavas C, Cheng HH, Hong F, Harris L, Mitchell EP, et al. Molecular analysis for therapy choice (MATCH) arm W: Phase II study of AZD4547 in patients with tumors with aberrations in the FGFR pathway. J Clin Oncol. 2018;36(15_suppl):2503–2503.', 'ArticleIdList': [StringElement('10.1200/JCO.2018.36.15_suppl.2503', attributes={'IdType': 'doi'})]}, {'Citation': 'Javle M, Roychowdhury S, Kelley RK, Sadeghi S, Macarulla T, Weiss KH, et al. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021;6(10):803–15.', 'ArticleIdList': [StringElement('34358484', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S2468-1253(21)00196-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Lassman AB, Sepúlveda-Sánchez JM, Cloughesy TF, Gil-Gil MJ, Puduvalli VK, Raizer JJ, et al. Infigratinib in patients with recurrent gliomas and FGFR alterations: a multicenter phase II study. Clin Cancer Res. 2022;28(11):2270–7.', 'ArticleIdList': [StringElement('35344029', attributes={'IdType': 'pubmed'}), StringElement('9167702', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-21-2664', attributes={'IdType': 'doi'})]}, {'Citation': 'Sternberg CN, Petrylak DP, Bellmunt J, Nishiyama H, Necchi A, Gurney H, et al. FORT-1: Phase II/III study of rogaratinib versus chemotherapy in patients with locally advanced or metastatic urothelial carcinoma selected based on FGFR1/3 mRNA expression. J Clin Oncol. 2023;41(3):629–39.', 'ArticleIdList': [StringElement('36240478', attributes={'IdType': 'pubmed'}), StringElement('10.1200/JCO.21.02303', attributes={'IdType': 'doi'})]}, {'Citation': 'Doi T, Shitara K, Kojima T, Kuboki Y, Matsubara N, Bando H, et al. Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors. Cancer Sci. 2023;114(2):574–85.', 'ArticleIdList': [StringElement('35838190', attributes={'IdType': 'pubmed'}), StringElement('10.1111/cas.15486', attributes={'IdType': 'doi'})]}, {'Citation': 'Cleary JM, Iyer G, Oh D-Y, Mellinghoff IK, Goyal L, Ng MCH, et al. Final results from the phase I study expansion cohort of the selective FGFR inhibitor Debio 1,347 in patients with solid tumors harboring an FGFR gene fusion. J Clin Oncol. 2020;38(15):3603–3603.', 'ArticleIdList': [StringElement('10.1200/JCO.2020.38.15_suppl.3603', attributes={'IdType': 'doi'})]}, {'Citation': 'Michael M, Bang Y-J, Park YS, Kang Y-K, Kim TM, Hamid O, et al. A Phase 1 study of LY2874455, an oral selective pan-FGFR inhibitor, in patients with advanced cancer. Target Oncol. 2017;12(4):463–74.', 'ArticleIdList': [StringElement('28589492', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s11523-017-0502-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Escudier B, Grünwald V, Ravaud A, Ou Y-C, Castellano D, Lin C-C, et al. Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer. Clin Cancer Res. 2014;20(11):3012–22.', 'ArticleIdList': [StringElement('24691021', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-13-3006', attributes={'IdType': 'doi'})]}, {'Citation': 'Heinrich MC, von Mehren M, Demetri GD, Fletcher JA, Sun JG, Kerstein D, et al. Ponatinib efficacy and safety in patients (pts) with advanced gastrointestinal stromal tumors (GIST) after tyrosine kinase inhibitor (TKI) failure: results from a phase 2 study. J Clin Oncol. 2015;33(15):10535–10535.', 'ArticleIdList': [StringElement('10.1200/jco.2015.33.15_suppl.10535', attributes={'IdType': 'doi'})]}, {'Citation': 'Reck M, Kaiser R, Mellemgaard A, Douillard J-Y, Orlov S, Krzakowski M, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol. 2014;15(2):143–55.', 'ArticleIdList': [StringElement('24411639', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S1470-2045(13)70586-2', attributes={'IdType': 'doi'})]}, {'Citation': 'Ellinghaus P, Neureiter D, Nogai H, Stintzing S, Ocker M. Patient selection approaches in FGFR inhibitor trials-many paths to the same end? Cells. 2022;11(19):3180.', 'ArticleIdList': [StringElement('36231142', attributes={'IdType': 'pubmed'}), StringElement('9563413', attributes={'IdType': 'pmc'}), StringElement('10.3390/cells11193180', attributes={'IdType': 'doi'})]}, {'Citation': 'Wainberg ZA, Enzinger PC, Kang Y-K, Qin S, Yamaguchi K, Kim I-H, et al. Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncol. 2022;23(11):1430–40.', 'ArticleIdList': [StringElement('36244398', attributes={'IdType': 'pubmed'}), StringElement('10.1016/S1470-2045(22)00603-9', attributes={'IdType': 'doi'})]}, {'Citation': 'Siefker-Radtke AO, Lugowska I, Tupikowski K, Andric ZG, Rezazadeh Kalebasty A, Curigliano G, et al. 917P - Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22. Ann Oncol. 2019;30: v365.', 'ArticleIdList': [StringElement('10.1093/annonc/mdz249.016', attributes={'IdType': 'doi'})]}, {'Citation': 'Kim SB, Meric-Bernstam F, Kalyan A, Babich A, Liu R, Tanigawa T, et al. First-in-human phase I study of aprutumab ixadotin, a fibroblast growth factor receptor 2 antibody-drug conjugate (BAY 1187982) in patients with advanced cancer. Target Oncol. 2019;14(5):591–601.', 'ArticleIdList': [StringElement('31502117', attributes={'IdType': 'pubmed'}), StringElement('6797631', attributes={'IdType': 'pmc'}), StringElement('10.1007/s11523-019-00670-4', attributes={'IdType': 'doi'})]}, {'Citation': 'Kollmannsberger C, Britten CD, Olszanski AJ, Walker JA, Zang W, Willard MD, et al. A phase 1 study of LY3076226, a fibroblast growth factor receptor 3 (FGFR3) antibody-drug conjugate, in patients with advanced or metastatic cancer. Invest New Drugs. 2021;39(6):1613–23.', 'ArticleIdList': [StringElement('34264412', attributes={'IdType': 'pubmed'}), StringElement('10.1007/s10637-021-01146-x', attributes={'IdType': 'doi'})]}, {'Citation': 'McCarthy JB, El-Ashry D, Turley EA. Hyaluronan, cancer-associated fibroblasts and the tumor microenvironment in malignant progression. Front Cell Dev Biol. 2018;6:48.', 'ArticleIdList': [StringElement('29868579', attributes={'IdType': 'pubmed'}), StringElement('5951929', attributes={'IdType': 'pmc'}), StringElement('10.3389/fcell.2018.00048', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhang Z, Tao D, Zhang P, Liu X, Zhang Y, Cheng J, et al. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion. J Exp Clin Cancer Res. 2016;35(1):181.', 'ArticleIdList': [StringElement('27884164', attributes={'IdType': 'pubmed'}), StringElement('5123319', attributes={'IdType': 'pmc'}), StringElement('10.1186/s13046-016-0458-0', attributes={'IdType': 'doi'})]}, {'Citation': 'Provenzano PP, Hingorani SR. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer. 2013;108(1):1–8.', 'ArticleIdList': [StringElement('23299539', attributes={'IdType': 'pubmed'}), StringElement('3553539', attributes={'IdType': 'pmc'}), StringElement('10.1038/bjc.2012.569', attributes={'IdType': 'doi'})]}, {'Citation': 'Thompson CB, Shepard HM, O’Connor PM, Kadhim S, Jiang P, Osgood RJ, et al. Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models. Mol Cancer Ther. 2010;9(11):3052–64.', 'ArticleIdList': [StringElement('20978165', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1535-7163.MCT-10-0470', attributes={'IdType': 'doi'})]}, {'Citation': 'Ramanathan RK, McDonough SL, Philip PA, Hingorani SR, Lacy J, Kortmansky JS, et al. Phase IB/II randomized study of FOLFIRINOX plus pegylated recombinant human hyaluronidase versus FOLFIRINOX alone in patients with metastatic pancreatic adenocarcinoma: SWOG S1313. J Clin Oncol. 2019;37(13):1062–9.', 'ArticleIdList': [StringElement('30817250', attributes={'IdType': 'pubmed'}), StringElement('6494359', attributes={'IdType': 'pmc'}), StringElement('10.1200/JCO.18.01295', attributes={'IdType': 'doi'})]}, {'Citation': 'Van Cutsem E, Tempero MA, Sigal D, Oh DY, Fazio N, Macarulla T, et al. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J Clin Oncol. 2020;38(27):3185–94.', 'ArticleIdList': [StringElement('32706635', attributes={'IdType': 'pubmed'}), StringElement('7499614', attributes={'IdType': 'pmc'}), StringElement('10.1200/JCO.20.00590', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhen DB, Whittle M, Ritch PS, Hochster HS, Coveler AL, George B, et al. Phase II study of PEGPH20 plus pembrolizumab for patients (pts) with hyaluronan (HA)-high refractory metastatic pancreatic adenocarcinoma (mPC): PCRT16–001. J Clin Oncol. 2022;40(4_suppl):576–576.', 'ArticleIdList': [StringElement('10.1200/JCO.2022.40.4_suppl.576', attributes={'IdType': 'doi'})]}, {'Citation': 'Ko AH, Kim KP, Siveke JT, Lopez CD, Lacy J, O’Reilly EM, et al. Atezolizumab plus PEGPH20 versus chemotherapy in advanced pancreatic ductal adenocarcinoma and gastric cancer: MORPHEUS Phase Ib/II umbrella randomized study platform. Oncologist. 2023;28(6):553-e472.', 'ArticleIdList': [StringElement('36940261', attributes={'IdType': 'pubmed'}), StringElement('10243783', attributes={'IdType': 'pmc'}), StringElement('10.1093/oncolo/oyad022', attributes={'IdType': 'doi'})]}, {'Citation': 'Garcia-Carbonero R, Bazan-Peregrino M, Gil-Martín M, Álvarez R, Macarulla T, Riesco-Martinez MC, et al. Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors. J Immunother Cancer. 2022;10(3): e003255.', 'ArticleIdList': [StringElement('35338084', attributes={'IdType': 'pubmed'}), StringElement('8961117', attributes={'IdType': 'pmc'}), StringElement('10.1136/jitc-2021-003255', attributes={'IdType': 'doi'})]}, {'Citation': 'Chronopoulos A, Robinson B, Sarper M, Cortes E, Auernheimer V, Lachowski D, et al. ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion. Nat Commun. 2016;7:12630.', 'ArticleIdList': [StringElement('27600527', attributes={'IdType': 'pubmed'}), StringElement('5023948', attributes={'IdType': 'pmc'}), StringElement('10.1038/ncomms12630', attributes={'IdType': 'doi'})]}, {'Citation': 'Carapuça EF, Gemenetzidis E, Feig C, Bapiro TE, Williams MD, Wilson AS, et al. Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma. J Pathol. 2016;239(3):286–96.', 'ArticleIdList': [StringElement('27061193', attributes={'IdType': 'pubmed'}), StringElement('5025731', attributes={'IdType': 'pmc'}), StringElement('10.1002/path.4727', attributes={'IdType': 'doi'})]}, {'Citation': 'Kocher HM, Basu B, Froeling FEM, Sarker D, Slater S, Carlin D, et al. Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer. Nat Commun. 2020;11(1):4841.', 'ArticleIdList': [StringElement('32973176', attributes={'IdType': 'pubmed'}), StringElement('7518421', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41467-020-18636-w', attributes={'IdType': 'doi'})]}, {'Citation': 'Tobin RP, Cogswell DT, Cates VM, Davis DM, Borgers JSW, Van Gulick RJ, et al. Targeting MDSC differentiation using ATRA: a phase I/II clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma. Clin Cancer Res. 2023;29(7):1209–19.', 'ArticleIdList': [StringElement('36378549', attributes={'IdType': 'pubmed'}), StringElement('10073240', attributes={'IdType': 'pmc'}), StringElement('10.1158/1078-0432.CCR-22-2495', attributes={'IdType': 'doi'})]}, {'Citation': 'Zhao ZX, Zhang YQ, Sun H, Chen ZQ, Chang JJ, Wang X, et al. Calcipotriol abrogates cancer-associated fibroblast-derived IL-8-mediated oxaliplatin resistance in gastric cancer cells via blocking PI3K/Akt signaling. Acta Pharmacol Sin. 2023;44(1):178–88.', 'ArticleIdList': [StringElement('35676532', attributes={'IdType': 'pubmed'}), StringElement('10.1038/s41401-022-00927-1', attributes={'IdType': 'doi'})]}, {'Citation': 'Gorchs L, Ahmed S, Mayer C, Knauf A, Fernández Moro C, Svensson M, et al. The vitamin D analogue calcipotriol promotes an anti-tumorigenic phenotype of human pancreatic CAFs but reduces T cell mediated immunity. Sci Rep. 2020;10(1):17444.', 'ArticleIdList': [StringElement('33060625', attributes={'IdType': 'pubmed'}), StringElement('7562723', attributes={'IdType': 'pmc'}), StringElement('10.1038/s41598-020-74368-3', attributes={'IdType': 'doi'})]}, {'Citation': 'Akiba T, Morikawa T, Odaka M, Nakada T, Kamiya N, Yamashita M, et al. Vitamin D supplementation and survival of patients with non–small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Clin Cancer Res. 2018;24(17):4089–97.', 'ArticleIdList': [StringElement('30018118', attributes={'IdType': 'pubmed'}), StringElement('10.1158/1078-0432.CCR-18-0483', attributes={'IdType': 'doi'})]}, {'Citation': 'Evans TRJ, Colston KW, Lofts FJ, Cunningham D, Anthoney DA, Gogas H, et al. A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br J Cancer. 2002;86(5):680–5.', 'ArticleIdList': [StringElement('11875725', attributes={'IdType': 'pubmed'}), StringElement('2375305', attributes={'IdType': 'pmc'}), StringElement('10.1038/sj.bjc.6600162', attributes={'IdType': 'doi'})]}, {'Citation': 'Ng K, Nimeiri HS, McCleary NJ, Abrams TA, Yurgelun MB, Cleary JM, et al. Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: the SUNSHINE randomized clinical trial. JAMA. 2019;321(14):1370–9.', 'ArticleIdList': [StringElement('30964527', attributes={'IdType': 'pubmed'}), StringElement('6459117', attributes={'IdType': 'pmc'}), StringElement('10.1001/jama.2019.2402', attributes={'IdType': 'doi'})]}, {'Citation': 'Dauer P, Zhao X, Gupta VK, Sharma N, Kesh K, Gnamlin P, et al. Inactivation of cancer-associated-fibroblasts disrupts oncogenic signaling in pancreatic cancer cells and promotes its regression. Cancer Res. 2018;78(5):1321–33.', 'ArticleIdList': [StringElement('29259015', attributes={'IdType': 'pubmed'}), StringElement('10.1158/0008-5472.CAN-17-2320', attributes={'IdType': 'doi'})]}, {'Citation': 'Banerjee S, Saluja A. Minnelide, a novel drug for pancreatic and liver cancer. Pancreatology. 2015;15(4 Suppl):S39-43.', 'ArticleIdList': [StringElement('26122306', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.pan.2015.05.472', attributes={'IdType': 'doi'})]}, {'Citation': 'Modi S, Giri B, Gupta VK, Lavania S, Sethi V, Sharma NS, et al. Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Cancer Lett. 2022;537: 215591.', 'ArticleIdList': [StringElement('35398530', attributes={'IdType': 'pubmed'}), StringElement('10.1016/j.canlet.2022.215591', attributes={'IdType': 'doi'})]}, {'Citation': 'Chauhan VP, Chen IX, Tong R, Ng MR, Martin JD, Naxerova K, et al. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy. Proc Natl Acad Sci USA. 2019;116(22):10674–80.', 'ArticleIdList': [StringElement('31040208', attributes={'IdType': 'pubmed'}), StringElement('6561160', attributes={'IdType': 'pmc'}), StringElement('10.1073/pnas.1819889116', attributes={'IdType': 'doi'})]}, {'Citation': 'Tranel J, Palm S, Graves SA, Feng FY, Hope TA. Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model. EJNMMI Phys. 2022;9(1):67.', 'ArticleIdList': [StringElement('36178531', attributes={'IdType': 'pubmed'}), StringElement('9525486', attributes={'IdType': 'pmc'}), StringElement('10.1186/s40658-022-00497-5', attributes={'IdType': 'doi'})]}, {'Citation': 'Mediavilla-Varela M, Boateng K, Noyes D, Antonia SJ. The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts. BMC Cancer. 2016;16:176.', 'ArticleIdList': [StringElement('26935219', attributes={'IdType': 'pubmed'}), StringElement('4776434', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12885-016-2162-z', attributes={'IdType': 'doi'})]}, {'Citation': 'Hauge A, Rofstad EK. Antifibrotic therapy to normalize the tumor microenvironment. J Transl Med. 2020;18(1):207.', 'ArticleIdList': [StringElement('32434573', attributes={'IdType': 'pubmed'}), StringElement('7240990', attributes={'IdType': 'pmc'}), StringElement('10.1186/s12967-020-02376-y', attributes={'IdType': 'doi'})]}]}], 'History': [DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '21'}, attributes={'PubStatus': 'medline'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '9', 'Hour': '0', 'Minute': '21'}, attributes={'PubStatus': 'pubmed'}), DictElement({'Year': '2024', 'Month': '4', 'Day': '5'}, attributes={'PubStatus': 'received'}), DictElement({'Year': '2024', 'Month': '11', 'Day': '9'}, attributes={'PubStatus': 'accepted'}), DictElement({'Year': '2025', 'Month': '1', 'Day': '8', 'Hour': '23', 'Minute': '59'}, attributes={'PubStatus': 'entrez'})], 'PublicationStatus': 'epublish', 'ArticleIdList': [StringElement('39780187', attributes={'IdType': 'pubmed'}), StringElement('10.1186/s12929-024-01099-2', attributes={'IdType': 'doi'}), StringElement('10.1186/s12929-024-01099-2', attributes={'IdType': 'pii'})]}}]\n"
     ]
    }
   ],
   "source": [
    "# Adding query to get the filtered papers\n",
    "query = \"cancer\"\n",
    "papers = fetch_papers(query, max_results=10)\n",
    "print(papers)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "256e6ee1-2cd9-4d03-b17e-28a9b2a23210",
   "metadata": {},
   "outputs": [],
   "source": [
    "def filter_non_academic_authors(paper: dict) -> dict:\n",
    "    non_academic_authors = []\n",
    "    company_affiliations = []\n",
    "\n",
    "    # Extract authors and affiliations\n",
    "    authors = paper.get(\"MedlineCitation\", {}).get(\"Article\", {}).get(\"AuthorList\", [])\n",
    "    for author in authors:\n",
    "        affiliations = author.get(\"AffiliationInfo\", [])\n",
    "        for aff in affiliations:\n",
    "            affiliation = aff.get(\"Affiliation\", \"\").lower()\n",
    "            if \"pharma\" in affiliation or \"biotech\" in affiliation:\n",
    "                non_academic_authors.append(author.get(\"LastName\", \"\") + \" \" + author.get(\"ForeName\", \"\"))\n",
    "                company_affiliations.append(affiliation)\n",
    "\n",
    "    return {\n",
    "        \"non_academic_authors\": non_academic_authors,\n",
    "        \"company_affiliations\": company_affiliations,\n",
    "    }"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "89699cc7-b4c0-46e1-ad78-736192eb2d15",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': ['Xia Yuqing'], 'company_affiliations': ['pharmaceutical sciences, massachusetts college of pharmacy and health science university, 179 longwood avenue, boston, massachusetts, 02115, usa.']}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n",
      "{'non_academic_authors': [], 'company_affiliations': []}\n"
     ]
    }
   ],
   "source": [
    "# Iterating through each paper\n",
    "for paper in papers:\n",
    "    filtered = filter_non_academic_authors(paper)\n",
    "    print(filtered)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "d2e8955a-9651-409d-8d77-2dc3c8fed088",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_csv(papers: list, filename: str = None) -> None:\n",
    "\n",
    "    # Initialising data as list\n",
    "    data = []\n",
    "\n",
    "    # Iterating through each paper and  storing filtered paper data in list\n",
    "    for paper in papers:\n",
    "        filtered = filter_non_academic_authors(paper)\n",
    "        if filtered[\"non_academic_authors\"]:\n",
    "            data.append({\n",
    "                \"PubmedID\": paper.get(\"MedlineCitation\", {}).get(\"PMID\", \"\"),\n",
    "                \"Title\": paper.get(\"MedlineCitation\", {}).get(\"Article\", {}).get(\"ArticleTitle\", \"\"),\n",
    "                \"Publication Date\": paper.get(\"MedlineCitation\", {}).get(\"Article\", {}).get(\"Journal\", {}).get(\"JournalIssue\", {}).get(\"PubDate\", {}).get(\"Year\", \"\"),\n",
    "                \"Non-academic Author(s)\": \", \".join(filtered[\"non_academic_authors\"]),\n",
    "                \"Company Affiliation(s)\": \", \".join(filtered[\"company_affiliations\"]),\n",
    "                \"Corresponding Author Email\": \"\"\n",
    "            })\n",
    "\n",
    "    df = pd.DataFrame(data)\n",
    "    if filename:\n",
    "        df.to_csv(filename, index=False)\n",
    "    else:\n",
    "        print(df.to_string(index=False))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "d4f22132-4601-4bd2-b771-b2c597424046",
   "metadata": {},
   "outputs": [],
   "source": [
    "generate_csv(papers, filename=f\"pubmed_data_{datetime.now().strftime('%Y%m%d_%H%M%S')}.csv\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
